Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3007080	s-ebvabg	u/ml (u/ml)	5532	6634	0.00%
3007080	s-ebvabg	— (—)	3571	4579	100.00%	Distribution not available
3007080	s-ebvnabg	u/ml (u/ml)	169	186	3.23%
3007080	s-ebvnabg	— (—)	103	105	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Certain infectious and parasitic diseases

2100

3911

2.74

320.64

1.4

1.2

268.33

249.14

u/ml

1.96

1391

2428

Enlarged lymph nodes

544

891

6.51

319.61

1.3

1.2

276.99

251.71

u/ml

0.82

321

543

Other disorders of kidney and ureter

475

679

7.62

319.33

1.9

1.2

266.07

283.62

u/ml

0.56

361

405

Cytomegalovirus infection, IBD co-morbidity

254

154

24.03

318.42

1.6

1.4

274.09

238.33

u/ml

0.61

180

Used for control exclusion in common control thyroid runs

2379

4836

2.54

316.28

1.3

277.30

244.06

u/ml

5.36

1481

3138

Cytomegaloviral disease

255

159

22.89

314.61

1.6

1.4

273.85

254.75

u/ml

0.26

181

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

423

549

8.28

308.50

1.3

1.2

294.67

285.28

u/ml

0.18

261

335

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2420

5120

3.31

307.65

1.7

1.2

281.49

252.29

u/ml

4.45

1701

3127

Extracorporeal dialysis

770

356

32.80

307.65

2.0

1.3

278.12

268.96

u/ml

0.18

594

209

Implicit bacterial Sepsis

866

1655

4.98

307.65

1.4

1.2

290.73

272.10

u/ml

0.92

582

1010

Autoimmune diseases

2484

5093

2.54

307.65

1.3

276.51

244.69

u/ml

5.18

1546

3306

Care involving dialysis

1085

403

41.12

307.65

2.0

1.2

267.48

257.99

u/ml

0.24

836

236

Other dialysis

434

216

33.44

307.65

2.0

1.4

254.86

259.11

u/ml

0.06

345

123

Preparatory care for dialysis

528

227

35.48

307.65

1.7

1.2

268.80

279.71

u/ml

0.17

402

138

Chronic kidney disease

1479

1183

13.89

307.65

1.9

1.2

265.85

277.53

u/ml

0.55

1094

704

Persons encountering health services for specific procedures and health care

2728

5533

3.14

307.65

1.6

1.2

271.78

253.38

u/ml

2.27

1931

3348

Diseases of liver

1136

2072

5.83

307.65

1.3

303.48

271.50

u/ml

2.43

696

1336

Explicit Sepsis

1081

2373

4.55

307.65

1.6

1.3

282.45

263.22

u/ml

1.20

722

1447

Autoimmune diseases related-to ILD

1951

6082

2.89

307.65

1.3

287.09

253.21

u/ml

4.53

1222

3978

ILD medications: immunosuppressive drugs

2657

3719

7.33

307.65

1.6

1.2

284.35

242.76

u/ml

8.11

1828

2326

Heart failure, not strict

1879

2963

4.54

307.65

1.6

1.2

289.61

266.50

u/ml

2.21

1362

1792

Transplanted organ and tissue status

1591

583

45.71

307.65

2.0

1.2

279.69

246.48

u/ml

1.73

1217

321

Primary_lymphoid and hematopoietic malignant neoplasms

941

1187

8.62

307.65

1.3

267.19

278.00

u/ml

0.38

560

733

Any gastric operation

2243

2767

4.18

307.65

1.4

1.2

255.26

234.38

u/ml

2.24

1425

1728

Bacterial Sepsis

990

2041

4.47

307.65

1.4

1.2

285.67

269.46

u/ml

0.84

650

1243

Renal failure

1724

1800

9.46

307.65

1.8

1.2

268.22

276.75

u/ml

0.44

1259

1058

Inflammatory bowel disease treatment related agents

2844

5446

3.04

307.65

1.4

1.3

289.21

244.31

u/ml

9.90

1808

3541

GASTRO-related operations

2243

2767

4.18

307.65

1.4

1.2

255.26

234.38

u/ml

2.24

1425

1728

Septicaemia

1034

2035

5.10

307.65

1.6

1.3

286.63

261.41

u/ml

1.67

688

1218

Dialysis

577

255

36.39

307.65

2.2

1.3

255.13

255.62

u/ml

0.01

448

144

Second line medication for Crohn's disease

1484

4501

3.42

307.65

1.5

1.3

292.62

260.46

u/ml

2.94

897

2932

ILD medications

3400

4580

4.22

307.65

1.5

1.2

279.33

238.15

u/ml

9.91

2264

2868

ILD medications: azathioprine

707

927

8.37

307.65

1.8

1.2

314.50

233.95

u/ml

6.10

447

561

Glomerular diseases

912

1128

9.03

307.65

1.9

1.2

263.91

267.70

u/ml

0.12

670

689

Dental caries

1106

1828

6.46

307.65

1.8

1.2

282.64

264.30

u/ml

0.97

790

1090

Dentinal caries

939

1586

6.34

307.65

1.7

1.2

285.54

263.06

u/ml

1.17

670

946

ILD medications: prednisolone, methylprednisolone, prednisone

3131

4360

4.20

307.65

1.5

1.2

286.23

241.49

u/ml

10.71

2121

2750

Deposits [accretions] on teeth

462

536

9.70

307.65

2.4

1.2

251.45

227.65

u/ml

0.69

322

256

Other septicaemia

945

1795

5.40

307.65

1.6

1.3

289.54

261.98

u/ml

1.77

635

1069

Renal tubulo-interstitial diseases

2223

4839

3.64

307.65

1.6

1.2

269.48

263.48

u/ml

0.40

1557

2972

Inflammatory bowel disease, strict (require KELA)

869

2037

4.54

307.65

1.3

279.07

252.87

u/ml

1.49

514

1308

Fever of other and unknown origin

2051

3182

6.32

307.65

1.4

1.3

274.27

252.77

u/ml

2.01

1314

1991

Anaemias

938

1053

6.27

307.65

1.6

1.2

276.71

238.51

u/ml

2.33

629

655

Inflammatory bowel disease

1024

2670

4.03

307.65

1.3

279.98

256.95

u/ml

1.36

610

1741

Autoimmune diseases excluding thyroid diseases

2519

5026

2.85

307.65

1.3

275.76

245.46

u/ml

4.86

1593

3271

Noninfective enteritis and colitis

1290

3868

3.46

307.65

1.3

273.01

256.35

u/ml

1.03

774

2477

Autoimmune diseases excluding thyroid diseases, strict definition

2475

4924

2.87

307.65

1.3

276.06

245.14

u/ml

4.97

1570

3209

IBD patients in KELA-register

869

1991

4.65

307.65

1.3

279.07

253.05

u/ml

1.47

514

1277

First line medication for Crohn's disease

3190

4560

3.94

307.65

1.5

1.2

278.18

237.89

u/ml

9.13

2120

2856

L04AX Other immunosuppressants

1374

4371

3.25

307.65

1.5

1.3

298.50

259.86

u/ml

3.64

819

2834

Chronic periodontitis

570

718

8.63

307.65

1.5

1.1

300.07

285.58

u/ml

0.41

409

448

L04AA Selective immunosuppressants

1374

1512

10.44

307.65

1.8

1.2

286.88

260.43

u/ml

1.98

1057

898

Acute renal failure

616

833

7.89

307.65

1.6

1.1

278.61

290.65

u/ml

0.36

447

493

Glomerular disorders in diseases classified elsewhere

688

661

12.05

307.65

1.8

1.2

261.92

270.81

u/ml

0.26

508

408

Disorders resulting from impaired renal tubular function

361

217

23.02

307.65

2.0

1.3

274.91

271.46

u/ml

0.05

279

128

Implicit Sepsis

1482

3710

3.19

307.65

1.4

1.2

279.75

263.26

u/ml

1.24

1009

2317

Azathioprine

707

1072

7.22

307.65

1.8

1.3

314.50

239.19

u/ml

5.45

447

658

Kidney transplant status

973

377

51.06

307.65

2.1

1.3

259.04

257.63

u/ml

0.03

777

207

Aplastic and other anaemias

943

2265

4.08

307.65

1.5

1.2

281.94

279.85

u/ml

0.06

615

1401

Primary_lymphoid and hematopoietic malignant neoplasms

941

1214

8.43

307.65

1.3

267.19

274.54

u/ml

0.24

560

742

Oral corticosteroids

2284

5048

2.80

307.65

1.3

295.44

249.62

u/ml

8.53

1446

3301

General symptoms and signs

2661

4294

3.18

307.65

1.3

278.33

247.97

u/ml

4.71

1749

2749

Dialysis, with operation codes

1451

663

30.15

307.65

1.9

1.2

276.30

267.21

u/ml

0.30

1131

386

Nephropathy related operations

1457

689

29.80

307.65

1.9

1.2

275.59

259.00

u/ml

0.68

1136

394

Chronic periapical parodontitis

642

1178

5.77

307.65

1.5

1.2

289.65

280.43

u/ml

0.28

452

734

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2444

5175

3.49

307.65

1.4

1.3

271.55

263.89

u/ml

0.55

1619

3270

Bacterial infection, other or unspecified

1423

2493

5.38

307.65

1.4

1.2

283.93

269.92

u/ml

0.77

944

1542

Secondary hypertension

591

388

17.93

307.65

2.0

1.2

272.04

261.61

u/ml

0.25

455

225

L04AD Calcineurin inhibitors

1453

764

28.36

307.65

1.9

1.2

287.59

243.49

u/ml

3.23

1157

427

Other bacterial diseases

2245

4715

3.39

307.65

1.5

1.3

283.29

260.52

u/ml

2.56

1489

2971

Other/unspecified cytomegaloviral diseases

232

129

27.43

304.28

1.6

1.4

267.32

250.89

u/ml

0.19

170

5-aminosalicylic acid

703

1556

4.77

294.75

1.3

278.64

244.15

u/ml

1.99

414

999

Hypertensive diseases (excluding secondary)

1300

2322

3.35

288.35

1.7

1.2

261.14

256.62

u/ml

0.20

917

1480

Failure and rejection of transplanted organs and tissues

207

105

34.85

286.33

2.0

1.4

277.74

267.12

u/ml

0.10

155

Cystic kidney disease

272

229

15.11

280.10

1.9

1.3

275.52

239.45

u/ml

0.74

217

129

Condition for Implicit Sepsis (Organ dysfunction codes)

1637

4432

2.74

279.45

1.4

1.3

280.66

261.52

u/ml

1.74

1123

2772

Diseases of pulp and periapical tissues

858

2303

3.86

276.21

1.4

1.2

279.81

270.40

u/ml

0.40

604

1460

Viral Sepsis

550

1048

5.54

274.98

1.7

1.3

292.20

258.52

u/ml

1.68

411

622

Infections, IBD-co-morbidities

558

706

6.06

271.45

1.5

1.3

281.93

252.25

u/ml

1.18

375

470

Implicit viral Sepsis

546

1047

5.50

271.04

1.7

1.3

292.59

258.80

u/ml

1.68

408

621

Donors of organs and tissues

186

35.85

270.42

1.8

1.2

212.64

231.76

u/ml

0.26

117

Malaise and fatigue

934

2179

3.66

267.34

1.2

1.3

290.15

261.58

u/ml

1.80

634

1349

Direct fill therapy

567

1163

5.30

263.08

1.8

1.3

293.63

242.77

u/ml

2.94

412

674

Any reimbursement code in KELA

1452

2489

2.99

257.09

1.4

1.2

266.20

226.18

u/ml

4.98

903

1604

Other viral diseases

962

2947

3.41

253.36

1.6

1.3

243.38

252.79

u/ml

0.44

631

1819

Diabetic nephropathy

479

857

5.93

252.98

1.7

1.2

279.64

298.13

u/ml

0.60

345

541

Other diseases of blood and blood-forming organs, wide

614

1386

4.67

251.24

1.4

1.3

265.65

273.25

u/ml

0.25

409

839

Unspecified kidney failure

300

328

9.83

251.14

1.8

1.1

262.09

285.53

u/ml

0.48

232

179

Diabetic nephropathy, excluding more controls

474

674

6.31

250.34

1.7

1.2

281.91

293.10

u/ml

0.30

340

420

Heart failure and antihypertensive medication

611

799

5.25

248.79

1.5

1.2

296.15

251.67

u/ml

2.58

448

491

Hypertension

1608

3438

2.70

248.69

1.6

1.2

267.83

269.17

u/ml

0.06

1113

2217

Hypertensive diseases

1609

3443

2.70

248.58

1.6

1.2

267.63

269.15

u/ml

0.07

1114

2219

Gastrointestinal diseases

1386

2365

3.00

246.93

1.4

1.2

254.38

235.36

u/ml

1.40

870

1502

Budesonide

458

817

5.98

246.76

1.2

286.81

240.10

u/ml

2.10

289

518

Glomerulonephritis

409

667

6.71

243.15

2.1

1.3

267.44

262.45

u/ml

0.11

307

405

Ulcerative colitis

744

1996

3.91

240.99

1.3

274.53

260.92

u/ml

0.51

439

1277

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1743

4492

2.48

234.59

1.4

1.2

292.48

251.49

u/ml

5.86

1104

2883

1743

4492

2.48

234.59

1.4

1.2

292.48

251.49

u/ml

5.86

1104

2883

Other and unspecified anaemias

761

2048

3.70

229.79

1.5

1.2

291.42

281.24

u/ml

0.33

482

1258

Other anaemias

764

2071

3.66

227.14

1.5

1.2

291.35

282.27

u/ml

0.29

484

1275

Other diseases of liver

506

1063

5.03

226.36

1.3

1.2

304.29

272.86

u/ml

1.39

313

681

Non-follicular lymphoma, hilmo, excluding all cancers

300

385

8.41

221.26

1.3

288.95

278.43

u/ml

0.17

182

236

Congenital malformations of the urinary system

348

537

7.47

221.07

1.9

1.4

263.16

225.74

u/ml

1.32

265

305

Myeloid leukaemia

183

119

18.94

217.16

1.4

1.3

253.25

237.74

u/ml

0.20

116

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

412

761

5.76

213.76

1.3

339.30

280.97

u/ml

2.40

262

466

Influenza and pneumonia

2084

6396

2.18

212.75

1.4

1.3

284.45

250.69

u/ml

5.24

1358

4075

Chronic periodontitis, complicated

335

511

7.13

212.19

1.6

1.2

287.71

277.99

u/ml

0.19

242

323

Other disorders involving the immune mechanism, not elsewhere classified

235

247

11.73

207.74

1.8

1.4

242.00

250.62

u/ml

0.13

180

143

Fibrosis and cirrhosis of liver

265

319

9.09

206.65

1.4

1.2

348.01

261.58

u/ml

2.51

157

190

Myeloid leukaemia

183

134

16.79

203.66

1.4

1.3

253.25

248.28

u/ml

0.05

116

Crohn disease

481

1074

4.79

200.75

1.2

1.3

307.43

247.80

u/ml

2.83

281

690

Non-follicular lymphoma

300

431

7.50

200.46

1.3

1.2

288.95

270.70

u/ml

0.33

182

260

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

224

236

11.78

197.91

1.8

1.4

243.63

242.51

u/ml

0.01

174

135

Cardiovascular diseases (excluding rheumatic etc)

1565

3793

2.43

197.88

1.6

1.2

258.78

239.80

u/ml

1.65

1082

2364

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

588

1549

4.01

196.18

1.3

270.65

257.41

u/ml

0.43

342

1006

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

169

115

16.71

193.69

1.3

276.37

245.27

u/ml

0.43

107

Anaemia in chronic diseases classified elsewhere

165

110

18.43

193.22

1.9

1.3

249.45

291.38

u/ml

0.45

115

Ulcerative colitis (strict definition, require KELA)

561

1451

4.09

192.26

1.3

271.79

256.06

u/ml

0.52

322

939

Acute peritonitis

259

335

8.52

190.71

1.8

1.2

256.76

278.29

u/ml

0.43

199

200

Pneumonias (Asthma/COPD co-morbidities)

1888

6167

2.16

190.30

1.4

1.3

289.61

251.64

u/ml

5.83

1227

3922

Other inflammatory liver diseases

263

348

8.31

189.81

1.2

307.24

242.15

u/ml

2.04

161

214

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

547

1405

4.12

189.37

1.3

270.22

257.14

u/ml

0.40

316

904

Heart failure,strict

780

1718

3.35

187.48

1.4

1.2

298.10

268.33

u/ml

1.82

533

1011

Intestinal infectious diseases

1819

6688

2.15

187.32

1.5

1.3

259.37

257.36

u/ml

0.10

1208

4243

Hypertension, essential

1375

3172

2.52

186.67

1.4

1.2

280.04

273.33

u/ml

0.31

920

2071

Other heart diseases

1079

2608

2.80

186.32

1.5

1.2

281.50

249.78

u/ml

2.73

764

1599

Cardiovascular diseases

1565

3659

2.38

185.45

1.6

1.2

242.83

234.99

u/ml

0.50

1068

2240

Examination and observation for other reasons

1176

2717

2.68

184.08

1.3

1.2

276.78

253.80

u/ml

1.67

820

1751

All pneumoniae

1908

6320

2.12

183.63

1.4

1.3

288.23

252.30

u/ml

5.42

1243

4028

Certain disorders involving the immune mechanism

525

1339

4.12

182.95

1.5

1.3

251.27

267.27

u/ml

0.60

372

815

IgA nephropathy (IgA glomerulonephritis)

183

172

13.23

175.07

1.8

1.2

260.51

260.82

u/ml

0.00

143

105

Mucosal proctocolitis

445

1046

4.53

173.84

1.2

1.3

271.11

255.58

u/ml

0.45

272

680

Pneumonia, organism unspecified

1638

5504

2.19

173.11

1.4

1.3

290.38

255.29

u/ml

4.45

1055

3497

Hyperparathyroidism

382

797

4.93

168.50

1.7

1.2

287.43

295.43

u/ml

0.18

274

477

COPD/asthma/ILD related infections

1881

4506

2.12

167.67

1.3

1.2

279.88

251.23

u/ml

3.29

1194

2889

COPD/asthma related infections

1881

4506

2.12

167.67

1.3

1.2

279.88

251.23

u/ml

3.29

1194

2889

Secondary and unspecified malignant neoplasm of lymph nodes

272

434

6.76

164.77

1.3

284.74

261.69

u/ml

0.51

167

264

Agranulocytosis

336

655

5.47

164.56

1.4

1.2

256.33

266.92

u/ml

0.25

223

384

Hepatic failure, not elsewhere classified

174

163

12.17

164.51

1.3

1.2

283.96

235.71

u/ml

0.85

121

Chronic nephritic syndrome

204

238

9.77

164.48

1.9

1.2

266.59

268.69

u/ml

0.03

160

143

Metabolic disorders

1607

4668

2.17

161.00

1.5

1.3

285.05

267.59

u/ml

1.31

1094

2994

Cirrhosis of liver, NAS

197

226

9.70

160.17

1.4

1.2

342.71

276.46

u/ml

1.30

121

131

Gout, FINNGEN

480

1256

3.93

160.11

1.5

1.2

280.87

283.74

u/ml

0.07

332

783

Disorders of parathyroid gland

409

940

4.45

159.64

1.7

1.2

287.94

291.88

u/ml

0.09

293

552

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1786

6205

2.05

159.52

1.4

1.3

289.29

254.68

u/ml

4.75

1157

3963

Other diseases of hard tissues of teeth

1191

3742

2.42

159.49

1.7

1.2

268.36

258.59

u/ml

0.51

798

2336

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

798

1269

3.21

159.44

1.3

249.68

223.55

u/ml

1.58

503

809

Headache

1119

3883

2.45

158.68

1.3

264.67

247.44

u/ml

1.11

727

2482

Abnormal findings on examination of blood, without diagnosis

839

2884

2.79

157.42

1.3

289.63

271.53

u/ml

0.87

525

1818

Acute upper respiratory infections of multiple and unspecified sites

1467

5096

2.19

157.33

1.4

1.3

267.38

254.95

u/ml

0.84

962

3277

Bronchitis

1908

6341

2.00

156.63

1.4

1.2

271.12

256.69

u/ml

1.24

1267

4024

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2003

5868

1.97

152.89

1.4

1.3

270.36

252.82

u/ml

1.75

1341

3688

Gout

480

1164

3.87

152.38

1.5

1.2

280.87

287.07

u/ml

0.17

332

735

Medical observation and evaluation for suspected diseases and conditions

1268

2744

2.40

151.95

1.3

1.2

271.94

253.14

u/ml

1.23

801

1766

Lung transplant status

115

31.91

151.95

1.2

1.5

412.87

214.71

u/ml

4.14

Lung transplantation

115

31.81

151.90

1.2

1.5

412.88

214.71

u/ml

4.14

Ulcerative colitis, NAS

433

1103

4.14

151.57

1.3

286.08

252.14

u/ml

1.21

250

703

Covid-19 confirmed case

640

2108

3.14

149.45

1.5

1.3

253.38

261.61

u/ml

0.26

441

1317

Coagulation defects, purpura and other haemorrhagic conditions

491

1386

3.70

147.71

1.3

267.94

267.65

u/ml

0.01

334

860

Cholangitis (primary sclerosing, PSC)

226

335

7.35

147.25

1.4

376.74

250.78

u/ml

3.49

136

187

Provisional assignment of new diseases of uncertain etiology

958

3929

2.50

145.84

1.4

1.3

248.85

261.74

u/ml

0.67

653

2492

Codes for special purposes

958

3933

2.50

145.52

1.4

1.3

248.85

261.72

u/ml

0.67

653

2495

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

280

521

5.83

145.15

1.2

200.63

266.59

u/ml

5.08

230

348

Persons encountering health services in other circumstances, wide

2136

5883

1.91

144.75

1.4

1.3

274.71

252.68

u/ml

2.60

1435

3695

Diarrhoea and gastroenteritis of presumed infectious origin

1347

5761

2.16

144.73

1.6

1.3

260.01

256.64

u/ml

0.15

915

3645

Hernia of abdominal wall, postoperative

276

501

5.66

144.63

1.6

1.1

306.78

263.52

u/ml

1.38

193

294

Ulcerative colitis (strict definition, all Crohn cases excluded)

443

1191

3.92

143.68

1.3

255.07

251.34

u/ml

0.09

261

767

Diseases of peritoneum

288

552

5.53

143.56

1.7

1.2

260.20

267.74

u/ml

0.16

218

338

Purpura and other haemorrhagic conditions

378

907

4.40

143.45

1.3

279.96

269.26

u/ml

0.21

251

549

General examination and investigation of persons without complaint and reported diagnosis

1207

2744

2.38

143.06

1.5

1.2

266.20

253.14

u/ml

0.79

801

1766

Acute upper respiratory infections

1796

5769

1.98

141.13

1.3

273.35

257.91

u/ml

1.23

1153

3686

1936

5313

1.95

140.17

1.3

1.2

276.38

256.04

u/ml

1.96

1264

3375

Symptoms and signs involving the digestive system and abdomen

1862

4761

1.99

140.03

1.4

1.3

274.36

250.64

u/ml

2.53

1201

2997

Acute myeloid leukaemia and myelodysplastic syndromes

111

20.43

138.21

1.4

1.3

255.80

273.91

u/ml

0.12

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

293

592

5.30

138.03

1.2

203.38

263.87

u/ml

4.48

235

383

Other special examinations and investigations of persons without complaint or reported diagnosis

1241

2744

2.32

137.73

1.4

1.2

270.07

253.14

u/ml

1.07

776

1766

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

320

698

4.79

136.51

1.3

285.70

279.84

u/ml

0.12

200

443

Secondary uncertain malignant neoplasm

298

614

5.09

136.34

1.3

1.2

282.50

273.62

u/ml

0.18

185

375

Nephrotic syndrome

187

249

8.76

136.08

2.6

1.5

279.01

257.70

u/ml

0.30

139

134

Acute tubulo-interstitial nephritis

980

3672

2.41

135.66

1.5

1.2

291.20

263.58

u/ml

2.01

657

2233

Genitourinary diseases

1334

3043

2.24

134.95

1.6

1.2

248.96

240.53

u/ml

0.46

873

1854

Other Crohn's disease

272

528

5.58

134.58

1.3

1.2

305.40

252.41

u/ml

1.51

165

319

Antihypertensive medication - note that there are other indications

1427

3702

2.15

134.09

1.6

1.2

257.31

230.79

u/ml

2.79

958

2315

Intrahepatic Cholestasis of Pregnancy (ICP)

280

562

5.40

133.43

1.2

200.63

267.92

u/ml

5.17

230

371

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

156

169

10.16

132.26

1.3

1.2

283.98

279.72

u/ml

0.04

111

Diffuse large B-cell lymphoma, helper endpoint

156

169

10.16

132.26

1.3

1.2

283.98

279.72

u/ml

0.04

111

Lymphoid leukaemia

196

280

7.64

132.15

1.3

1.5

248.09

236.35

u/ml

0.16

105

149

Other disorders of teeth and supporting structures

433

1213

3.69

131.17

1.5

1.2

319.42

276.30

u/ml

1.85

293

756

Heart failure, strict

792

2188

2.65

127.66

1.4

1.2

297.49

279.40

u/ml

0.90

539

1339

Excluding asthma or asthma-COPD overlap

1403

3337

2.13

127.56

1.3

272.85

249.87

u/ml

1.92

911

2145

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

280

586

5.19

127.29

1.2

1.3

289.79

249.39

u/ml

1.19

169

348

Other pulmonary diagnosis

1402

3337

2.13

127.24

1.3

273.51

249.87

u/ml

1.99

916

2145

Crohn disease (strict definition, require KELA)

271

556

5.32

126.26

1.2

1.3

291.57

246.35

u/ml

1.37

164

332

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

293

642

4.88

125.39

1.2

203.38

270.37

u/ml

5.04

235

420

Crohn disease (strict definition, require KELA, min 2 HDR)

268

549

5.33

125.12

1.2

1.3

292.07

247.01

u/ml

1.34

162

328

Care involving use of rehabilitation procedures

975

4066

2.31

125.10

1.4

1.2

274.03

263.25

u/ml

0.57

684

2444

COPD differential diagnosis

1393

3337

2.12

124.39

1.3

272.78

249.72

u/ml

1.91

902

2146

ILD differential diagnosis

1393

3337

2.12

124.38

1.3

272.78

249.72

u/ml

1.91

902

2146

Polyarthropathies

1263

3996

2.14

124.34

1.3

291.37

264.80

u/ml

2.36

808

2632

Oesophageal varices

168

217

8.62

124.24

1.4

1.3

393.73

264.20

u/ml

2.99

113

124

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

247

308

6.13

123.50

1.2

341.06

272.53

u/ml

1.51

164

201

Thrombocytopenia, unspecified

222

389

6.13

122.43

1.3

285.14

260.18

u/ml

0.43

149

225

Nausea and vomiting

536

1754

3.09

122.24

1.7

1.3

273.04

253.84

u/ml

0.75

377

1040

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

515

1641

3.19

120.66

1.9

1.4

259.72

238.06

u/ml

0.97

376

942

Endocrine, nutritional and metabolic diseases

1656

4382

1.95

118.82

1.5

1.3

261.49

238.59

u/ml

2.30

1068

2768

Diffuse large B-cell lymphoma

156

196

8.74

117.73

1.3

1.2

283.98

300.64

u/ml

0.18

111

104

Hypertensive Renal Disease

120

105

12.40

117.70

1.6

1.1

293.33

298.05

u/ml

0.04

Acute myeloid leukaemia, excluding all cancers (controls excluding all cancers)

27.72

117.66

1.4

1.5

243.57

174.76

u/ml

1.28

Acute myeloid leukaemia, helper endpoint

27.72

117.66

1.4

1.5

243.57

174.76

u/ml

1.28

Abdominal and pelvic pain

1769

4754

1.89

116.46

1.3

269.54

250.78

u/ml

1.78

1148

2995

Other heart diseases, wide

1653

5469

1.90

115.70

1.5

1.3

277.55

258.02

u/ml

1.72

1137

3460

Diseases of arteries, arterioles and capillaries (FINNGEN)

419

811

3.70

115.59

1.5

1.2

311.74

272.86

u/ml

1.51

306

490

Systemic connective tissue disorders

600

2196

2.80

115.26

1.2

284.07

277.81

u/ml

0.17

375

1394

Lymphoid leukaemia

196

325

6.56

114.73

1.3

1.4

248.09

262.50

u/ml

0.19

105

171

Tramadol

1250

3906

2.08

114.53

1.3

1.2

300.43

265.80

u/ml

3.15

837

2550

6-mercaptopurine

157

207

8.55

114.43

1.2

1.3

227.96

209.49

u/ml

0.32

104

121

All-cause Heart Failure

750

2145

2.56

113.12

1.4

1.2

292.67

279.26

u/ml

0.58

501

1308

Ascites

185

292

6.72

112.91

1.3

1.1

340.96

301.95

u/ml

0.72

140

171

Oedema, not elsewhere classified

442

1370

3.28

112.61

1.4

1.2

279.58

266.34

u/ml

0.40

293

848

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

912

3772

2.28

112.24

1.3

321.37

270.49

u/ml

3.94

563

2418

ILD, hospital admission 2, with pulmonary infections

193

323

6.24

110.75

1.2

357.52

264.36

u/ml

1.89

125

195

Other disorders of fluid, electrolyte and acid-base balance

461

1436

3.17

109.94

1.6

1.2

284.23

280.46

u/ml

0.09

307

882

Crohn disease (strict definition, all UC cases excluded)

207

380

5.95

109.25

1.2

1.3

296.39

245.01

u/ml

1.40

131

233

Complications of medical and surgical care

1111

5162

2.07

108.56

1.4

1.2

290.45

270.13

u/ml

1.33

746

3327

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

106

13.40

107.94

1.2

360.56

278.45

u/ml

0.96

Chronic lymphocytic leukaemia, helper endpoint

106

13.40

107.94

1.2

360.56

278.45

u/ml

0.96

Other noninfective gastroenteritis and colitis

523

1850

2.91

107.42

1.4

253.65

250.40

u/ml

0.08

316

1134

Chronic hepatitis, not elsewhere classified

145

190

8.50

105.99

1.3

1.2

346.92

246.14

u/ml

2.12

113

Acute myeloid leukaemia

21.67

105.64

1.4

243.57

258.10

u/ml

0.08

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

778

2036

2.46

104.73

1.4

1.2

296.62

260.19

u/ml

2.44

519

1319

Abnormal serum enzyme levels

490

1675

2.96

104.20

1.2

1.3

287.12

275.93

u/ml

0.31

304

1047

Opioids

1725

5020

1.82

102.75

1.3

1.2

273.80

251.79

u/ml

2.28

1167

3253

Complications of surgical and medical care, not elsewhere classified

1513

5913

1.86

102.17

1.4

1.2

282.40

264.15

u/ml

1.45

1026

3784

Disorders of other endocrine glands

817

3604

2.28

101.13

1.7

1.3

275.30

258.79

u/ml

0.90

555

2228

Reimbursement for rheumatic diseases

937

4429

2.15

100.94

1.3

308.75

267.80

u/ml

3.00

556

2866

Insulin, combination of fast acting with intermediate-acting or long-acting

975

4317

2.11

99.82

1.5

1.3

302.66

260.64

u/ml

3.57

646

2751

Crohn's disease of small intestine

235

520

4.84

99.54

1.2

1.3

335.22

253.84

u/ml

2.23

143

323

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

170

280

6.37

99.29

1.5

1.2

244.16

279.30

u/ml

0.55

173

Alcoholic liver disease

224

475

4.95

99.21

1.2

325.31

278.02

u/ml

1.20

147

300

Other respiratory diseases principally affecting the interstitium

292

762

3.95

98.15

1.2

332.83

284.26

u/ml

1.14

195

458

Symptoms and signs involving the circulatory and respiratory systems

1847

5303

1.77

97.65

1.3

270.54

248.01

u/ml

2.33

1216

3394

Diseases of oral cavity, salivary glands and jaws

1426

3869

1.91

97.50

1.5

1.2

265.39

257.54

u/ml

0.44

935

2399

Gingival hyperplasia

144

207

7.75

97.13

3.2

1.1

222.21

252.03

u/ml

0.38

Factors influencing health status and contact with health services

545

937

2.96

96.39

1.3

1.1

269.23

234.75

u/ml

1.53

339

569

Anxiety disorders, excluding more controls

1447

5240

1.85

95.64

1.3

268.52

254.79

u/ml

1.01

957

3339

Diseases of the skin and subcutaneous tissue

1742

4951

1.78

95.36

1.3

269.46

251.89

u/ml

1.57

1110

3186

Abnormalities of breathing

1581

5238

1.81

95.33

1.3

280.57

248.74

u/ml

3.66

1032

3348

Leukaemia of unspecified cell type

22.85

95.30

1.3

1.1

247.79

183.33

u/ml

1.00

Haemolytic anaemias

142

206

7.64

94.89

1.4

272.82

230.63

u/ml

0.73

116

Acquired haemolytic anaemia

109

115

10.75

94.80

1.4

1.2

275.18

244.26

u/ml

0.35

Insulin, fast-acting

681

2911

2.39

94.59

1.5

1.3

277.39

254.88

u/ml

1.21

467

1833

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

892

4254

2.12

93.41

1.4

1.2

290.43

272.33

u/ml

0.93

603

2738

Erysipelas

695

2728

2.36

92.94

1.3

1.2

281.99

268.20

u/ml

0.54

466

1730

Other disorders of skin and subcutaneous tissue

981

4443

2.05

92.75

1.4

1.3

292.37

271.91

u/ml

1.34

638

2836

ILD, hospital admissions 1, main diag only

238

562

4.39

91.87

1.2

350.88

290.99

u/ml

1.18

156

330

Insulin medication

975

4110

2.06

91.84

1.5

1.3

302.66

257.14

u/ml

4.08

646

2629

Atrial fibrillation and flutter

482

1089

2.94

91.71

1.4

1.2

293.82

271.30

u/ml

0.83

334

686

Bleeding

1198

4572

1.93

91.31

1.4

1.3

290.94

264.63

u/ml

2.27

792

2880

Noninfectious colitis NAS

322

946

3.54

91.29

1.3

259.91

259.86

u/ml

0.00

204

589

Dependence on enabling machines and devices, not elsewhere classified

13.00

91.15

3.6

1.2

245.28

195.76

u/ml

0.48

Viral infections characterized by skin and mucous membrane lesions

765

3492

2.23

90.85

1.6

1.3

280.24

261.92

u/ml

0.84

510

2184

Persons encountering health services for examination and investigation

1106

2744

2.04

90.62

1.3

1.2

268.76

253.14

u/ml

0.93

690

1766

Anxiety disorders

1562

6321

1.77

90.45

1.3

267.18

258.14

u/ml

0.60

1026

4063

Neurotic, stress-related and somatoform disorders

1553

6298

1.77

90.28

1.3

267.12

258.44

u/ml

0.56

1022

4049

Oxycodone

494

1793

2.71

89.60

1.3

1.2

297.74

276.15

u/ml

0.77

321

1108

Insulin, fast-acting or short human

683

2999

2.33

89.15

1.5

1.3

277.12

256.98

u/ml

1.03

468

1879

All influenza

471

1740

2.78

89.15

1.5

1.3

292.26

252.50

u/ml

1.81

326

1058

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

12.39

89.07

1.3

1.1

310.46

278.10

u/ml

0.28

Other medical care

548

2124

2.56

88.85

1.3

1.2

299.72

265.60

u/ml

1.64

378

1256

Disorders of gallbladder, biliary tract and pancreas

1416

5055

1.82

88.72

1.3

290.84

271.05

u/ml

1.51

899

3329

Asthma, excluding more controls

1155

3140

1.98

88.65

1.3

1.2

279.45

247.79

u/ml

2.63

758

2009

Diseases of oesophagus, stomach and duodenum

1647

5791

1.75

87.90

1.3

299.97

257.78

u/ml

5.95

1074

3731

Type 2 diabetes, wide definition

1081

3589

1.99

87.58

1.4

1.2

297.97

271.39

u/ml

2.00

701

2354

Parasetamol

1511

4306

1.81

87.46

1.3

257.56

252.79

u/ml

0.25

980

2755

Cholangitis (primary sclerosing, PSC), with reimbursement 202

113

141

9.45

87.06

1.5

1.6

399.20

238.04

u/ml

2.05

Other viral diseases, not elsewhere classified

462

1714

2.78

86.81

1.8

1.4

261.17

248.25

u/ml

0.38

304

1020

Colitis, primary sclerosing

100

108

11.29

86.63

1.4

1.3

397.70

177.32

u/ml

3.46

Chronic lymphocytic leukaemia

106

121

9.71

86.57

1.2

1.1

360.56

333.57

u/ml

0.21

Missing teeth due to accident, extraction or parodontitis

236

580

4.23

86.51

1.5

1.1

342.76

266.30

u/ml

2.86

169

348

Interstitial lung disease endpoints

251

645

4.02

86.36

1.2

344.06

288.62

u/ml

1.14

164

380

Other interstitial pulmonary diseases

251

645

4.02

86.36

1.2

344.06

288.62

u/ml

1.14

164

380

Interstitial lung disease

251

645

4.02

86.36

1.2

344.06

288.62

u/ml

1.14

164

380

ILD, hospital admissions

250

641

4.03

86.31

1.2

344.52

288.96

u/ml

1.14

163

379

317

958

3.44

85.95

1.5

1.2

306.36

260.13

u/ml

1.77

250

581

Unspecified jaundice

138

214

6.85

85.81

1.4

1.3

301.76

258.70

u/ml

0.62

116

Leukaemia of unspecified cell type

18.48

85.75

1.3

1.2

247.79

257.60

u/ml

0.05

Cardiomyopathy

314

942

3.43

85.71

1.5

1.3

288.88

270.99

u/ml

0.50

235

586

Crohn's disease NAS

214

496

4.60

85.52

1.3

351.74

250.06

u/ml

2.74

116

301

Autoimmune hepatitis

31.66

85.17

1.3

1.9

293.74

204.78

u/ml

—

ILD, hospital admissions 3, with pneumonia sepsis

155

272

5.94

84.77

1.2

358.33

254.19

u/ml

2.58

101

160

Hypothyroidism (congenital or acquired)

553

1218

2.66

84.18

1.3

1.2

262.48

233.30

u/ml

1.40

343

770

Other diseases of intestines

1787

6211

1.69

84.06

1.3

277.68

253.41

u/ml

2.54

1161

3996

Gout, idiopatic and unspecified

347

1125

3.16

83.22

1.5

1.2

298.22

291.06

u/ml

0.16

239

706

Insulin, intermediate and long-acting

835

4001

2.08

82.75

1.4

1.3

287.67

262.67

u/ml

1.63

545

2547

Other diseases of biliary tract

180

370

5.08

82.71

1.6

1.3

342.98

278.34

u/ml

1.40

132

222

Hyperkalaemia

130

197

6.97

82.54

1.6

1.1

299.53

302.41

u/ml

0.03

114

Multiple myeloma, excluding all cancers (controls excluding all cancers)

116

158

7.82

81.28

1.5

1.2

230.18

250.54

u/ml

0.20

Asthma

1168

3310

1.91

81.18

1.3

279.10

250.09

u/ml

2.33

769

2129

Congenital malformations, deformations and chromosomal abnormalities

1120

5861

1.86

79.66

1.5

1.3

258.25

254.29

u/ml

0.18

764

3717

Other bacterial intestinal infections

320

1020

3.23

79.18

1.4

1.2

286.54

271.50

u/ml

0.33

201

625

Diabetic retinopathy, strict definition

350

1020

3.13

78.76

1.6

1.3

281.59

304.08

u/ml

0.68

252

648

Disorders of lens

912

2861

2.04

78.50

1.5

1.2

300.75

277.24

u/ml

1.38

600

1812

Multiple myeloma and malignant plasma cell neoplasms

114

160

7.58

77.79

1.6

1.2

233.38

258.68

u/ml

0.25

Fungal Sepsis

118

173

7.38

77.72

1.5

1.2

309.14

274.93

u/ml

0.38

Depression medications

662

1425

2.38

77.38

1.3

1.2

244.60

227.51

u/ml

0.82

400

904

Non-ischemic cardiomyopathy

396

1151

2.88

77.33

1.5

1.2

275.03

279.18

u/ml

0.10

278

694

Gingivitis and periodontal diseases

1330

3832

1.81

77.27

1.4

1.2

265.12

258.06

u/ml

0.38

876

2389

Hypothyroidism and >3 levothyroxin purchases

533

1209

2.58

76.86

1.3

1.2

263.86

234.19

u/ml

1.40

333

766

Hypothyroidism, levothyroxine purchases

533

1209

2.58

76.86

1.3

1.2

263.86

234.19

u/ml

1.40

333

766

Malignant neoplasm

1301

4342

1.80

76.20

1.3

277.15

273.01

u/ml

0.17

813

2875

Other disorders of gingiva or/and edentulous alveolar ridge

158

314

5.39

76.10

3.1

1.1

221.64

248.53

u/ml

0.44

109

159

Statin medication

1121

3363

1.89

76.08

1.5

1.2

278.07

260.93

u/ml

1.07

780

2162

Dermatitis and eczema

1723

6919

1.65

75.85

1.3

264.96

258.22

u/ml

0.43

1090

4460

Maternal care for other conditions predominantly related to pregnancy

456

1776

2.61

75.69

1.2

213.04

264.59

u/ml

5.69

348

1165

Gout, strict definition

261

755

3.55

75.46

1.6

1.2

299.25

294.66

u/ml

0.08

176

466

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

127

206

6.46

75.37

1.3

1.2

359.69

293.73

u/ml

1.03

124

Gout, unspecified

287

882

3.34

75.35

1.5

1.2

305.11

295.70

u/ml

0.20

201

548

Disorders of tooth development and eruption

209

510

4.29

75.11

3.1

1.2

230.89

223.40

u/ml

0.11

130

260

Asthma (mode)

1130

3337

1.88

75.00

1.3

270.77

249.72

u/ml

1.49

743

2146

Malignant neoplasm, wide definition for exclusion

1322

4440

1.78

74.89

1.3

282.14

271.32

u/ml

0.57

837

2939

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

1322

4440

1.78

74.89

1.3

282.14

271.32

u/ml

0.57

837

2939

Cardiomyopathies, Primary/intrinsic

228

607

3.88

74.72

1.6

1.3

294.45

269.48

u/ml

0.66

173

374

Other necrotizing vasculopathies

158

318

5.22

74.57

1.4

1.2

264.09

289.61

u/ml

0.40

105

190

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

1320

4443

1.77

74.24

1.3

282.17

271.32

u/ml

0.57

835

2939

Neoplasms

1493

4694

1.72

74.15

1.4

1.3

257.54

244.03

u/ml

0.98

965

3027

Abnormal findings on diagnostic imaging of lung

577

2478

2.30

73.99

1.3

1.2

325.43

277.72

u/ml

2.31

363

1559

Pain (limb, back, neck, head abdominally)

1261

3509

1.82

73.93

1.3

260.80

248.34

u/ml

0.76

809

2203

Type 1 diabetes

545

2359

2.36

73.74

1.6

1.3

271.26

246.51

u/ml

1.22

384

1472

Crohn's disease of large intestine

172

378

4.86

73.59

1.3

340.90

250.30

u/ml

2.13

106

240

Asthma (only as main-diagnosis), excluding more controls

1005

3140

1.93

73.35

1.3

1.2

275.11

247.79

u/ml

1.89

649

2009

Other acute lower respiratory infections

891

4431

1.95

73.26

1.5

1.3

270.61

257.93

u/ml

0.61

593

2736

Enterocolitis due to Clostridium difficile

202

501

4.18

73.15

1.4

1.2

287.31

261.26

u/ml

0.46

123

303

Cardiomyopathy (excluding other)

232

637

3.76

72.70

1.6

1.3

294.37

263.89

u/ml

0.90

176

398

Ulcer of lower limb, not elsewhere classified

226

610

3.82

72.57

1.5

1.2

287.96

279.47

u/ml

0.18

167

371

Bacterial intestinal infections, IBD co-morbidities

317

1062

3.07

72.06

1.4

1.2

285.39

274.95

u/ml

0.21

198

651

Hypertensive heart and/or renal disease

317

792

3.16

71.71

1.5

1.2

276.59

287.64

u/ml

0.25

219

475

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

140

264

5.73

71.70

1.5

1.2

291.74

270.38

u/ml

0.34

106

172

Pneumocystosis

10.98

71.41

1.3

269.65

288.17

u/ml

0.14

Implicit fungal Sepsis

108

158

7.40

71.31

1.5

1.2

320.72

280.37

u/ml

0.43

Non-Hodgkin lymphoma, all

106

152

7.45

71.04

1.3

1.2

329.90

260.02

u/ml

0.74

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

10.31

71.03

1.2

360.87

250.35

u/ml

1.66

Erosion of teeth

102

144

8.32

70.81

2.5

1.2

330.41

192.00

u/ml

3.22

Cerebrovascular diseases (FINNGEN)

450

1253

2.61

70.79

1.4

1.2

277.79

268.08

u/ml

0.28

302

787

Viral pneumonia

260

785

3.43

70.60

1.5

1.3

273.35

247.91

u/ml

0.67

177

489

Infections of the skin and subcutaneous tissue

983

5342

1.86

70.59

1.5

1.3

275.59

259.57

u/ml

0.98

644

3424

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

122

206

6.53

70.53

1.4

1.6

204.66

221.78

u/ml

0.18

106

Pain, not elsewhere classified

404

1555

2.65

70.39

1.3

1.2

284.22

258.36

u/ml

0.71

257

982

Disorders of lipoprotein metabolism and other lipidaemias

1033

3502

1.87

70.23

1.4

1.2

290.21

276.18

u/ml

0.68

700

2248

Dyspnoea

1256

5578

1.74

69.96

1.3

297.12

266.36

u/ml

3.00

810

3585

Vitreous haemorrhage

208

546

3.97

69.83

1.7

1.2

261.73

287.25

u/ml

0.59

149

334

Diseases of the digestive system

665

3185

2.12

69.42

1.5

1.3

298.68

266.10

u/ml

1.76

408

2003

Idiopathic pulmonary fibrosis

139

266

5.45

69.32

1.1

1.2

357.27

275.30

u/ml

1.49

101

149

Other ulcerative colitis

174

405

4.56

69.16

1.4

1.3

278.37

256.32

u/ml

0.34

254

Other disorders of white blood cells

151

314

5.11

68.91

1.3

249.86

249.88

u/ml

0.00

101

192

Toxic liver disease

11.61

68.55

1.2

1.3

231.31

236.11

u/ml

0.04

Nutritional anaemias

641

2967

2.13

68.12

1.4

1.3

292.12

270.43

u/ml

1.10

410

1868

IBD (strict) with PSC

13.33

68.01

1.4

481.97

163.91

u/ml

3.52

Other reaction to severe stress, and adjustment disorders

700

3465

2.06

67.56

1.4

1.3

281.11

254.90

u/ml

1.48

463

2278

Iron deficiency anaemia

569

2576

2.22

67.26

1.5

1.3

290.10

271.33

u/ml

0.82

365

1614

Asthma, unspecified (mode), excluding more controls

689

2622

2.09

66.81

1.3

287.82

254.77

u/ml

1.92

446

1672

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

491

1841

2.38

66.60

1.2

1.3

290.33

284.75

u/ml

0.16

324

1181

Asthma (only as main-diagnosis)

1009

3310

1.86

66.26

1.3

274.69

250.09

u/ml

1.62

651

2129

Diabetic retinopathy, excluding more controls

419

888

2.72

66.14

1.5

1.2

299.63

299.00

u/ml

0.01

297

537

Nonalcoholic fatty liver disease

223

643

3.63

65.43

1.2

298.30

272.28

u/ml

0.69

125

404

Hypoplasia of dental enamel, including avohilmo

108

187

8.59

65.20

4.2

1.7

209.71

176.10

u/ml

0.39

Diseases of the respiratory system

1020

2773

1.86

64.44

1.2

1.3

270.93

249.02

u/ml

1.39

640

1775

Infectious mononucleosis

282

950

3.12

64.39

1.3

188.24

232.74

u/ml

1.85

176

585

Syncope and collapse

523

2066

2.27

64.16

1.3

1.2

290.53

258.63

u/ml

1.58

344

1284

Multiple myeloma and malignant plasma cell neoplasms

114

196

6.17

64.10

1.6

1.2

233.38

298.43

u/ml

0.82

110

Atrial fibrillation and flutter with reimbursement

335

740

2.95

64.05

1.3

1.2

296.55

283.12

u/ml

0.33

225

451

Postviral fatigue syndrome

13.65

64.01

1.3

264.15

164.99

u/ml

2.20

Colitis, primary sclerosing, strict definition

11.19

63.99

1.4

1.3

378.12

188.30

u/ml

2.24

Streptococcal septicaemia

162

379

4.44

63.51

1.5

1.3

251.95

240.71

u/ml

0.18

104

223

Pneumonia due to other infectious organisms, not elsewhere classified

150

7.11

63.24

1.4

1.2

254.59

245.68

u/ml

0.10

Depression

1528

6564

1.62

63.23

1.3

267.74

259.97

u/ml

0.46

1004

4204

Adjustment and management of implanted device

227

675

3.43

62.79

1.4

1.2

299.41

281.41

u/ml

0.40

171

394

Diseases of arteries, arterioles and capillaries

797

3097

1.94

62.63

1.4

1.2

303.78

275.18

u/ml

1.82

553

1937

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

10.52

62.39

1.5

1.1

210.41

328.56

u/ml

1.25

Multiple myeloma

10.52

62.39

1.5

1.1

210.41

328.56

u/ml

1.25

Parodontitis or operation codes

1205

5247

1.71

62.20

1.4

1.2

290.14

271.43

u/ml

1.25

810

3421

Mood disorders, excluding more controls

1443

5392

1.64

62.07

1.3

270.06

255.09

u/ml

1.07

957

3436

Pericarditis

102

163

6.67

61.77

1.4

1.2

291.89

234.03

u/ml

1.12

Chronic periodontitis, including avohilmo

1197

5241

1.71

61.64

1.4

1.2

291.03

271.43

u/ml

1.33

805

3420

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

203

572

3.69

61.57

1.6

1.2

272.81

275.06

u/ml

0.03

140

348

Rare circulating lymphoid malignancy

122

235

5.71

61.42

1.4

1.5

204.66

240.48

u/ml

0.43

122

Asthma, unspecified (mode)

692

2750

2.02

61.37

1.3

287.07

258.68

u/ml

1.53

449

1762

Other diseases of the digestive system

438

1870

2.38

61.16

1.5

1.3

318.63

267.98

u/ml

2.39

273

1159

Finngen Rheumatological endpoints

1541

5487

1.62

61.08

1.3

279.38

256.42

u/ml

2.20

975

3607

Parodontitis

1199

5249

1.70

60.88

1.4

1.2

290.59

271.38

u/ml

1.29

805

3424

Anxiety (asthma-related co-morbidities)

1072

4897

1.75

60.56

1.3

256.47

250.99

u/ml

0.26

714

3153

Other diseases of pericardium

110

193

6.03

60.54

1.5

1.2

307.67

250.07

u/ml

1.08

109

Dermatitis

867

4777

1.84

60.37

1.4

1.3

278.69

268.56

u/ml

0.47

567

3114

Need for immunization against other single viral diseases

131

7.72

60.26

1.6

1.3

233.26

264.57

u/ml

0.40

Other and unspecified dermatitis

743

3903

1.93

60.22

1.4

1.3

279.74

270.81

u/ml

0.36

480

2530

Diseases of the eye and adnexa

1523

4737

1.63

60.08

1.4

1.3

263.94

246.97

u/ml

1.38

975

3024

Acute sinusitis

839

4260

1.86

60.04

1.3

276.89

258.72

u/ml

0.90

531

2802

Other infectious diseases

163

401

4.23

59.91

1.5

1.3

307.23

257.01

u/ml

1.05

116

245

Sub-endpoint used in defining T1D endpoints

544

2522

2.16

59.72

1.6

1.3

271.62

250.94

u/ml

0.93

382

1567

Explicit bacterial Sepsis

193

536

3.72

59.60

1.4

1.2

256.49

253.36

u/ml

0.05

120

316

Osteopathies and chondropathies

766

3858

1.91

59.48

1.3

279.38

270.83

u/ml

0.31

503

2426

GI-bleeding

433

1870

2.35

58.88

1.5

1.3

320.42

268.07

u/ml

2.46

268

1156

Cardiomyopathy, other and unspecified

161

398

4.21

58.77

1.4

1.2

302.54

255.37

u/ml

1.13

120

247

Codeine

1418

4807

1.63

58.59

1.3

1.2

276.04

254.47

u/ml

1.79

936

3129

Heart failure and bmi 25plus

409

1145

2.50

58.55

1.3

1.2

299.33

282.96

u/ml

0.50

270

706

Other and unspecified polyneuropathies, also in other diseases

275

961

2.93

58.01

1.4

1.2

301.83

284.24

u/ml

0.38

181

611

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

161

6.44

57.68

1.2

315.10

240.52

u/ml

0.87

Polyneuropathies and other disorders of the peripheral nervous system

314

1180

2.72

57.68

1.4

1.3

291.89

283.21

u/ml

0.18

205

749

Complications of procedures, not elsewhere classified

1080

5510

1.71

57.67

1.4

1.2

288.44

267.38

u/ml

1.34

737

3536

All anxiety disorders

1090

5184

1.71

57.61

1.3

257.06

252.51

u/ml

0.21

726

3343

Parodontitis and operation codes

1125

5198

1.70

57.56

1.4

1.2

288.59

272.99

u/ml

0.90

757

3393

Type 1 diabetes, wide definition, subgroup 1

445

1970

2.31

57.38

1.6

1.3

263.80

245.33

u/ml

0.76

320

1226

Other retinal disorders

766

3275

1.90

57.29

1.5

1.2

280.33

275.25

u/ml

0.19

525

2064

Pain in throat and chest

1276

4749

1.66

56.84

1.3

278.62

255.22

u/ml

1.75

847

3051

Molar incisor enamel hypoplasia, with caries

155

8.51

56.41

4.0

1.5

210.84

155.91

u/ml

0.72

Other necrotizing vasculopathies (FG)

120

243

5.15

56.24

1.4

1.3

269.26

272.00

u/ml

0.03

139

Insulin, fast-acting (human)

319

1227

2.68

56.22

1.6

1.2

286.30

258.66

u/ml

0.92

231

791

Gout due to impairment of renal function

14.40

56.04

1.6

1.2

325.65

319.61

u/ml

0.02

Pulmonary heart disease, diseases of pulmonary circulation

393

1663

2.40

55.98

1.3

1.2

308.13

282.81

u/ml

0.82

261

1020

Other cataract

530

1926

2.16

55.91

1.5

1.2

288.36

277.89

u/ml

0.33

346

1214

Disorders of mineral metabolism

161

414

4.04

55.71

1.6

1.2

280.54

271.54

u/ml

0.13

101

247

Drug-induced cataract

142

6.99

55.68

2.0

1.3

294.37

283.28

u/ml

0.10

Dentofacial anomalies [including malocclusion]

473

2149

2.22

55.53

1.9

1.2

249.43

253.80

u/ml

0.11

292

1306

Mood [affective] disorders

1570

6673

1.56

55.52

1.3

267.59

259.73

u/ml

0.48

1031

4273

Other and unspecified iron deficiency

449

2020

2.26

55.46

1.4

1.3

281.06

268.49

u/ml

0.42

286

1249

Pain in joint

893

3300

1.81

55.28

1.2

1.3

272.40

251.54

u/ml

1.10

551

2108

Mood disorders

1571

6676

1.56

55.24

1.3

267.51

259.73

u/ml

0.47

1032

4273

Type 1 diabetes, wide definition

459

2093

2.24

55.05

1.6

1.3

266.25

245.95

u/ml

0.85

329

1303

Symptoms and signs involving the skin and subcutaneous tissue

961

5580

1.73

54.92

1.3

271.47

268.19

u/ml

0.11

628

3584

Biological medication for rheuma

349

1420

2.53

54.85

1.2

1.3

310.03

248.84

u/ml

3.06

210

904

Chronic tubulo-interstitial nephritis

167

6.13

54.41

1.5

1.1

260.93

274.10

u/ml

0.14

Venous thromboembolism

631

3156

1.96

53.85

1.3

1.2

285.86

282.38

u/ml

0.10

422

2002

Primary biliary cholangitis (PBC)

10.91

53.44

1.3

397.94

254.67

u/ml

1.20

Cardiac arrhythmias

964

3678

1.75

53.28

1.3

284.23

253.27

u/ml

2.31

652

2366

Drug-induced neutropenia

151

384

4.11

53.21

1.3

1.2

264.51

274.43

u/ml

0.14

105

238

Acute bronchitis

606

3038

1.98

53.03

1.4

1.3

286.09

261.36

u/ml

1.13

411

1898

Protozoal diseases

159

6.37

53.03

1.3

268.11

264.16

u/ml

0.04

Other and unspecified disorders of white blood cells

111

223

5.30

52.86

1.3

252.68

271.93

u/ml

0.23

131

Other systemic involvement of connective tissue (FG)

358

1482

2.44

52.82

1.2

282.14

269.53

u/ml

0.27

221

942

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

135

317

4.41

52.69

1.3

1.2

324.01

269.83

u/ml

1.09

189

Benign neoplasm: Colon

521

1909

2.12

52.26

1.2

1.3

308.79

283.01

u/ml

0.91

344

1246

Other autoimmune haemolytic anaemias

12.57

52.16

1.3

1.2

314.55

301.48

u/ml

0.06

Bacterial pneumonia (organism specified)

598

2785

1.98

51.71

1.4

1.3

290.53

266.46

u/ml

1.15

403

1737

Presence of cardiac and vascular implants and grafts

446

1522

2.24

51.63

1.3

1.1

294.87

266.65

u/ml

1.30

314

916

Neurological diseases, wide definition

670

1714

1.99

51.25

1.3

243.84

227.95

u/ml

0.73

431

1087

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

737

4070

1.83

50.94

1.4

1.2

294.51

272.23

u/ml

1.07

493

2618

SLE (Finngen)

141

6.44

50.73

1.2

1.3

361.83

246.78

u/ml

1.07

Senile cataract

708

2332

1.90

50.51

1.4

1.2

304.69

283.06

u/ml

1.01

456

1475

Mycoses

411

1858

2.26

50.43

1.4

1.3

296.74

267.93

u/ml

1.09

259

1184

Zoster [herpes zoster]

257

937

2.81

50.16

1.3

1.2

278.95

267.19

u/ml

0.26

170

561

Diseases of the musculoskeletal system and connective tissue

1086

3252

1.69

50.11

1.3

254.18

237.05

u/ml

1.07

676

2063

Other and unspecified aplastic anaemias

12.32

49.64

1.5

279.00

233.74

u/ml

0.29

Bacterial pneumonia, not elsewhere classified

503

2168

2.08

49.60

1.4

1.3

295.81

259.70

u/ml

1.83

338

1360

Benign neoplasm of colon, rectum, anus and anal canal

595

2168

1.98

49.34

1.3

306.22

280.86

u/ml

1.02

396

1429

Diabetic retinopathy

469

1379

2.19

48.50

1.5

1.3

289.83

302.25

u/ml

0.38

332

848

Follicular lymphoma

165

5.81

48.39

1.2

254.76

289.09

u/ml

0.51

Cystitis

1191

4545

1.62

48.18

1.3

279.06

259.29

u/ml

1.49

777

2874

Other diseases of pleura

511

2242

2.04

48.16

1.3

302.12

274.44

u/ml

1.33

348

1372

Acute pharyngitis

347

1483

2.39

48.11

1.4

1.3

243.89

241.89

u/ml

0.04

215

931

Ulcerative colitis (strict) with PSC

12.17

48.05

1.3

1.4

422.50

163.90

u/ml

2.09

Ischaemic heart disease, wide definition

888

3217

1.74

48.02

1.3

1.2

307.46

277.92

u/ml

1.75

607

2037

Disorders of calcium metabolism

125

298

4.37

48.02

1.6

1.2

281.79

260.84

u/ml

0.31

176

Other and unspecified types of non-Hodgkin lymphoma, hilmo

192

5.39

47.94

1.2

315.10

286.92

u/ml

0.23

107

Amputation

149

403

3.80

47.82

1.6

1.1

269.34

281.06

u/ml

0.22

116

240

Any event in cancer register

1289

4874

1.58

47.45

1.3

286.88

267.33

u/ml

1.31

824

3221

Peripheral artery operations in Hilmo

167

491

3.47

47.15

1.6

1.2

274.97

282.16

u/ml

0.13

128

298

Bacterial pneumoniae

523

2330

2.01

47.15

1.4

1.3

293.92

261.93

u/ml

1.57

350

1461

Idiopathic thrombocytopenic purpura

181

5.58

47.13

1.3

1.4

348.58

261.44

u/ml

0.63

102

Disorders of choroid and retina

962

4205

1.68

46.98

1.4

1.2

277.19

274.67

u/ml

0.10

651

2680

Pure hypercholesterolaemia

800

3060

1.77

46.27

1.3

1.2

280.64

277.32

u/ml

0.10

514

1946

Cutaneous abscess, furuncle and carbuncle

442

2129

2.12

46.25

1.4

1.3

280.47

261.91

u/ml

0.73

314

1352

Other diseases of urinary system

1467

5445

1.53

45.88

1.3

280.28

259.89

u/ml

1.81

961

3476

Ulcerative ileocolitis

116

273

4.50

45.59

1.2

345.00

248.53

u/ml

1.54

171

Other systemic involvement of connective tissue

371

1678

2.25

45.43

1.2

283.07

276.84

u/ml

0.12

230

1067

Ischemic heart diseases

900

3334

1.71

45.09

1.4

1.2

307.07

276.84

u/ml

1.83

610

2120

Asthma-related infections

855

5026

1.69

44.82

1.3

279.77

258.75

u/ml

1.13

554

3141

Asthma, hospital admission 2, infections

855

5026

1.69

44.82

1.3

279.77

258.75

u/ml

1.13

554

3141

Other arthritis (FG)

452

2221

2.07

44.67

1.3

274.93

262.38

u/ml

0.40

283

1407

Other or ill-defined heart diseases

121

298

4.23

44.54

1.5

1.3

247.23

250.29

u/ml

0.03

178

Osteoporosis

278

1060

2.54

44.54

1.3

1.2

305.18

283.88

u/ml

0.50

190

618

Valvular heart disease excluding rheumatic fever

566

2154

1.94

44.52

1.5

1.3

287.81

270.63

u/ml

0.68

385

1308

Other soft tissue disorders, not elsewhere classified

1394

5681

1.53

44.50

1.3

273.10

254.53

u/ml

1.37

903

3642

Congenital malformations of gallbladder, bile ducts and liver

9.26

44.47

2.4

1.9

256.12

205.56

u/ml

0.40

DVT of lower extremities and pulmonary embolism

469

2332

2.03

44.27

1.3

1.2

283.59

285.28

u/ml

0.04

316

1459

Cerebral cysts

142

397

3.75

43.89

1.4

1.3

289.08

248.90

u/ml

0.78

244

Ulcerative rectosigmoiditis

177

568

3.23

43.80

1.2

243.27

263.84

u/ml

0.43

113

360

Abnormal results of function studies

181

589

3.19

43.78

1.3

308.29

251.15

u/ml

1.30

110

364

Endocarditis

152

5.76

43.72

1.3

299.49

236.36

u/ml

1.09

Arthropathies in other diseases classified elsewhere

175

5.37

43.38

1.6

1.2

324.64

245.47

u/ml

1.68

106

Diabetes, varying definitions

1427

5679

1.51

43.23

1.4

1.3

292.68

257.75

u/ml

3.76

937

3684

Non-rheumatic valve diseases

551

2100

1.94

43.03

1.5

1.3

291.99

271.97

u/ml

0.82

374

1282

Paroxysmal tachycardia

329

1208

2.34

42.91

1.3

1.2

267.11

256.39

u/ml

0.30

234

717

Viral hepatitis, IBD co-morbidity

131

352

3.86

42.71

1.3

1.2

275.49

262.80

u/ml

0.18

104

243

Chronic hepatitis NAS

9.02

42.29

1.3

1.2

280.50

223.54

u/ml

0.45

Pacemaker

320

1359

2.32

42.22

1.3

1.2

309.37

285.54

u/ml

0.77

219

816

709

4073

1.75

41.94

1.3

274.00

255.04

u/ml

0.84

460

2530

Renal tubulo-interstitial disorders in diseases classified elsewhere

11.20

41.92

1.7

1.1

222.83

314.15

u/ml

0.67

Hyperlipidaemia, other/unspecified

395

1781

2.12

41.86

1.4

1.2

293.92

286.84

u/ml

0.19

274

1102

Other gastritis (incl. Duodenitis)

293

1243

2.40

41.75

1.3

1.2

325.13

268.40

u/ml

1.57

199

783

Unspecified nephritic syndrome

128

6.26

41.68

1.8

1.1

335.96

286.75

u/ml

0.39

Diabetes mellitus

1427

5717

1.50

41.63

1.4

1.3

289.26

258.67

u/ml

3.30

941

3708

Neurological diseases

1491

5051

1.50

41.57

1.3

259.71

248.43

u/ml

0.79

940

3248

Pulmonary embolism

336

1515

2.25

41.41

1.3

1.2

299.04

280.97

u/ml

0.49

225

935

Cough

574

3005

1.85

41.27

1.4

1.3

249.35

254.19

u/ml

0.16

355

1842

Tumor necrosis factor alpha inhibitors

302

1315

2.36

40.95

1.2

1.3

308.54

249.38

u/ml

2.48

175

837

Pulmonary heart disease

336

1522

2.24

40.95

1.3

1.2

299.04

282.80

u/ml

0.43

225

940

Other anxiety disorders

792

4207

1.69

40.70

1.3

250.69

247.08

u/ml

0.14

541

2718

Other disorders of urethra and urinary system

889

4078

1.65

40.58

1.4

1.3

275.94

265.70

u/ml

0.47

572

2591

Type 2 diabetes

1253

4889

1.53

40.40

1.4

1.2

299.03

266.47

u/ml

3.15

809

3251

Coronary atherosclerosis

734

2736

1.75

40.27

1.4

1.2

303.81

281.06

u/ml

1.01

492

1724

Peripheral artery disease

427

1696

2.05

39.95

1.5

1.2

307.81

277.67

u/ml

1.27

302

1036

Acute pancreatitis

267

1110

2.45

39.89

1.3

1.2

301.75

278.11

u/ml

0.59

171

688

ILD medications: pirfenidone

14.84

39.78

1.1

1.0

441.46

253.92

u/ml

1.59

Psychiatric diseases

1594

5490

1.46

39.75

1.3

281.06

252.97

u/ml

3.08

1031

3477

ILD-related respiratory insufficiency

124

6.06

39.37

1.2

318.36

292.74

u/ml

0.22

Other specified/unspecified arthritis

397

1951

2.07

39.33

1.3

273.85

264.36

u/ml

0.26

255

1252

Other antidepressants

1515

5404

1.47

39.32

1.3

269.39

260.14

u/ml

0.61

955

3533

Molar incisor enamel hypoplasia

156

494

3.42

39.32

3.4

1.5

206.07

180.92

u/ml

0.45

100

231

Any mental disorder

1606

5551

1.46

39.30

1.3

280.62

253.37

u/ml

2.98

1048

3506

Diagnoses used for exclusion with ILD

328

1499

2.22

39.22

1.3

1.2

281.58

276.47

u/ml

0.12

211

942

Amputation of toe

114

295

4.00

39.18

1.7

1.2

261.44

289.96

u/ml

0.51

173

Diverticular disease of intestine

772

3037

1.70

39.04

1.2

1.3

295.01

281.90

u/ml

0.52

507

1956

Adalimumab

209

787

2.75

38.84

1.3

322.37

249.84

u/ml

2.48

130

494

Follicular lymphoma, hilmo

201

4.76

38.69

1.2

254.76

291.67

u/ml

0.52

107

All influenza (not pneumonia)

268

1136

2.41

38.48

1.6

1.3

285.01

244.38

u/ml

1.11

180

687

Dental operations

807

2454

1.70

38.47

1.4

1.2

266.31

262.33

u/ml

0.14

520

1569

Myocarditis

234

4.39

38.44

1.3

1.2

286.77

260.74

u/ml

0.36

143

Codeine or tramadol medication

1582

6083

1.45

38.39

1.3

274.34

262.32

u/ml

0.82

1039

3994

Liver disorders in diseases classified elsewhere

24.49

38.33

1.1

1.3

553.11

136.18

u/ml

—

Systemic lupus erythematosus

184

4.92

38.04

1.2

1.3

361.83

267.57

u/ml

0.79

112

Pain in limb

1104

5226

1.54

37.75

1.3

271.43

258.44

u/ml

0.70

723

3350

Sarcoidosis

216

842

2.63

37.19

1.3

1.2

286.01

273.98

u/ml

0.24

142

525

Malignant neoplasm of liver and intrahepatic bile ducts

124

5.85

37.10

1.4

1.3

388.38

260.13

u/ml

1.93

Benign neoplasm: Colon

526

2830

1.84

37.09

1.2

312.24

284.46

u/ml

1.03

346

1758

Hypo-osmolality and hyponatraemia

192

704

2.77

36.87

1.6

1.2

279.07

288.65

u/ml

0.17

134

410

Hypothyroidism, strict autoimmune

891

3680

1.61

36.86

1.3

1.2

287.11

253.68

u/ml

2.25

544

2427

Other and unspecified tonsillitis

654

3240

1.74

36.81

1.4

1.3

226.25

240.61

u/ml

0.76

418

2096

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

170

4.96

36.51

1.4

1.2

405.08

285.54

u/ml

1.78

Other skin changes

231

938

2.51

36.43

1.3

1.2

313.14

273.45

u/ml

0.77

156

563

Hodgkin lymphoma

196

4.74

36.34

1.4

1.2

254.32

241.82

u/ml

0.14

120

Hypoplasia of dental enamel , including avohilmo

143

456

3.42

36.19

3.5

1.5

204.08

182.18

u/ml

0.36

210

Dental caries 2

1183

6260

1.50

35.92

1.5

1.3

254.17

257.95

u/ml

0.18

780

4030

Chronic gastritis

297

1353

2.22

35.77

1.2

333.46

281.10

u/ml

1.45

197

837

Convulsions, not elsewhere classified

343

1638

2.10

35.44

1.4

1.3

257.17

242.69

u/ml

0.38

200

982

Collagenous colitis

149

490

3.13

35.38

1.3

278.80

269.97

u/ml

0.12

302

Recurrent or chronic depression

663

2814

1.72

35.36

1.2

1.3

279.02

257.66

u/ml

1.04

443

1867

Acute pancreatitis (for exclusion)

267

1172

2.32

35.32

1.3

1.2

301.75

284.04

u/ml

0.40

171

720

Amiodarone users

144

465

3.18

35.22

1.2

295.35

287.38

u/ml

0.11

110

282

Cholelithiasis, broad definition with cholecystitis

994

4414

1.55

35.21

1.3

1.2

281.30

277.01

u/ml

0.17

623

2916

Soft tissue disorders

1613

5923

1.42

35.11

1.3

263.68

252.42

u/ml

0.77

1025

3779

Persons encountering health services for specific procedures, not carried out

150

498

3.11

35.10

1.3

1.2

306.47

246.05

u/ml

0.99

107

300

SLE, strict definition

181

4.77

34.96

1.2

1.3

355.69

263.71

u/ml

0.73

110

SLE, ICD10

181

4.77

34.96

1.2

1.3

355.69

263.71

u/ml

0.73

110

Gastro-oesophageal reflux disease

820

4558

1.61

34.89

1.3

286.06

264.79

u/ml

1.19

507

2906

Symptoms and signs concerning food and fluid intake

154

520

3.03

34.74

1.8

1.2

289.37

263.25

u/ml

0.29

288

Benign neoplasm of colon, rectum, anus and anal canal

618

3263

1.72

34.66

1.3

1.2

309.33

280.19

u/ml

1.33

410

2051

Non-invasive ventilation

298

1289

2.20

34.63

1.5

1.3

326.37

253.24

u/ml

3.06

174

820

Diaphragmatic hernia

390

1998

1.97

34.33

1.2

296.96

291.78

u/ml

0.12

253

1245

Symptoms and signs involving the urinary system

924

4612

1.56

34.02

1.4

1.3

256.97

271.34

u/ml

0.90

597

2928

Volume depletion

131

408

3.29

33.98

1.7

1.2

262.12

271.10

u/ml

0.13

239

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

8.59

33.77

1.4

1.2

372.00

257.24

u/ml

0.53

Dental caries 2 and operation codes

1154

6234

1.48

33.50

1.5

1.3

255.96

257.61

u/ml

0.07

757

4022

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1229

5119

1.48

33.44

1.4

1.3

298.39

260.84

u/ml

4.15

814

3323

Dental caries 1 and operation codes

1137

3890

1.51

33.31

1.3

1.2

258.50

258.06

u/ml

0.02

734

2477

Other metabolic disorders

210

852

2.52

33.30

1.4

1.2

311.18

267.67

u/ml

1.10

140

530

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

8.27

33.29

1.4

1.1

351.80

261.97

u/ml

0.66

Urticaria and erythema

556

3216

1.75

33.26

1.4

1.3

266.83

264.49

u/ml

0.07

360

2021

Depression or dysthymia

1010

3692

1.54

33.25

1.3

270.99

258.29

u/ml

0.61

642

2375

Any operation in hilmo

102

4.89

33.22

1.3

1.2

202.83

180.17

u/ml

0.36

Asthma-related pneumonia

445

2406

1.87

33.16

1.3

311.38

264.74

u/ml

2.07

299

1464

Exposure to unspecified factor

1356

7387

1.43

33.04

1.3

247.32

260.87

u/ml

1.15

933

4658

Other diseases of intestine

163

585

2.85

32.98

1.4

1.2

275.59

278.72

u/ml

0.04

108

363

Arthropathies

1500

5386

1.43

32.94

1.3

264.70

250.07

u/ml

1.13

943

3491

ILD medications: nintedanib

18.01

32.93

1.1

1.0

357.74

233.33

u/ml

—

Asthma-related pneumonia or sepsis

445

2414

1.86

32.81

1.3

311.38

264.67

u/ml

2.07

299

1468

Asthma, hospital admissions 3, pneumonia

445

2414

1.86

32.81

1.3

311.38

264.67

u/ml

2.07

299

1468

Gastroduodenal ulcer

267

1206

2.23

32.66

1.4

1.2

314.84

278.44

u/ml

1.16

182

753

Haemorrhage from respiratory passages

393

1899

1.94

32.57

1.3

291.29

261.09

u/ml

1.24

262

1162

Hydronephrosis

152

530

2.93

32.45

1.6

1.2

272.52

276.33

u/ml

0.05

301

Hodgkin lymphoma, hilmo

216

4.30

32.11

1.4

1.2

254.32

255.85

u/ml

0.01

128

Other viral hepatitis

155

553

2.92

32.09

1.3

1.2

261.24

246.49

u/ml

0.24

121

357

Other diseases of lip and oral mucosa

207

848

2.48

32.06

1.3

1.2

259.64

280.00

u/ml

0.47

126

509

Osteomyelitis

120

369

3.37

32.00

1.5

1.3

264.97

257.24

u/ml

0.10

213

Diseases of spleen

6.76

31.74

1.2

320.32

296.53

u/ml

0.17

Episodal and paroxysmal disorders

1675

6222

1.39

31.51

1.3

269.97

253.13

u/ml

1.44

1068

3992

Cholelithiasis

937

4318

1.53

31.35

1.2

280.45

277.87

u/ml

0.09

591

2844

Seborrhoeic keratosis

237

1041

2.31

31.31

1.4

1.2

287.28

286.85

u/ml

0.01

161

629

Viral pneumonia (unknown virus, not influenza)

143

495

3.00

31.23

1.4

1.3

254.50

253.66

u/ml

0.01

308

Other diseases of the respiratory system

226

974

2.35

31.21

1.4

1.3

297.30

273.50

u/ml

0.56

163

584

Other respiratory disorders and diseases

226

974

2.35

31.21

1.4

1.3

297.30

273.50

u/ml

0.56

163

584

Atherosclerosis, excluding cerebral and coronary sclerosis

363

1478

1.98

31.17

1.5

1.2

318.93

286.73

u/ml

1.15

253

883

Viral hepatitis

164

612

2.78

31.12

1.3

1.2

268.91

252.09

u/ml

0.29

127

389

Other embolism and thrombosis

183

719

2.60

31.04

1.3

1.2

320.51

268.99

u/ml

1.37

129

448

Erosion of teeth, including avohilmo

319

1527

2.05

30.91

1.7

1.2

287.44

261.68

u/ml

0.73

223

955

Ulcerative proctitis

130

429

3.14

30.87

1.2

237.23

257.90

u/ml

0.36

270

Hepatocellular carcinoma

6.63

30.83

1.2

422.67

298.07

u/ml

1.19

Persons encountering health services in other circumstances

541

3169

1.73

30.82

1.4

1.3

262.33

250.80

u/ml

0.48

325

1955

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

12.63

30.49

1.5

1.1

237.05

269.63

u/ml

0.17

Isolated proteinuria

207

4.27

30.45

1.9

1.2

236.13

272.69

u/ml

0.54

124

Early onset COPD, excluding more controls

227

990

2.32

30.43

1.2

1.3

316.49

278.79

u/ml

0.86

148

622

Nonischemic cardiomyopathy

110

332

3.44

30.27

1.6

1.3

253.31

267.05

u/ml

0.21

200

Respiratory insufficiency

223

3.97

30.13

1.4

1.3

308.80

283.05

u/ml

0.32

131

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

141

4.91

30.10

1.4

1.1

263.32

292.22

u/ml

0.27

Hepatomegaly and splenomegaly, not elsewhere classified

8.72

30.00

1.7

1.1

269.42

265.90

u/ml

0.02

Other diseases of arteries and capillaries

131

440

3.05

29.99

1.4

1.2

306.84

263.59

u/ml

0.75

266

Mature T/NK-cell lymphomas, hilmo

7.30

29.88

1.4

1.2

351.80

265.59

u/ml

0.63

Osteonecrosis

101

291

3.59

29.84

1.4

1.2

224.95

254.17

u/ml

0.45

171

Herpesviral [herpes simplex] infections

194

800

2.48

29.81

1.3

1.2

271.60

259.37

u/ml

0.18

134

491

Hypertensive Heart Disease

209

713

2.42

29.73

1.5

1.2

262.69

289.24

u/ml

0.66

140

426

Disorders of vitreous body

486

2736

1.75

29.50

1.4

1.2

278.33

289.96

u/ml

0.33

336

1705

Phlebitis and thrombophlebitis (not including DVT)

280

1349

2.11

29.43

1.4

1.2

285.55

276.07

u/ml

0.20

189

849

Other CVD (FINNGEN)

125

313

3.20

29.39

1.4

1.2

282.50

279.42

u/ml

0.03

184

Sequelae of external causes of morbidity and mortality

315

1586

2.02

29.35

1.4

1.2

261.28

272.77

u/ml

0.30

206

998

Glucagon-like peptide-1 (GLP-1) analogues

560

2739

1.70

29.29

1.4

1.2

318.00

282.07

u/ml

2.10

356

1755

Benign neoplasms

1197

4708

1.45

29.22

1.4

1.3

273.22

248.57

u/ml

2.17

790

3080

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

510

2957

1.73

29.20

2.0

1.3

230.42

249.53

u/ml

0.87

331

1855

Hypothyroidism, drug reimbursement

201

586

2.49

29.12

1.4

1.2

284.62

258.59

u/ml

0.52

120

383

Diabetes, insulin treatment (Kela reimbursement)

1263

5442

1.43

29.07

1.4

1.3

297.52

264.04

u/ml

3.51

838

3528

Immunodeficiencies

108

332

3.39

28.97

1.5

1.3

219.20

245.23

u/ml

0.43

196

Immunodeficiency with predominantly antibody defects

172

4.51

28.85

1.6

1.4

203.79

243.30

u/ml

0.67

Unspecified haematuria

456

2207

1.79

28.85

1.5

1.2

258.33

274.99

u/ml

0.68

304

1373

Disorders of vitreous body and globe

499

2838

1.73

28.82

1.4

1.2

277.48

288.97

u/ml

0.33

342

1774

Viral warts

194

816

2.44

28.65

2.2

1.3

273.25

248.04

u/ml

0.54

130

491

Haemorrhage, not elsewhere classified

124

5.10

28.59

1.5

1.1

288.70

300.82

u/ml

0.08

Benign neoplasm: Colon, unspecified

221

975

2.28

28.54

1.2

358.99

288.65

u/ml

1.55

137

629

Secondary thrombocytopenia

8.09

28.49

1.3

1.2

295.10

179.52

u/ml

1.87

Systemic lupus erythematosus, unspecified

162

4.55

28.21

1.2

1.3

366.24

265.61

u/ml

0.67

100

Fluid overload

23.35

28.19

2.1

1.2

231.98

296.20

u/ml

—

Charcot foot

6.09

28.17

1.7

1.2

336.59

269.79

u/ml

0.68

Cytomegaloviral hepatitis

21.43

28.12

1.0

1.1

476.50

142.78

u/ml

—

Visual disturbances and blindness

628

3921

1.62

28.02

1.3

275.92

266.62

u/ml

0.29

392

2462

Pleural effusion

165

649

2.58

27.90

1.3

1.2

315.77

286.26

u/ml

0.59

114

395

Idiopathic gout

116

379

3.13

27.89

1.5

1.2

280.76

292.83

u/ml

0.17

227

Candidiasis

208

912

2.33

27.83

1.4

1.2

305.35

265.76

u/ml

1.06

135

564

Disorders of skin appendages

705

4537

1.57

27.63

1.3

263.05

257.09

u/ml

0.23

474

2878

Sequelae with surgical and medical care as external cause

246

1160

2.16

27.43

1.4

1.2

261.85

277.49

u/ml

0.39

160

717

Filling of root of tooth

210

4.02

27.34

1.3

368.32

251.42

u/ml

1.96

124

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

146

552

2.71

26.93

1.3

1.2

307.58

268.89

u/ml

0.77

341

Presence of other functional implants

473

1932

1.75

26.85

1.4

1.1

299.81

270.60

u/ml

1.37

299

1145

Dental caries 3 and operation codes

1188

4284

1.43

26.79

1.3

264.54

255.59

u/ml

0.49

771

2717

Other acute viral hepatitis

6.13

26.77

1.2

182.23

258.50

u/ml

0.96

Melanocytic naevi

382

2113

1.83

26.76

1.5

1.3

264.05

266.68

u/ml

0.06

263

1369

Myelodysplastic syndrome

13.47

26.69

1.3

1.1

294.65

363.33

u/ml

0.20

Abnormal findings on examination of urine, without diagnosis

305

3.39

26.52

1.8

1.2

245.59

259.82

u/ml

0.20

177

Other disorders of lacrimal gland

398

2238

1.80

26.36

1.3

1.2

271.61

277.77

u/ml

0.15

261

1419

Chronic pancreatitis

164

663

2.52

26.30

1.4

1.2

309.95

290.27

u/ml

0.35

107

411

Diabetes medication

1326

5828

1.39

26.28

1.4

1.3

298.36

258.64

u/ml

4.47

864

3786

Other problems related to primary support group, including family circumstances

264

1270

2.08

26.27

2.6

1.3

214.16

234.88

u/ml

0.55

160

746

L01XE Protein kinase inhibitors

292

3.40

26.14

1.2

312.92

265.04

u/ml

0.75

170

Dental pulpitis 2

887

3034

1.51

25.95

1.3

1.2

260.80

256.19

u/ml

0.19

570

1914

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1130

5208

1.42

25.68

1.3

294.26

269.51

u/ml

2.03

750

3405

Need for other prophylactic measures

113

384

3.05

25.61

1.6

1.3

269.84

237.07

u/ml

0.47

221

Other diseases of anus and rectum

324

1723

1.90

25.60

1.3

313.22

270.83

u/ml

1.55

201

1095

Iron deficiency anaemia secondary to blood loss (chronic)

185

800

2.35

25.49

1.5

1.2

301.84

272.50

u/ml

0.64

122

493

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

9.72

25.49

1.5

1.2

237.05

333.37

u/ml

0.48

Hard cardiovascular diseases

831

3573

1.50

25.13

1.3

308.64

276.95

u/ml

1.90

556

2294

Stomatitis and related lesions

140

537

2.67

25.12

1.6

1.1

263.14

248.41

u/ml

0.13

310

STROKE

617

2694

1.60

25.10

1.3

1.2

292.66

271.12

u/ml

0.85

413

1728

Other and unspecified drugs and medicaments

138

527

2.69

25.02

1.3

1.2

301.30

262.02

u/ml

0.97

318

Migraine

751

4242

1.52

24.99

1.3

252.01

250.90

u/ml

0.03

474

2730

Irritable bowel syndrome

365

2035

1.82

24.94

1.2

1.3

257.05

265.82

u/ml

0.26

232

1301

Heart failure and hypertrophic cardiomyopathy

6.28

24.67

1.4

1.1

361.05

274.97

u/ml

0.73

Disorders of thyroid, IBD co-morbidities

253

895

2.09

24.59

1.3

1.2

301.75

254.32

u/ml

1.23

173

608

Gastric ulcer

179

775

2.34

24.56

1.4

1.2

338.11

278.07

u/ml

1.79

125

478

Hypersensitivity angiitis

13.05

24.55

1.6

1.2

344.06

275.21

u/ml

0.20

Cellulitis

308

1639

1.91

24.52

1.5

1.3

274.28

258.16

u/ml

0.44

201

1013

Injury, poisoning and certain other consequences of external causes

865

2914

1.50

24.52

1.3

255.99

250.28

u/ml

0.22

539

1815

Visual disturbances

582

3688

1.59

24.51

1.3

274.78

266.01

u/ml

0.26

363

2312

Disorders of sclera, cornea, iris and ciliary body

683

4485

1.54

24.50

1.3

258.95

271.30

u/ml

0.54

449

2884

Cholecystectomy

743

4373

1.51

24.46

1.3

1.2

275.19

281.77

u/ml

0.23

462

2873

COPD-related respiratory insufficiency

128

475

2.74

24.41

1.2

308.63

292.17

u/ml

0.20

283

Disorders of lacrimal system

469

2821

1.68

24.39

1.3

272.69

278.50

u/ml

0.15

295

1796

Other functional intestinal disorders

523

3073

1.63

24.38

1.3

1.4

285.25

257.12

u/ml

0.98

312

1896

Abnormalities of heart beat

413

2380

1.74

24.30

1.3

286.77

258.83

u/ml

0.88

271

1499

Heart failure and coronary heart disease

273

1023

2.01

24.17

1.3

1.2

302.54

299.60

u/ml

0.05

176

616

Erythema nodosum

143

4.45

24.16

1.3

1.2

270.53

252.34

u/ml

0.17

Obesity related asthma

410

2386

1.74

24.16

1.3

251.81

272.77

u/ml

0.89

255

1523

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

6.98

24.15

1.2

268.04

286.68

u/ml

0.11

Sleep disorders (combined)

1253

5984

1.38

24.11

1.3

279.06

266.79

u/ml

0.73

783

3908

Viral and other specified intestinal infections

422

2421

1.73

24.10

1.8

1.3

237.19

231.17

u/ml

0.16

284

1432

Other specific joint derangements/joint disorders

1068

5087

1.42

24.03

1.3

269.51

253.77

u/ml

0.89

661

3328

Intestinal stricture

319

1727

1.87

23.96

1.3

298.71

279.86

u/ml

0.43

207

1071

Other pleural conditions

118

425

2.83

23.85

1.3

1.2

342.66

279.05

u/ml

1.33

262

Tubulo-interstitial nephritis, not specified as acute or chronic

324

3.13

23.80

1.5

1.2

260.70

264.17

u/ml

0.03

174

Follow-up examination after treatment for conditions other than malignant neoplasms

529

2124

1.64

23.72

1.3

1.2

291.33

253.38

u/ml

2.09

338

1375

Diabetic neuropathy

162

684

2.41

23.44

1.6

1.4

272.54

310.53

u/ml

0.92

115

444

Diseases of middle ear and mastoid

897

5114

1.45

23.43

1.4

1.3

252.51

248.10

u/ml

0.18

598

3275

Isolated proteinuria with specified morphological lesion

6.65

23.29

1.8

1.2

235.23

264.41

u/ml

0.21

Persons with potential health hazards related to communicable diseases

667

4377

1.53

23.24

1.5

1.3

256.80

244.21

u/ml

0.59

448

2764

Other nutritional deficiencies

849

5751

1.45

23.21

1.3

276.60

263.93

u/ml

0.67

525

3765

Use of hypnotics and sedatives

1328

5669

1.36

23.03

1.3

282.05

268.83

u/ml

0.91

899

3679

Non-allergic asthma (mode), excluding more controls

229

1112

2.06

23.03

1.4

1.3

291.22

260.52

u/ml

0.65

156

653

Asthma (diagnoses ohter than nonallergic)

1139

7092

1.38

23.00

1.3

275.79

256.56

u/ml

1.28

730

4512

Myeloproliferative diseases

111

397

2.86

22.81

1.2

315.82

268.82

u/ml

0.75

243

Eosinophilic disease (BM)

6.37

22.78

1.2

1.4

242.88

242.87

u/ml

0.00

Postprocedural endocrine and metabolic disorders, not elsewhere classified

171

753

2.31

22.73

1.3

1.2

305.61

268.21

u/ml

0.86

115

474

Dental caries 1

966

3446

1.44

22.72

1.3

1.2

255.72

257.27

u/ml

0.06

624

2188

Dental caries, including avohilmo

965

3443

1.44

22.70

1.3

1.2

255.82

257.34

u/ml

0.06

623

2186

Viral pneumonia (known virus, not influenza)

151

4.28

22.67

1.7

1.5

283.19

272.08

u/ml

0.08

Other/unspecified dorsalgia

469

2863

1.64

22.59

1.3

298.70

273.21

u/ml

0.81

303

1854

Mantle cell lymphoma

8.70

22.57

1.4

1.1

473.50

225.95

u/ml

—

Haemolytic-uraemic syndrome

14.37

22.49

2.1

1.5

162.65

176.73

u/ml

0.11

Secondary right heart disease

173

3.94

22.47

1.3

1.2

380.50

293.38

u/ml

0.86

Diseases of pulp and periapical tissues, including avohilmo

1508

5907

1.33

22.28

1.3

259.86

255.68

u/ml

0.23

990

3732

Dental pulpitis 4

1510

5917

1.33

22.24

1.3

259.81

255.60

u/ml

0.23

990

3740

Other general symptoms and signs

313

3.10

22.23

1.4

1.3

228.50

243.41

u/ml

0.24

168

Other and unspecified local infections of skin and subcutaneous tissue

150

631

2.43

22.22

1.6

1.3

287.57

259.34

u/ml

0.55

111

385

Dental pulpitis 1

1508

5916

1.33

22.07

1.3

259.92

255.64

u/ml

0.23

989

3738

Other and unspecified acquired haemolytic anaemias

8.07

22.03

1.5

1.2

243.73

248.04

u/ml

0.03

Other renal tubulo-interstitial diseases

117

4.65

21.74

1.7

1.1

223.92

242.66

u/ml

0.17

Invasive ventilation

115

431

2.74

21.71

1.8

1.4

324.38

262.72

u/ml

1.17

251

Amputation of ankle bones

5.36

21.69

1.5

1.2

289.37

282.98

u/ml

0.04

Benign neoplasm of other and ill-defined parts of digestive system

171

767

2.26

21.68

1.2

304.48

278.28

u/ml

0.56

114

486

Acute nephritic syndrome

143

4.30

21.68

1.9

1.3

281.49

264.63

u/ml

0.14

Infliximab

7.71

21.67

1.2

1.3

223.00

227.22

u/ml

0.03

Continuous positive airway pressure

225

959

2.05

21.64

1.5

1.3

274.70

261.25

u/ml

0.30

149

583

Other local infections of skin and subcutaneous tissue

156

677

2.36

21.54

1.6

1.3

292.75

261.64

u/ml

0.64

113

416

Other specified/unspecified systemic involvement of connective tissue

302

3.10

21.47

1.3

1.2

304.85

274.22

u/ml

0.22

186

Other pulmonary heart/vessel disease

207

3.59

21.44

1.3

1.2

374.74

272.56

u/ml

1.17

106

Vocal cord dysfunction

164

671

2.30

21.41

1.3

299.50

221.97

u/ml

1.78

429

Rheumatoid arthritis

351

1832

1.76

21.39

1.2

314.88

279.04

u/ml

1.36

194

1202

Non-allergic asthma (mode)

229

1143

2.01

21.39

1.4

1.3

291.22

263.34

u/ml

0.57

156

679

Childhood asthma (age<16), excluding more controls

291

1247

1.88

21.38

1.3

1.2

233.83

220.95

u/ml

0.29

177

755

Hypokalaemia

137

562

2.48

21.36

1.6

1.2

263.49

272.90

u/ml

0.13

328

External causes of morbidity and mortality

1022

3652

1.41

21.31

1.3

261.36

254.36

u/ml

0.31

643

2292

Diseases of salivary glands

224

1123

2.02

21.28

1.2

299.46

271.42

u/ml

0.59

147

687

Excessive attrition of teeth

536

1824

1.61

21.27

1.7

1.2

268.02

254.44

u/ml

0.46

356

1116

Use of pramipexole

232

1180

1.99

21.16

1.4

1.2

289.18

284.52

u/ml

0.09

158

733

Paralytic ileus and intestinal obstruction

252

1318

1.93

21.09

1.3

298.53

273.40

u/ml

0.53

169

814

Melanocytic naevi of trunk

168

761

2.25

20.93

1.6

1.2

296.41

258.69

u/ml

0.71

110

489

Acquired absence of organs, not elsewhere classified

6.75

20.87

1.6

1.1

312.59

287.73

u/ml

0.10

Mixed connective tissue disease

100

356

2.88

20.82

1.2

306.56

268.20

u/ml

0.32

213

Chronic ulcer of skin, not elsewhere classified

302

3.05

20.79

1.4

1.2

336.17

256.69

u/ml

1.60

172

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

317

2.97

20.75

1.2

288.78

302.47

u/ml

0.15

193

Low back pain

959

5307

1.40

20.73

1.3

273.42

261.38

u/ml

0.57

638

3472

Functional dyspepsia

309

1735

1.80

20.72

1.3

1.2

293.38

265.64

u/ml

0.96

207

1114

Total colectomy operation

294

3.11

20.67

1.2

1.3

262.65

247.43

u/ml

0.20

181

Total colectomy

294

3.11

20.67

1.2

1.3

262.65

247.43

u/ml

0.20

181

Other interventions on the root canals of the tooth

132

4.36

20.48

1.5

1.3

360.78

229.68

u/ml

1.07

Microscopic polyangiitis

10.43

20.42

1.8

1.4

246.22

299.14

u/ml

0.16

Benign neoplasms

1404

5941

1.33

20.38

1.3

275.43

254.48

u/ml

1.89

927

3825

Spondyloarthritis

232

1198

1.96

20.28

1.2

302.88

263.62

u/ml

1.11

145

765

Hypoplasia of dental enamel, prenatal

11.09

20.24

5.3

2.2

147.67

103.21

u/ml

0.50

Covid-19 suspected case

335

1943

1.75

20.19

1.4

1.3

251.83

261.79

u/ml

0.28

221

1234

Other complications of surgical and medical care, not elsewhere classified

142

609

2.38

20.16

1.4

1.2

263.79

264.40

u/ml

0.01

379

Childhood asthma (age<16)

291

1272

1.85

20.14

1.3

1.2

233.83

221.21

u/ml

0.29

177

777

Unspecified acute lower respiratory infection

219

1113

2.00

20.14

1.5

1.3

251.69

262.71

u/ml

0.25

144

704

Recurring oral aphthae

315

2.99

20.06

1.8

1.3

262.63

246.68

u/ml

0.09

180

Osteonecrosis due to drugs

6.69

20.05

1.6

1.2

238.09

278.23

u/ml

0.23

Abnormal findings on diagnostic imaging of other body structures

157

704

2.27

20.04

1.3

1.2

318.91

268.49

u/ml

1.07

101

432

Injuries to the ankle and foot

998

6644

1.38

20.01

1.4

1.3

237.61

258.91

u/ml

1.74

632

4281

Congenital malformation of biliary tract

8.95

19.75

3.1

2.2

249.17

123.17

u/ml

1.59

L04AC Interleukin inhibitors

102

380

2.78

19.63

1.2

315.52

246.86

u/ml

1.41

235

Acute lymphocytic leukaemia, helper endpoint

5.62

19.55

1.5

1.8

114.71

171.64

u/ml

1.33

Acute lymphocytic leukaemia, excluding all cancers (controls excluding all cancers)

5.62

19.55

1.5

1.8

114.71

171.64

u/ml

1.33

Undetermined asthma, excluding more controls

152

679

2.27

19.50

1.3

1.2

253.15

262.61

u/ml

0.15

392

Disorders of oesophagus in diseases classified elsewhere

5.18

19.46

1.3

1.1

342.35

256.74

u/ml

0.93

Dental pulpitis 2, only avohilmo

878

3176

1.42

19.39

1.3

1.2

256.50

257.03

u/ml

0.02

562

2011

Other or unspecified ileus, impaction or obstruction

179

855

2.12

19.39

1.3

269.20

279.89

u/ml

0.16

118

524

Adverse effects, not elsewhere classified

303

1732

1.78

19.27

1.4

1.3

266.85

254.67

u/ml

0.31

192

1084

Hypoplasia of dental enamel, prenatal , including avohilmo

6.02

19.23

4.2

2.2

187.30

122.58

u/ml

0.85

Hernia

1132

5722

1.35

19.12

1.4

1.3

272.40

266.65

u/ml

0.28

742

3693

Other and unspecified effects of external causes

419

2614

1.62

19.09

1.4

1.3

267.28

258.17

u/ml

0.27

262

1644

Dermatitis due to substances taken internally

368

2.77

19.08

1.6

1.3

343.40

247.15

u/ml

1.59

220

Acute lymphocytic leukaemia

5.49

19.05

1.5

1.8

114.71

165.30

u/ml

1.12

Other diseases of upper respiratory tract

1476

5927

1.30

18.88

1.3

259.69

257.12

u/ml

0.12

920

3815

Asthma, including avohilmo

1577

7138

1.29

18.85

1.2

1.3

268.94

256.57

u/ml

0.88

1015

4557

Undetermined asthma

152

690

2.23

18.78

1.3

1.2

253.15

260.33

u/ml

0.11

405

Other headache syndromes

529

3489

1.53

18.77

1.2

1.3

276.54

267.50

u/ml

0.26

339

2288

Other diseases of blood and blood-forming organs

354

2.78

18.74

1.3

1.2

260.09

257.92

u/ml

0.03

223

Fibrosis of liver

8.68

18.67

1.6

1.2

269.77

207.63

u/ml

0.47

Encephalopathy

7.11

18.61

1.2

1.1

349.77

336.22

u/ml

0.05

Ulcerative enterocolitis

193

3.50

18.54

1.2

1.3

343.24

242.69

u/ml

0.72

125

Sleep apnoea

1036

5198

1.36

18.40

1.3

287.13

274.22

u/ml

0.66

641

3439

Benign neoplasm: Transverse colon

374

2.69

18.37

1.3

1.2

298.24

285.70

u/ml

0.15

235

Adult-onset Still disease

12.65

18.35

1.3

1.4

312.29

145.56

u/ml

—

Behavioural syndromes associated with physiological disturbances and physical factors

502

3294

1.54

18.30

1.4

1.3

244.35

251.52

u/ml

0.26

340

2075

Amputation of foot

104

4.51

18.22

1.5

1.2

289.97

300.17

u/ml

0.07

Hernia of abdominal wall

493

3224

1.54

18.21

1.5

1.3

280.76

277.96

u/ml

0.08

330

2078

Peripheral arterial reconstruction

142

636

2.26

18.13

1.5

1.2

310.26

299.84

u/ml

0.16

109

385

Malignant immunoproliferative diseases

8.57

18.13

1.9

1.1

262.33

259.63

u/ml

0.01

Other CVD

170

819

2.10

18.06

1.4

1.2

280.14

289.07

u/ml

0.14

112

489

Sleep apnoea, including avohilmo

1121

5458

1.34

18.00

1.3

280.08

271.88

u/ml

0.39

699

3624

Melanocytic naevi

382

2364

1.63

18.00

1.5

1.2

264.05

267.12

u/ml

0.07

263

1494

Asthma, hospital admissions , main diagnosis only

1069

7194

1.34

17.84

1.3

270.19

256.55

u/ml

0.75

685

4592

Chronic lower respiratory diseases

1645

7011

1.27

17.76

1.3

272.99

255.33

u/ml

1.51

1056

4485

Other specified disorders of kidney and ureter

179

3.54

17.73

1.6

1.2

245.58

274.26

u/ml

0.34

104

Other arrhythmias

703

3769

1.44

17.68

1.3

281.57

267.25

u/ml

0.57

468

2410

Other and unspecified diseases of blood and blood-forming organs

124

4.12

17.65

1.4

1.2

237.35

270.90

u/ml

0.31

Temporomandibular joint disorders

212

1115

1.93

17.64

1.2

268.31

268.78

u/ml

0.01

133

694

Benign neoplasm: Colon, unspecified

221

1178

1.90

17.61

1.2

358.99

286.25

u/ml

1.65

137

731

Other juvenile arthritis

111

457

2.52

17.55

1.3

1.5

250.95

198.14

u/ml

0.91

259

Rheumatoid arthritis, including avohilmo

389

2433

1.61

17.49

1.2

306.33

282.04

u/ml

0.84

216

1543

Hypersplenism

12.69

17.43

1.2

1.3

278.50

195.44

u/ml

—

Parodontitis or/and operation codes

854

3663

1.40

17.43

1.4

1.3

290.19

268.76

u/ml

1.11

582

2417

Subjective visual disturbances

294

1714

1.74

17.43

1.2

270.80

271.14

u/ml

0.01

193

1085

Personal history of other diseases and conditions

205

1070

1.95

17.36

1.5

1.2

280.49

237.68

u/ml

1.11

135

597

Atopic dermatitis

820

5068

1.39

17.32

1.3

226.80

253.70

u/ml

2.33

494

3278

295

1617

1.73

17.24

1.2

295.02

292.87

u/ml

0.04

173

983

Dental caries 3

1026

3886

1.36

17.15

1.3

257.40

254.54

u/ml

0.12

665

2462

Dorsalgia

1368

5730

1.30

17.14

1.3

265.01

256.66

u/ml

0.46

907

3716

Other disorders of glucose regulation and pancreatic internal secretion

136

616

2.26

17.10

1.6

1.4

260.52

254.20

u/ml

0.09

368

Sulfasalazine

307

1822

1.70

16.99

1.2

1.3

315.56

257.03

u/ml

2.86

187

1177

Pruritus

147

688

2.17

16.98

1.4

1.2

251.77

275.06

u/ml

0.49

442

L01XX Other antineoplastic agents

224

3.16

16.97

1.2

367.89

289.17

u/ml

0.60

127

Colectomy operation

177

888

2.02

16.92

1.2

313.35

275.19

u/ml

0.78

100

545

Other congenital malformations of the digestive system

119

512

2.41

16.87

2.2

1.6

224.05

206.56

u/ml

0.33

264

Other neurological diseases

718

4101

1.42

16.82

1.3

290.53

275.24

u/ml

0.59

482

2599

Shock, not elsewhere classified

8.14

16.75

1.8

1.2

235.76

254.00

u/ml

0.09

Actinic keratosis

260

1400

1.78

16.75

1.2

291.42

293.16

u/ml

0.03

149

847

Nonorganic sleeping disorders, excluding more controls

263

1507

1.77

16.64

1.2

1.3

260.38

250.36

u/ml

0.24

175

955

Dorsopathies

1486

5944

1.28

16.63

1.3

255.92

254.14

u/ml

0.08

964

3816

Dysphagia

224

1222

1.85

16.61

1.3

1.2

270.53

273.60

u/ml

0.06

143

755

Cardiac arrest

209

3.06

16.59

1.6

1.2

323.49

254.31

u/ml

0.91

123

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

11.13

16.56

1.6

2.4

294.90

137.55

u/ml

—

Chronic myeloproliferative disease

6.00

16.55

1.5

1.2

287.33

288.11

u/ml

0.00

Obesity and other hyperalimentation

772

5546

1.39

16.44

1.3

281.39

265.19

u/ml

0.86

473

3646

Fibromyalgia

125

556

2.29

16.40

1.2

301.12

260.45

u/ml

0.99

348

Obesity

769

5529

1.39

16.37

1.3

281.67

264.70

u/ml

0.92

472

3636

Other coagulation defects

111

470

2.42

16.36

1.3

1.2

268.71

260.42

u/ml

0.07

287

712

4678

1.41

16.36

1.3

292.87

261.08

u/ml

2.33

479

3015

Complications of cardiac and vascular prosthetic devices, implants and grafts

4.55

16.34

1.5

1.2

269.24

299.02

u/ml

0.20

Accidents

1194

4566

1.32

16.26

1.3

267.48

259.60

u/ml

0.39

754

2908

DVT of lower extremities

192

1006

1.93

16.18

1.3

1.2

276.60

279.05

u/ml

0.04

129

622

Special screening examination for infectious and parasitic diseases

372

1737

1.62

16.14

1.2

256.68

244.68

u/ml

0.29

236

1171

Generalized skin eruption due to drugs and medicaments

265

2.93

16.02

1.7

1.3

363.04

243.96

u/ml

1.53

149

Acute generalized exanthematous pustulosis

293

2.82

15.96

1.7

1.3

357.73

233.97

u/ml

1.83

166

Skin changes due to chronic exposure to nonionizing radiation

267

1465

1.74

15.93

1.2

298.18

291.57

u/ml

0.13

153

886

Cerebrovascular diseases

685

3482

1.42

15.90

1.3

285.27

283.81

u/ml

0.05

441

2205

Nonsuppurative otitis media

446

2538

1.54

15.86

1.6

1.3

232.99

222.52

u/ml

0.33

280

1524

Elevated blood glucose level

117

514

2.32

15.84

1.6

1.3

283.25

264.76

u/ml

0.23

306

Allergic asthma (mode), excluding more controls

318

1905

1.65

15.83

1.2

253.22

242.66

u/ml

0.26

191

1188

Symptoms and signs involving cognition, perception, emotional state and behaviour

1138

6123

1.31

15.81

1.2

1.3

277.34

267.78

u/ml

0.49

740

3954

Hypotension

136

636

2.16

15.68

1.4

1.2

282.24

294.11

u/ml

0.17

383

Alcohol use disorder, Swedish definition

658

4347

1.41

15.65

1.3

293.84

264.78

u/ml

1.90

437

2833

Other obstetric conditions, not elsewhere classified

516

2259

1.50

15.62

1.2

239.15

251.60

u/ml

0.58

356

1500

Chronic myeloid leukaemia, excluding all cancers (controls excluding all cancers)

6.87

15.61

1.1

1.2

352.11

232.59

u/ml

0.95

Eosinophilia

4.41

15.56

1.4

1.5

238.33

255.32

u/ml

0.13

Dermatopolymyositis (FG)

5.43

15.51

1.2

299.62

225.97

u/ml

0.53

Other diseases of stomach and duodenum

280

2.81

15.48

1.4

1.2

351.09

267.62

u/ml

1.32

175

Osteoporosis with pathological fracture (FG)

184

3.26

15.48

1.2

262.61

248.79

u/ml

0.16

107

Umbilical hernia

317

1947

1.64

15.48

1.5

1.3

267.31

278.15

u/ml

0.31

210

1256

Disorder of lipoprotein metabolism, unspecified

123

556

2.24

15.47

1.3

1.2

267.52

285.53

u/ml

0.36

338

Suppurative and unspecified otitis media

611

3817

1.43

15.38

1.5

1.3

241.27

236.19

u/ml

0.18

395

2414

Urticaria

415

2719

1.54

15.37

1.4

1.3

262.50

259.39

u/ml

0.08

270

1706

Other disorders of skin and subcutaneous tissue, not elsewhere classified

160

803

2.02

15.35

1.3

1.2

312.39

270.91

u/ml

1.03

482

Cardiodefibrillation

310

1893

1.65

15.33

1.3

1.2

306.59

284.22

u/ml

0.66

221

1156

Drug-induced osteoporosis with pathological fracture

5.53

15.32

1.2

1.4

296.48

297.47

u/ml

0.00

Selective serotonin reuptake inhibitors

1341

5525

1.28

15.31

1.2

1.3

262.23

258.82

u/ml

0.17

844

3580

Recurring oral aphthae, including avohilmo

195

1049

1.89

15.30

1.5

1.3

246.69

261.07

u/ml

0.19

117

623

Seropositive rheumatoid arthritis

240

1368

1.77

15.28

1.1

1.2

313.79

279.49

u/ml

0.98

131

860

Disorders of eyelid, lacrimal system and orbit

929

5479

1.34

15.25

1.3

273.79

271.77

u/ml

0.07

597

3502

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

506

2216

1.50

15.25

1.2

238.67

249.99

u/ml

0.50

349

1475

AV-block

146

640

2.09

15.23

1.5

1.2

318.55

269.77

u/ml

1.19

394

Disorders of the thyroid gland

1154

5826

1.30

15.17

1.3

283.11

263.07

u/ml

1.31

718

3811

Thyroiditis, ILD-related definition

152

753

2.05

15.16

1.4

1.2

322.90

258.81

u/ml

1.06

106

463

Localized swelling, mass and lump of skin and subcutaneous tissue

355

2252

1.59

15.15

1.3

261.64

272.40

u/ml

0.28

230

1418

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

434

2621

1.53

15.11

1.6

1.4

238.69

219.21

u/ml

0.81

256

1582

Other dorsopathies, not elsewhere classified

1397

5808

1.27

15.11

1.3

256.40

255.57

u/ml

0.04

917

3755

Acute suppurative otitis media

490

3114

1.49

15.02

1.6

1.3

234.49

230.42

u/ml

0.13

312

1965

Special screening examination for other diseases and disorders

123

564

2.22

15.00

1.5

1.2

242.72

235.70

u/ml

0.09

340

Other external causes of accidental injury

1182

4566

1.30

15.00

1.3

268.68

259.60

u/ml

0.47

745

2908

Benign neoplasm: Ascending colon

110

481

2.32

14.99

1.2

295.93

277.02

u/ml

0.27

301

Paracetamol of NSAID medication

359

1120

1.63

14.92

1.3

1.5

232.02

242.42

u/ml

0.25

201

670

741

4854

1.38

14.92

1.3

290.90

262.01

u/ml

2.06

493

3140

Melanocytic naevi of trunk

168

868

1.97

14.91

1.6

1.2

296.41

261.03

u/ml

0.65

110

545

Juvenile arthritis (FINNGEN)

115

518

2.29

14.86

1.4

1.5

259.20

207.78

u/ml

0.84

296

Other symptoms and signs involving the digestive system and abdomen

176

923

1.93

14.85

1.4

1.3

269.27

266.05

u/ml

0.04

545

Personality disorders, excluding more controls

362

2323

1.57

14.74

1.2

1.3

288.16

250.24

u/ml

1.71

229

1539

Unspecified contracted kidney

7.97

14.69

1.8

1.1

252.58

235.89

u/ml

0.05

Squamous cell neoplasms and carcinomas of the skin

381

2.47

14.65

1.2

1.1

288.78

312.05

u/ml

0.28

220

Arterial embolism and thrombosis

222

2.98

14.64

1.3

1.2

323.92

276.55

u/ml

0.56

124

Renal agenesis and other reduction defects of kidney

6.47

14.63

1.4

218.30

167.00

u/ml

0.46

Allergic asthma (mode)

318

1945

1.62

14.61

1.2

253.22

244.15

u/ml

0.21

191

1225

Diseases of the ear and mastoid process

1594

6481

1.25

14.52

1.3

267.22

258.04

u/ml

0.56

1024

4195

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

437

1974

1.52

14.50

1.3

1.2

297.44

292.43

u/ml

0.12

264

1279

Opening and dilatation of root channel of tooth

112

503

2.28

14.50

1.3

1.2

342.65

257.18

u/ml

1.55

306

Phobic anxiety disorders

240

1402

1.74

14.31

1.4

1.3

247.87

243.18

u/ml

0.09

149

881

Other diseases of pancreas

363

2.50

14.26

1.4

1.2

240.67

283.23

u/ml

0.80

219

Chronic rhinitis, nasopharyngitis and pharyngitis

391

2571

1.53

14.26

1.2

1.3

272.29

272.08

u/ml

0.00

253

1660

Other and unspecified coagulation defects

318

2.62

14.13

1.3

284.81

259.27

u/ml

0.17

192

Retinal detachments and breaks

306

1908

1.62

14.05

1.4

1.2

265.87

285.03

u/ml

0.70

212

1209

In situ neoplasms

301

1780

1.62

14.03

1.3

1.2

310.31

281.54

u/ml

0.91

197

1167

Giant cell arteritis

146

3.44

13.91

1.2

262.96

305.01

u/ml

0.37

Myocardial infarction

438

2105

1.50

13.88

1.3

1.2

313.43

280.31

u/ml

1.12

292

1309

Wegener granulomatosis

4.35

13.88

1.4

296.92

283.26

u/ml

0.07

Dermatophytosis

152

778

1.98

13.87

1.4

1.2

268.26

267.37

u/ml

0.01

485

Other maternal disorders predominantly related to pregnancy

692

3160

1.39

13.83

1.2

250.74

271.87

u/ml

1.37

473

2026

Acute posthaemorrhagic anaemia

137

3.52

13.81

1.4

1.1

324.51

308.41

u/ml

0.11

Other obstructive and reflux uropathy

281

2.70

13.80

1.5

1.2

262.33

244.11

u/ml

0.19

157

Lower back pain or/and sciatica

1237

6779

1.27

13.79

1.2

1.3

272.04

263.24

u/ml

0.46

820

4395

COPD (mode)

229

1045

1.75

13.77

1.2

320.85

279.04

u/ml

0.94

142

638

Type 2 diabetes, definitions combined

984

4494

1.31

13.69

1.3

1.2

303.36

268.34

u/ml

2.90

608

2971

Seborrhoeic dermatitis

124

593

2.13

13.66

1.4

1.2

267.80

268.28

u/ml

0.01

377

Vasculitis limited to skin, not elsewhere classified

134

3.56

13.61

1.3

1.2

281.46

249.29

u/ml

0.25

Hyperkinetic disorders, excluding more controls

218

1225

1.76

13.60

1.5

1.3

242.58

214.78

u/ml

0.75

124

727

Migraine with aura

343

2218

1.56

13.56

1.3

240.10

256.30

u/ml

0.40

226

1430

Myeloproliferative diseases (CML excluded)

354

2.47

13.52

1.2

303.29

264.99

u/ml

0.48

207

Sicca syndrome [Sjögren]

102

453

2.29

13.51

1.2

290.55

285.05

u/ml

0.07

274

Benign neoplasm of other and ill-defined parts of digestive system

171

919

1.88

13.45

1.2

304.48

283.49

u/ml

0.42

114

567

Acute lymphadenitis

111

513

2.22

13.44

1.5

1.3

248.27

235.91

u/ml

0.17

311

Nerve, nerve root and plexus disorders

1196

5920

1.27

13.43

1.3

281.28

269.42

u/ml

0.66

775

3888

Irregular menses

602

3509

1.40

13.41

1.3

1.2

260.10

260.57

u/ml

0.01

379

2333

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

606

4285

1.39

13.41

1.3

277.55

270.34

u/ml

0.20

374

2813

Benzodiazepine use

1183

6643

1.27

13.39

1.2

1.3

275.68

264.78

u/ml

0.65

737

4382

Polyarteritis nodosa and related conditions

4.42

13.37

1.5

1.4

281.20

268.50

u/ml

0.06

Special screening examination for neoplasms

160

3.25

13.33

1.2

257.46

246.84

u/ml

0.11

102

Polymyalgia rheumatica

102

456

2.26

13.24

1.2

281.67

299.30

u/ml

0.23

274

Constipation

947

5211

1.31

13.23

1.3

303.99

267.64

u/ml

2.66

595

3298

Chronic sinusitis

494

3453

1.44

13.21

1.2

1.3

277.28

272.12

u/ml

0.12

299

2278

Obesity due to excess calories

563

4047

1.40

12.91

1.3

284.38

265.56

u/ml

0.79

333

2648

Erythema multiforme

129

3.54

12.91

1.3

1.2

310.05

267.04

u/ml

0.31

Exposure to other specified factors

956

6957

1.30

12.91

1.3

254.40

260.41

u/ml

0.26

633

4439

Dermatopolymyositis

4.47

12.83

1.2

1.5

289.90

265.57

u/ml

0.13

Abnormality of white blood cells, not elsewhere classified

5.87

12.82

1.5

1.2

292.44

248.56

u/ml

0.22

Migraine without aura

311

1995

1.58

12.81

1.3

281.02

249.96

u/ml

0.79

207

1281

Type 2 diabetes, strict (exclude DM1)

986

4549

1.30

12.81

1.3

1.2

303.36

269.74

u/ml

2.70

608

3013

Cholecystitis

125

614

2.06

12.78

1.3

1.2

285.86

280.57

u/ml

0.06

375

Other specified/unspecified necrotizing vasculopathies

5.14

12.78

1.4

1.2

229.70

254.82

u/ml

0.20

Pre-eclampsia or poor fetal growth

385

2580

1.50

12.74

1.3

1.2

276.87

265.21

u/ml

0.37

282

1706

Methotrexate

150

787

1.93

12.72

1.2

275.91

248.22

u/ml

0.56

478

Other congenital malformations of urinary system

5.26

12.62

3.6

1.4

177.39

200.72

u/ml

0.21

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

361

1622

1.53

12.60

1.3

1.2

309.51

290.91

u/ml

0.52

214

1047

Myalgia

277

1735

1.61

12.60

1.3

1.2

254.88

269.53

u/ml

0.38

170

1121

Type 2 diabetes, definitions combined, including avohilmo

995

4567

1.29

12.59

1.3

1.2

304.84

268.36

u/ml

3.12

613

3033

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

222

2.90

12.59

2.2

1.5

217.49

221.45

u/ml

0.03

118

Myocardial infarction, without ST-elevation

297

1738

1.59

12.58

1.2

314.90

291.21

u/ml

0.49

189

1082

Malignant immunoproliferative diseases

5.69

12.50

1.9

1.2

262.33

331.39

u/ml

0.28

Erectile dysfunction

386

2.35

12.50

1.4

1.3

252.29

285.42

u/ml

0.56

228

Osteopathy in diseases classified elsewhere

7.30

12.49

2.0

1.5

397.42

288.00

u/ml

0.28

Symptoms and signs involving the nervous and musculoskeletal systems

628

4621

1.37

12.42

1.4

1.3

273.91

269.65

u/ml

0.15

403

2939

Carcinoma in situ of skin

232

2.75

12.42

1.3

1.1

281.98

296.97

u/ml

0.15

139

Late syphilis

4.48

12.39

1.5

1.2

324.32

275.16

u/ml

0.28

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

327

1650

1.55

12.38

1.3

1.2

320.99

293.39

u/ml

0.77

212

1078

Carcinoma in situ of skin of other and unspecified parts of face

178

3.02

12.34

1.1

274.13

316.62

u/ml

0.44

100

Speech and linguistic disorders, excluding more controls

185

988

1.80

12.34

1.9

1.4

209.07

200.88

u/ml

0.17

110

560

Other joint disorders

1252

5322

1.26

12.33

1.2

1.3

257.54

250.83

u/ml

0.36

791

3468

Marginal zone B-cell lymphoma

6.40

12.31

1.0

1.1

331.86

324.68

u/ml

0.03

Benign neoplasm: Rectum, anus and anal canal

152

812

1.89

12.20

1.2

337.21

284.88

u/ml

0.79

102

519

Disturbances of skin sensation

332

2184

1.53

12.19

1.2

253.15

270.70

u/ml

0.53

212

1408

Asthma and allergy, excluding more controls

195

1111

1.75

12.18

1.2

233.53

243.87

u/ml

0.19

117

667

Enteropathic arthropathies

134

3.40

12.18

1.3

336.80

229.73

u/ml

1.21

Chronic myeloid leukaemia [CML], BCR/ABL-positive

5.34

12.16

1.1

1.2

352.11

261.70

u/ml

0.52

Pre-eclampsia or eclampsia

261

1629

1.62

12.08

1.3

1.2

275.49

273.14

u/ml

0.05

195

1077

Disease of hard tissues of teeth, NOS

4.92

12.07

1.4

1.2

377.00

236.66

u/ml

0.88

Hypothyroidism, other/unspecified

1048

5445

1.28

12.05

1.3

283.73

264.61

u/ml

1.11

636

3568

Carcinoma in situ of skin of upper limb, including shoulder

4.66

11.98

1.1

355.29

319.89

u/ml

0.18

Other arterial embolism and thrombosis

106

3.68

11.96

1.5

1.2

318.04

251.73

u/ml

0.66

Benign neoplasm: Rectum

137

713

1.94

11.92

1.2

345.53

289.88

u/ml

0.78

460

Noninflammatory disorders of female genital tract

613

2239

1.39

11.88

1.3

1.2

251.43

256.04

u/ml

0.15

387

1423

Sleep disorders

297

1920

1.56

11.86

1.2

1.3

257.59

259.06

u/ml

0.03

197

1213

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

524

3295

1.40

11.85

1.3

1.2

271.44

267.88

u/ml

0.11

359

2190

Other abnormalities of plasma proteins

4.65

11.81

1.7

1.3

221.56

259.23

u/ml

0.22

Hypoglycaemia, other or unspecified

106

507

2.13

11.79

1.5

1.4

260.63

255.37

u/ml

0.07

303

Delirium, not induced by alcohol and other psychoactive substances

434

2.21

11.73

1.2

311.56

283.83

u/ml

0.37

264

Dizziness and giddiness

776

4805

1.32

11.72

1.3

274.03

274.84

u/ml

0.02

509

3100

Lichen simplex chronicus and prurigo

335

2.40

11.72

1.5

1.2

272.35

269.24

u/ml

0.03

205

Other and unspecified immunodeficiencies with predominantly antibody defects

4.01

11.70

1.8

1.4

139.67

236.42

u/ml

1.53

Injuries to the abdomen, lower back, lumbar spine and pelvis

430

2982

1.44

11.67

1.3

252.79

265.26

u/ml

0.44

278

1875

Systemic sclerosis (FG)

3.99

11.64

1.2

1.4

332.65

219.42

u/ml

1.40

Calcific aortic valvular stenosis, operated

201

1157

1.71

11.63

1.2

281.71

288.27

u/ml

0.12

128

699

Calcific aortic valvular stenosis

201

1157

1.71

11.63

1.2

281.71

288.27

u/ml

0.12

128

699

Operations 2 for CAVS

199

1144

1.71

11.57

1.2

283.46

290.79

u/ml

0.14

127

691

Calcific aortic valvular stenosis, diagnosis (helper)

199

1144

1.71

11.57

1.2

283.46

290.79

u/ml

0.14

127

691

Pain and other conditions associated with female genital organs and menstrual cycle

289

1790

1.56

11.52

1.3

1.2

246.22

257.45

u/ml

0.32

177

1171

Hypothyreosis and Thyroxine purchase for inclusion criteria

1072

5616

1.26

11.51

1.3

283.10

264.76

u/ml

1.07

649

3686

Asthma and allergy

194

1123

1.73

11.48

1.2

233.53

242.46

u/ml

0.16

117

680

Iridocyclitis

260

1642

1.60

11.48

1.3

284.53

272.16

u/ml

0.27

158

1042

Disorders of conjunctiva

1039

6913

1.26

11.47

1.3

260.91

256.56

u/ml

0.20

673

4415

Calcific aortic valvular stenosis, including rheumatic fever

200

1154

1.71

11.44

1.2

282.57

290.69

u/ml

0.16

128

698

Benign neoplasm: Transverse colon

466

2.16

11.43

1.3

1.2

298.24

294.23

u/ml

0.04

284

Misadventures to patients during surgical and medical care

149

811

1.86

11.36

1.4

1.2

303.68

282.50

u/ml

0.24

504

Intestinal malabsorption

286

2.51

11.32

1.4

1.3

266.78

243.37

u/ml

0.29

170

Hypertrophic cardiomyopathy

245

2.64

11.30

1.6

1.2

347.90

259.36

u/ml

1.31

143

Early onset COPD

227

1393

1.64

11.28

1.2

1.3

316.49

286.25

u/ml

0.64

148

865

Benign neoplasm: Stomach

378

2.28

11.27

1.2

334.70

276.56

u/ml

1.16

230

Other and unspecified vasculitis limited to skin

126

3.37

11.22

1.3

1.2

272.05

245.15

u/ml

0.19

Panic disorder

232

1436

1.64

11.21

1.2

232.81

248.30

u/ml

0.45

158

916

Neovascular glaucoma

206

2.78

11.17

1.5

1.2

279.83

276.35

u/ml

0.03

119

Vascular disorders of the intestines

234

2.64

11.14

1.3

1.2

275.56

279.96

u/ml

0.05

139

Post-traumatic stress disorder

145

790

1.87

11.12

1.3

1.2

216.99

246.64

u/ml

0.75

492

Rosacea

136

725

1.90

11.11

1.4

1.2

277.71

265.87

u/ml

0.15

444

Benign neoplasm: Caecum

356

2.30

11.04

1.2

274.30

278.82

u/ml

0.04

220

Substance abuse, excluding more controls

638

4189

1.34

11.00

1.2

1.3

282.73

257.25

u/ml

1.52

430

2715

Nonalcoholic steatohepatitis

5.49

10.99

1.2

347.92

245.92

u/ml

0.54

Injuries to the wrist and hand

1244

7329

1.23

10.98

1.3

253.36

260.23

u/ml

0.37

769

4722

Neuromuscular dysfunction of bladder

104

509

2.07

10.87

1.4

1.2

253.48

262.23

u/ml

0.14

302

Acquired pure red cell aplasia [erythroblastopenia]

8.18

10.75

1.3

1.8

236.57

363.73

u/ml

—

Temporal arteritis

124

3.30

10.74

1.2

290.00

316.26

u/ml

0.17

Somatoform disorder

200

1205

1.68

10.74

1.2

275.28

274.42

u/ml

0.02

123

766

Major coronary heart disease event excluding revascularizations

553

2798

1.37

10.72

1.2

314.63

286.65

u/ml

1.03

357

1777

Encephalitis

206

2.76

10.68

1.2

1.4

301.61

234.71

u/ml

0.55

120

Benign neoplasm: Sigmoid colon

135

727

1.87

10.64

1.3

1.2

296.10

295.95

u/ml

0.00

457

Heartburn

114

581

1.99

10.64

1.3

1.2

262.94

274.61

u/ml

0.15

341

Emphysema

294

2.42

10.61

1.2

383.33

271.16

u/ml

1.22

172

Conjunctivitis (acute, non atopic)

366

2521

1.46

10.61

1.5

1.4

271.74

258.01

u/ml

0.37

238

1552

Cardiomyopathy, Hypertrophic obstructive

3.91

10.59

1.8

1.2

373.96

238.12

u/ml

1.36

Open wound of lower leg

184

1089

1.71

10.59

1.4

1.3

298.86

255.51

u/ml

1.05

127

664

Glaucoma secondary to other eye disorders

212

2.70

10.59

1.5

1.2

279.83

279.68

u/ml

0.00

120

Juvenile rheumatoid arthirtis

168

2.96

10.58

1.3

274.30

225.60

u/ml

0.41

Keratitis

398

2795

1.43

10.55

1.3

258.57

265.14

u/ml

0.17

268

1810

Atopic dermatitis, strict definition with reimbursement

476

3343

1.39

10.55

1.4

1.3

228.28

244.94

u/ml

0.78

289

2125

Major coronary heart disease event

611

3042

1.35

10.50

1.3

1.2

309.17

285.15

u/ml

0.92

395

1928

Symptoms and signs involving speech and voice

315

2117

1.50

10.50

1.2

293.64

276.79

u/ml

0.40

203

1334

Falls/tendency to fall

1512

6269

1.21

10.49

1.3

267.08

257.41

u/ml

0.58

958

4005

Conjunctivitis

952

6607

1.26

10.43

1.3

259.63

255.95

u/ml

0.15

616

4209

Generalized anxiety disorder

235

1486

1.60

10.43

1.2

276.03

248.89

u/ml

0.68

157

944

Other epidermal thickening

255

2.53

10.42

1.5

1.3

305.51

251.10

u/ml

0.77

152

Granulomatous disorders of skin and subcutaneous tissue

148

3.07

10.38

1.6

1.3

262.85

232.44

u/ml

0.32

Polymyositis

5.90

10.36

1.3

1.2

224.38

236.00

u/ml

0.05

Retention of urine

282

1562

1.54

10.34

1.4

1.2

298.14

280.75

u/ml

0.45

184

988

Ovarian cyst

468

1934

1.41

10.33

1.3

1.2

274.72

267.27

u/ml

0.18

295

1273

Fall on same level

1518

7051

1.21

10.29

1.3

263.94

257.32

u/ml

0.36

982

4498

Infection of intervertebral disc (pyogenic)

4.40

10.24

1.2

1.1

250.19

357.81

u/ml

0.79

Viral infections of the central nervous system

104

522

2.03

10.21

1.2

298.20

257.76

u/ml

0.52

316

Excessive, frequent and irregular menstruation

521

2111

1.38

10.19

1.4

1.2

261.74

259.99

u/ml

0.05

326

1361

Cyst of kidney

300

2.37

10.18

1.4

1.2

252.98

282.22

u/ml

0.41

173

Left ventricular outflow tract obstruction (LVOTO), broad definition

149

842

1.80

10.17

1.6

1.4

262.48

254.76

u/ml

0.13

113

507

Nonorganic sleeping disorders

263

1716

1.55

10.17

1.2

1.3

260.38

253.62

u/ml

0.15

175

1095

Retinal haemorrhage

3.61

10.13

1.8

1.2

221.23

282.22

u/ml

0.52

Background retinopathy and retinal vascular changes

3.55

10.12

1.6

1.1

337.32

261.62

u/ml

0.62

Fissure and fistula of anal and rectal regions

257

1670

1.55

10.07

1.3

268.63

268.07

u/ml

0.01

157

1081

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

237

1513

1.58

10.04

1.2

312.84

283.32

u/ml

0.78

129

948

Other encephalitis

190

2.77

10.03

1.2

1.4

304.00

239.32

u/ml

0.50

116

Inflammatory diseases of the central nervous system

113

588

1.95

10.00

1.3

275.54

264.88

u/ml

0.12

356

Pre-eclampsia

242

1556

1.57

9.98

1.3

1.2

274.87

272.31

u/ml

0.05

179

1032

Decubitus ulcer and pressure area

236

2.54

9.97

1.7

1.2

324.95

272.25

u/ml

0.54

127

Pregnancy hypertension

474

3118

1.38

9.92

1.3

1.2

271.66

267.81

u/ml

0.11

331

2059

Ventral hernia

218

1369

1.60

9.92

1.4

1.2

298.73

285.65

u/ml

0.27

149

854

Other/unspecified seropositive rheumatoid arthritis

239

1534

1.57

9.90

1.2

314.05

284.58

u/ml

0.79

130

958

Anuria and oliguria

7.21

9.85

2.2

1.5

198.11

222.00

u/ml

—

Artificial opening status

250

2.49

9.82

1.7

1.2

270.00

240.46

u/ml

0.31

137

Other disorders of adrenal gland

313

2.32

9.76

1.4

285.82

237.78

u/ml

0.55

176

Disorders of plasma-protein metabolism, not elsewhere classified

4.94

9.74

1.1

1.2

405.06

253.91

u/ml

0.67

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

402

2.14

9.74

1.3

284.54

278.96

u/ml

0.06

244

Giant cell arteritis with polymyalgia rheumatica

132

3.10

9.72

1.2

290.00

312.77

u/ml

0.15

Other follicular disorders

108

560

1.96

9.70

1.4

1.2

262.52

260.79

u/ml

0.03

357

Unspecified privation

134

744

1.83

9.69

1.4

1.3

317.63

265.64

u/ml

0.94

462

Inflammatory diseases of female pelvic organs

672

3890

1.31

9.69

1.2

261.45

265.55

u/ml

0.13

439

2533

Drug-induced hypoglycaemia without coma

3.75

9.66

1.5

1.2

290.21

259.06

u/ml

0.20

Unknown and unspecified causes of morbidity

352

2.22

9.63

1.2

251.82

267.15

u/ml

0.18

219

Transport accidents

597

4019

1.32

9.59

1.3

254.35

258.08

u/ml

0.10

384

2578

Reactive arthropathies

109

569

1.94

9.56

1.2

278.03

255.56

u/ml

0.34

360

Seropositive rheumatoid arthritis, wide

240

1555

1.55

9.55

1.1

1.2

313.79

285.20

u/ml

0.76

131

973

Corns and callosities

367

2.19

9.53

1.6

1.2

358.75

268.58

u/ml

1.77

220

Melanocytic naevi, other sites/unspecified

100

508

2.00

9.51

1.5

1.2

280.01

248.73

u/ml

0.49

320

Other (seronegative) rheumatoid arthritis, wide

178

1076

1.67

9.47

1.2

313.31

284.81

u/ml

0.57

100

671

Drug-induced adrenocortical insufficiency

3.62

9.47

1.4

1.3

353.62

262.31

u/ml

0.54

Traction detachment of retina

4.94

9.44

1.9

1.2

212.31

262.36

u/ml

0.31

Injuries to the head

1359

7364

1.21

9.44

1.3

261.64

258.26

u/ml

0.17

845

4725

UC patients in KELA-register (code 208), prior to 1994

243

2.48

9.43

1.3

1.2

341.71

286.75

u/ml

0.56

147

Nonhereditary hypogammaglobulinemia

4.25

9.40

1.3

233.33

257.14

u/ml

0.15

Rash and other nonspecific skin eruption

117

629

1.89

9.39

1.3

286.29

267.15

u/ml

0.17

366

Portal vein thrombosis

3.78

9.39

1.6

1.4

329.37

269.33

u/ml

0.39

Dental caries 2, only avohilmo

1000

6390

1.24

9.34

1.3

249.95

258.19

u/ml

0.44

636

4140

Acute and subacute iridocyclitis

217

1383

1.58

9.33

1.3

284.59

269.45

u/ml

0.31

132

866

Abscess of anal and rectal regions

116

624

1.89

9.31

1.2

1.3

296.37

254.73

u/ml

0.79

391

Complications of internal orthopaedic prosthetic devices, implants and grafts

163

968

1.70

9.27

1.3

1.2

318.63

289.94

u/ml

0.58

100

580

Carcinoma in situ of skin of upper limb, including shoulder

3.79

9.24

1.1

355.29

313.35

u/ml

0.20

Obesity, other/unspecified

387

2773

1.41

9.23

1.2

1.3

276.14

269.76

u/ml

0.17

243

1829

Speech therapy

263

1753

1.51

9.21

1.4

1.3

269.06

281.06

u/ml

0.26

184

1088

Other abnormal findings of blood chemistry

246

2.45

9.20

1.3

1.2

276.79

259.14

u/ml

0.18

144

Problems related to lifestyle

143

824

1.76

9.15

1.2

307.78

252.97

u/ml

1.51

104

526

Procreative management

484

3033

1.36

9.06

1.4

247.44

255.27

u/ml

0.27

329

1893

Henoch-Schönlein purpura nephritis (HSPN)

6.38

9.04

1.4

1.3

154.82

195.13

u/ml

0.65

Small fibre neuropathy

155

2.86

9.02

1.4

1.2

276.16

290.60

u/ml

0.10

Other sleep disorders

133

754

1.79

9.00

1.2

1.3

259.54

259.38

u/ml

0.00

471

Other disorders of optic [2nd] nerve and visual pathways

424

2.07

8.94

1.4

239.24

253.32

u/ml

0.23

242

Unspecified misadventure during surgical and medical care

293

2.30

8.93

1.5

1.2

269.37

262.18

u/ml

0.07

177

Fracture of lumbar spine and pelvis

180

1107

1.64

8.92

1.3

1.2

274.68

272.81

u/ml

0.03

117

677

Other and unspecified follicular disorders

269

2.36

8.89

1.3

1.2

269.80

232.30

u/ml

0.55

168

Xerosis cutis

4.15

8.88

1.3

327.18

288.11

u/ml

0.22

Other overlap syndromes

3.52

8.87

1.1

1.3

275.88

261.03

u/ml

0.08

Myocardial infarction, strict

382

1992

1.41

8.83

1.2

311.36

280.01

u/ml

0.94

257

1237

Chronic diseases of tonsils and adenoids

1058

5474

1.23

8.82

1.4

1.3

263.69

255.73

u/ml

0.34

652

3550

Conduction disorders

245

1342

1.53

8.81

1.4

1.3

318.57

269.41

u/ml

1.81

161

796

Other symptoms and signs involving cognitive functions and awareness

376

2532

1.40

8.78

1.2

1.3

290.88

280.79

u/ml

0.27

235

1584

Benign neoplasm: Ascending colon

110

594

1.87

8.72

1.2

295.93

299.20

u/ml

0.04

354

Other diseases of gallbladder

186

2.63

8.71

1.2

303.67

299.94

u/ml

0.03

106

Prurigo nodularis

104

3.26

8.71

1.4

1.2

315.96

272.34

u/ml

0.26

Stroke, excluding SAH

482

2666

1.35

8.68

1.3

1.2

285.39

282.71

u/ml

0.07

316

1686

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, excluding all cancers (controls excluding all cancers)

6.69

8.62

1.5

1.1

313.00

246.40

u/ml

—

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

456

1.99

8.61

1.3

279.58

278.70

u/ml

0.01

279

Tick-borne viral encephalitis

8.16

8.56

1.0

1.5

270.86

157.17

u/ml

—

Aspergillosis

4.72

8.52

1.5

1.1

347.40

312.87

u/ml

—

Anterior Iridocyclitis

225

1479

1.53

8.48

1.3

285.91

269.61

u/ml

0.34

135

931

Tonsillectomy and adenotomy

884

4972

1.24

8.47

1.4

1.3

254.78

246.94

u/ml

0.35

547

3215

Systemic sclerosis

106

3.20

8.45

1.2

1.3

332.65

260.25

u/ml

0.67

Angina pectoris

478

2405

1.35

8.45

1.3

1.2

343.12

282.52

u/ml

2.72

301

1511

Aortic valve malfunction, age under 60 years

128

734

1.77

8.40

1.6

1.3

253.01

264.00

u/ml

0.19

100

461

Pulmonary oedema

4.07

8.39

1.6

1.1

326.06

285.09

u/ml

0.20

KRA_PSY_EATING, excluding more controls

144

851

1.71

8.38

1.4

1.3

221.36

230.74

u/ml

0.19

536

Otitis media, unspecified

221

1337

1.54

8.34

1.9

1.3

244.27

206.21

u/ml

1.11

121

737

Weight loss

112

619

1.83

8.30

1.4

299.16

249.95

u/ml

0.49

368

Adrenocortical insufficiency

197

2.55

8.30

1.5

1.3

331.32

258.34

u/ml

0.70

113

Stroke, including SAH

518

2904

1.33

8.30

1.3

1.2

282.39

282.51

u/ml

0.00

336

1838

Degenerative macular diseases

450

1.97

8.22

1.2

271.21

277.34

u/ml

0.07

271

Fracture of rib(s), sternum and thoracic spine

268

1839

1.47

8.17

1.2

316.03

269.60

u/ml

1.18

181

1164

Helminthiases

114

3.09

8.16

1.5

1.4

171.20

235.64

u/ml

1.11

Parodontitis, under 40 years, or operation codes

184

1171

1.60

8.12

1.5

1.3

240.42

234.64

u/ml

0.11

135

775

Allergic purpura

230

2.41

8.12

1.4

1.3

243.78

248.59

u/ml

0.04

137

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

421

2.03

8.11

1.7

1.4

320.46

212.83

u/ml

1.80

220

Valvular operations

126

726

1.75

8.08

1.5

1.3

303.58

274.35

u/ml

0.52

439

Dental operations, only avohilmo

753

3055

1.27

8.07

1.3

269.11

264.10

u/ml

0.19

478

1975

In situ neoplasms

301

2116

1.43

8.06

1.3

1.2

310.31

285.30

u/ml

0.76

197

1342

Injuries to the knee and lower leg

1468

7133

1.18

8.05

1.3

259.08

258.55

u/ml

0.02

992

4518

Insomnia

210

1378

1.54

8.03

1.2

1.3

282.27

252.78

u/ml

0.78

139

889

Acne

202

1316

1.56

8.03

1.4

1.3

240.72

223.75

u/ml

0.39

136

802

Voice disturbances

253

1724

1.48

8.02

1.2

294.21

275.33

u/ml

0.40

158

1095

Lung diseases due to external agents

116

654

1.79

8.01

1.3

1.2

288.52

275.05

u/ml

0.18

398

Dermatographic urticaria

491

1.93

8.00

1.4

1.2

279.15

267.08

u/ml

0.15

306

Diseases of male genital organs

701

2788

1.28

7.99

1.4

266.54

251.02

u/ml

0.67

453

1774

Other benign neoplasms of skin

295

2033

1.43

7.91

1.4

1.3

282.40

278.06

u/ml

0.09

177

1322

Injury of unspecified body region

514

1.90

7.90

1.3

258.55

250.25

u/ml

0.13

297

Psoriatic and enteropathic arthropathies

133

784

1.71

7.90

1.2

323.62

264.29

u/ml

1.22

505

Diseases of external ear

358

2604

1.38

7.89

1.4

1.3

234.26

269.60

u/ml

1.81

219

1625

Iron deficiency

167

2.66

7.89

1.2

1.4

265.84

217.91

u/ml

0.50

103

Parodontitis, operation under 40 years and operation codes

176

1117

1.60

7.88

1.5

1.3

239.36

233.60

u/ml

0.10

129

741

Retinal vascular disorders

457

1.94

7.88

1.3

1.1

291.77

292.41

u/ml

0.01

285

Diplopia

137

815

1.70

7.87

1.2

286.37

272.07

u/ml

0.21

507

Other disorders of eye and adnexa

174

1100

1.60

7.86

1.3

282.05

261.15

u/ml

0.28

121

671

Spondylopathies (FG)

174

1100

1.60

7.85

1.2

299.90

253.22

u/ml

1.17

109

710

Injuries to unspecified part of trunk, limb or body region

122

704

1.76

7.84

1.3

255.45

257.55

u/ml

0.03

422

Disorders of adult personality and behaviour

393

2906

1.36

7.84

1.2

1.3

275.97

256.59

u/ml

0.69

246

1900

Abnormal weight loss

100

544

1.86

7.83

1.3

1.4

321.28

253.37

u/ml

0.64

318

Carcinoma in situ of skin

290

2.20

7.83

1.3

1.1

281.97

316.51

u/ml

0.42

168

Lack of expected normal physiological development

275

2.20

7.82

2.6

1.4

195.42

178.44

u/ml

0.19

130

Arthropathy in ulcerative colitis

3.56

7.78

1.3

307.07

261.15

u/ml

0.29

Presence of other devices

148

900

1.65

7.74

1.4

1.1

273.76

272.84

u/ml

0.01

535

Aortic aneurysm

163

1000

1.61

7.68

1.3

1.2

306.35

281.54

u/ml

0.48

109

623

Other and unspecified rosacea

498

1.89

7.65

1.2

314.92

269.19

u/ml

0.53

306

Other and unspecified urticaria

250

1718

1.47

7.65

1.4

1.3

253.02

261.35

u/ml

0.18

157

1065

Other and unspecified vascular occlusions

326

2.11

7.62

1.3

1.1

292.11

289.80

u/ml

0.02

190

Other diseases of oesophagus

456

1.93

7.61

1.3

1.2

278.84

259.64

u/ml

0.27

274

Retinal vascular occlusion

449

1.93

7.60

1.3

1.1

291.77

292.89

u/ml

0.01

282

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

316

1547

1.41

7.60

1.3

1.2

301.77

293.88

u/ml

0.17

186

998

Injuries to the thorax

440

3323

1.33

7.57

1.3

311.23

266.62

u/ml

1.85

296

2152

Nail disorders

110

624

1.79

7.54

1.4

1.3

241.72

255.38

u/ml

0.25

368

Parodontitis, under 40 years

181

1169

1.57

7.53

1.5

1.3

240.28

234.26

u/ml

0.11

133

774

Systemic sclerosis, icd10

114

2.97

7.50

1.2

1.3

332.65

244.82

u/ml

0.92

Carcinoma in situ of skin of other and unspecified parts of face

231

2.32

7.50

1.1

274.13

325.09

u/ml

0.56

127

Chronic viral hepatitis

453

1.94

7.50

1.3

1.2

313.14

250.59

u/ml

1.10

295

Hordeolum and other deep inflammation of eyelid

404

1.99

7.50

1.3

274.67

234.60

u/ml

0.61

235

Other symptoms and signs involving the nervous and musculoskeletal systems

443

3356

1.33

7.48

1.4

1.3

275.44

268.25

u/ml

0.21

276

2106

Other diseases of jaws

411

1.97

7.46

1.2

1.1

290.76

263.63

u/ml

0.31

235

Disorders of psychological development

252

1616

1.47

7.45

1.8

1.5

200.91

203.88

u/ml

0.07

140

914

Acidosis

104

3.07

7.44

1.7

1.3

278.07

254.44

u/ml

0.15

Migraine without aura and triptan purchases

230

1565

1.48

7.43

1.3

274.99

258.61

u/ml

0.39

155

1014

Other specified/unspecified bacterial intestinal infections

357

2.05

7.42

1.4

1.3

273.72

260.89

u/ml

0.14

211

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

321

1580

1.40

7.39

1.3

1.2

300.51

292.42

u/ml

0.18

190

1018

Vasomotor and allergic rhinitis

504

3841

1.30

7.33

1.2

1.3

240.22

253.45

u/ml

0.55

299

2464

Chorioretinal inflammation

173

2.55

7.33

1.3

1.2

298.52

262.39

u/ml

0.34

109

Discitis, unspecified

3.49

7.33

1.5

1.1

291.27

322.13

u/ml

0.19

Viral haemorrhagic fevers, not elsewhere classified/unspecified

513

1.86

7.32

1.4

1.2

255.78

279.30

u/ml

0.39

321

Parodontitis, under 40 years and operation codes

173

1114

1.58

7.31

1.5

1.3

239.20

233.85

u/ml

0.09

127

739

Polyarthritis, unspecified

191

2.45

7.31

1.3

1.2

341.42

251.17

u/ml

1.18

114

Ocular pain

104

587

1.80

7.27

1.3

287.86

254.10

u/ml

0.33

352

Temporomandibular joint disorders, including avohilmo

525

4082

1.29

7.26

1.2

1.3

254.24

256.19

u/ml

0.05

331

2635

Acquired absence of limb

4.66

7.26

1.5

1.2

297.75

301.86

u/ml

0.02

Bacterial, viral and other infectious agents

123

729

1.71

7.24

1.6

1.3

262.06

258.74

u/ml

0.05

468

Malnutrition

151

2.68

7.23

2.7

1.8

233.76

238.60

u/ml

0.02

Benign neoplasm of other and unspecified endocrine glands

114

661

1.74

7.22

1.2

242.67

274.76

u/ml

0.56

423

Personality disorders

362

2681

1.36

7.19

1.2

1.3

288.16

257.26

u/ml

1.26

229

1749

Urolithiasis

293

2098

1.40

7.14

1.3

1.2

279.38

278.43

u/ml

0.01

176

1355

Hypothyroidism, strict autoimmune, 3 medication purchases required

916

5157

1.22

7.11

1.3

290.15

264.63

u/ml

1.48

561

3394

Congenital malformations of the circulatory system

218

1435

1.49

7.11

1.8

1.5

251.84

242.03

u/ml

0.21

148

822

Arthropod-borne viral fevers and viral haemorrhagic fevers

107

613

1.77

7.10

1.4

1.2

261.14

266.88

u/ml

0.08

388

Other shoulder lesions

109

628

1.76

7.09

1.4

1.2

290.32

255.99

u/ml

0.59

390

Drug-induced osteoporosis

4.00

7.07

1.4

1.1

286.75

290.22

u/ml

0.01

Migraine with aura and triptan purchases

212

1435

1.49

7.06

1.3

241.36

252.15

u/ml

0.26

133

922

Specific development disorders of scholastic skills

114

662

1.75

7.05

1.7

1.5

218.26

191.07

u/ml

0.57

374

Fitting and adjustment of other devices

213

1337

1.49

7.04

1.3

1.1

261.63

270.86

u/ml

0.18

125

771

Folate deficiency anaemia

5.40

7.04

1.2

1.1

404.50

279.73

u/ml

—

Benign neoplasm: Pancreas

3.21

7.04

1.2

322.67

285.16

u/ml

0.19

Respiratory conditions due to other external agents

3.37

7.03

1.2

268.76

349.43

u/ml

0.47

Melanocytic naevi, other sites/unspecified

100

564

1.80

7.02

1.5

1.2

280.01

255.04

u/ml

0.36

341

Duodenal ulcer

448

1.89

7.00

1.4

1.2

248.50

274.25

u/ml

0.47

275

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

172

2.54

6.99

2.0

1.6

219.68

210.72

u/ml

0.07

Other specified and unspecified retinal disorders

171

2.51

6.98

1.5

1.2

322.45

258.28

u/ml

0.75

103

Autonomic disorders

119

2.85

6.98

1.4

1.2

246.33

254.78

u/ml

0.05

Viral agents as the cause of diseases classified to other chapters

154

2.61

6.95

2.0

1.4

193.21

269.06

u/ml

1.22

Fracture of foot, except ankle

296

2136

1.40

6.94

1.4

1.3

262.91

268.36

u/ml

0.12

199

1352

Hyphaema and other vascular disorders of iris and ciliary body

103

3.00

6.93

1.3

1.2

282.50

216.32

u/ml

0.77

Postprocedural disorders of nervous system

104

596

1.77

6.93

1.2

225.63

262.52

u/ml

0.87

386

Syphilis

166

2.54

6.92

1.4

1.2

318.42

258.16

u/ml

0.59

106

Essential (haemorrhagic) thrombocythaemia

154

2.58

6.89

1.1

1.2

266.93

262.63

u/ml

0.03

Carrier of infectious disease

161

2.56

6.85

1.3

1.2

297.57

238.81

u/ml

0.65

100

Benign neoplasm: Stomach

459

1.87

6.85

1.2

334.70

289.47

u/ml

0.80

274

Atopic dermatitis, strict definition

461

3494

1.30

6.78

1.4

227.43

244.45

u/ml

0.77

277

2189

Excessive vomiting in pregnancy

107

622

1.74

6.78

1.2

232.72

270.99

u/ml

0.88

397

Other peripheral vascular diseases

454

1.87

6.76

1.1

1.2

282.50

261.23

u/ml

0.28

274

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

207

1408

1.48

6.74

1.2

245.94

259.40

u/ml

0.34

129

905

Diabetes mellitus in pregnancy

425

2093

1.32

6.72

1.2

262.30

261.45

u/ml

0.02

299

1381

Otitis externa

251

1771

1.43

6.72

1.4

1.3

235.46

264.68

u/ml

1.06

155

1112

Scleritis and episcleritis

392

1.94

6.71

1.3

1.2

224.54

249.77

u/ml

0.49

247

Reactive arthropathies, FINNGEN

485

1.84

6.68

1.2

1.3

277.12

255.10

u/ml

0.28

299

Open wound of ankle and foot

133

823

1.64

6.66

1.4

1.3

250.98

255.92

u/ml

0.09

516

Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)

3.42

6.60

1.1

343.06

269.72

u/ml

0.31

Drug-induced polyneuropathy

3.83

6.60

1.6

2.1

205.27

232.62

u/ml

0.11

Persistent mood disorders

207

1416

1.47

6.54

1.2

289.41

273.80

u/ml

0.31

121

910

Polycythaemia vera

123

2.73

6.54

1.2

1.1

380.95

294.34

u/ml

0.57

Infections with a predominantly sexual mode of transmission

404

3083

1.32

6.54

1.3

1.2

275.22

251.29

u/ml

1.06

280

2017

Carcinoma in situ of skin of ear and external auricular canal

4.95

6.49

1.6

1.1

257.63

212.75

u/ml

—

Other disorders starting during childhood or adolecense, excluding more controls

118

690

1.69

6.47

2.1

1.5

193.49

193.48

u/ml

0.00

376

Cardiac murmurs and other cardiac sounds

146

920

1.59

6.47

1.4

1.5

258.92

213.25

u/ml

0.93

498

Speech and linguistic disorders

194

1264

1.50

6.46

1.9

1.5

212.93

199.27

u/ml

0.32

114

718

Intestinal adhesions without obstruction

383

1.93

6.44

1.2

375.92

284.24

u/ml

1.43

232

Calculus of kidney and ureter

272

1960

1.40

6.44

1.3

1.2

278.82

280.37

u/ml

0.02

164

1257

COPD, hospital admission 2, with asthma infections

225

1332

1.45

6.42

1.2

307.41

288.01

u/ml

0.38

146

819

Myositis

154

2.53

6.42

1.2

1.1

243.80

242.01

u/ml

0.01

Bipolar affective disorders

243

1720

1.42

6.42

1.2

263.09

264.70

u/ml

0.03

158

1127

Spondylopathies in diseases classified elsewhere

4.18

6.42

1.4

1.2

280.60

401.57

u/ml

—

Other and unspecified haemorrhagic conditions

3.18

6.39

1.6

1.3

215.64

233.38

u/ml

0.12

Scleritis

3.36

6.36

1.5

1.2

305.27

232.76

u/ml

0.59

Sacroiliitis, not elsewhere classified

400

1.91

6.36

1.4

1.2

309.73

261.72

u/ml

0.58

248

Mental and behavioural disorders due to psychoactive substance use

678

5213

1.23

6.33

1.2

1.3

288.69

261.85

u/ml

1.70

455

3389

Acute laryngitis and tracheitis

194

1300

1.48

6.33

1.5

1.3

222.79

228.25

u/ml

0.10

121

784

Colonic or urogenital fistula

270

1952

1.39

6.29

1.3

275.28

276.02

u/ml

0.01

166

1248

Disturbance of activity and attention

207

1413

1.47

6.28

1.5

1.4

240.93

216.26

u/ml

0.63

122

846

Polycystic ovarian syndrome, consortium definition

779

3863

1.22

6.27

1.3

1.2

267.99

262.60

u/ml

0.19

481

2537

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

345

2593

1.34

6.27

1.4

1.3

272.88

266.08

u/ml

0.18

224

1631

Emotionally unstable personality disorder

185

1251

1.49

6.26

1.2

257.55

247.53

u/ml

0.21

124

814

Specific personality disorders

314

2329

1.36

6.26

1.2

1.3

274.23

259.21

u/ml

0.42

203

1515

Benign neoplasm: Caecum

446

1.83

6.18

1.2

274.30

294.27

u/ml

0.22

264

Haemorrhoids and perianal venous thrombosis

222

1555

1.43

6.16

1.2

264.77

272.36

u/ml

0.17

125

987

Intracerebral haemorrhage

482

1.80

6.16

1.4

1.2

281.32

290.83

u/ml

0.12

292

Acute appendicitis

804

6306

1.21

6.14

1.3

259.74

266.44

u/ml

0.32

538

4134

Other postsurgical states

327

1.98

6.13

2.0

1.1

300.85

239.81

u/ml

0.84

176

Acute bronchiolitis

163

971

1.54

6.13

2.1

1.6

228.64

175.14

u/ml

1.36

103

482

Disorders of optic nerve and visual pathways

118

725

1.65

6.12

1.3

246.58

258.64

u/ml

0.22

434

Sequelae of cerebrovascular disease

235

1458

1.42

6.11

1.2

288.46

285.85

u/ml

0.05

151

907

Complications following infusion, transfusion and therapeutic injection

3.17

6.11

2.0

1.3

248.94

281.36

u/ml

0.22

Certain conditions originating in the perinatal period

204

1252

1.47

6.11

1.9

1.5

205.98

195.35

u/ml

0.21

111

669

Anomalies of dental arch relationship, including avohilmo

302

2005

1.36

6.10

1.9

1.3

231.08

235.72

u/ml

0.09

161

1195

Abnormal findings in nipple discharge synovial fluid wound secretions

100

2.90

6.08

1.6

1.4

330.52

239.73

u/ml

0.46

Otitis externa, unspecified

139

890

1.58

6.07

1.4

1.3

241.07

260.51

u/ml

0.41

549

Coeliac disease

152

993

1.55

6.07

1.4

1.3

263.78

246.33

u/ml

0.29

584

Degeneration of macula and posterior pole

287

1730

1.37

6.07

1.3

1.2

287.30

287.89

u/ml

0.01

180

1048

Dental pulpitis 4, only avohilmo

1390

6277

1.16

6.06

1.3

256.17

257.33

u/ml

0.05

896

4005

Injuries to the neck

275

2009

1.38

6.05

1.2

1.3

226.42

260.54

u/ml

1.72

174

1282

Disorders of muscles

114

696

1.65

6.05

1.2

296.23

264.45

u/ml

0.49

432

Benign neoplasm: Rectum

137

874

1.58

6.04

1.2

345.53

291.94

u/ml

0.74

537

Other disorders of iris and ciliary body

141

2.54

6.00

1.3

1.2

268.65

269.26

u/ml

0.00

Ischaemic Stroke, excluding all haemorrhages

419

2449

1.30

5.96

1.3

1.2

282.09

286.56

u/ml

0.12

270

1542

Embedded and impacted teeth

455

3036

1.28

5.94

1.4

1.3

216.88

231.30

u/ml

0.57

283

1895

Benign neoplasm: Sigmoid colon

135

863

1.57

5.91

1.3

1.2

296.10

290.72

u/ml

0.07

530

Fentanyl

380

1.88

5.91

1.2

237.44

281.37

u/ml

0.93

225

Benign neoplasm: Rectum, anus and anal canal

152

998

1.53

5.90

1.2

337.21

282.71

u/ml

0.84

102

620

Social phobias

138

890

1.57

5.88

1.3

1.2

239.19

238.39

u/ml

0.01

560

Concussion

599

4202

1.24

5.86

1.3

247.09

248.89

u/ml

0.06

382

2707

Shoulder lesions

752

3800

1.21

5.86

1.3

1.2

282.45

276.74

u/ml

0.19

482

2493

Acute appendicitis, no complications

657

5374

1.22

5.85

1.3

256.90

267.77

u/ml

0.56

441

3541

Diseases of appendix

848

6486

1.19

5.83

1.3

261.80

266.39

u/ml

0.21

565

4245

Appendicitis, broad definition

843

6467

1.20

5.82

1.3

260.20

266.35

u/ml

0.30

562

4236

Postprocedural disorders of digestive system, not elsewhere classified

168

2.37

5.79

1.6

1.3

329.87

266.09

u/ml

0.40

101

Childhood allergy (age < 16)

344

2153

1.33

5.78

1.4

197.10

209.85

u/ml

0.41

193

1284

Hyperkinetic disorders

221

1555

1.42

5.73

1.5

1.4

241.19

217.67

u/ml

0.62

126

933

Pyogenic arthritis

350

1.91

5.70

1.4

1.2

257.76

271.52

u/ml

0.14

212

Other (not insulin) diabetes medications

935

4759

1.19

5.68

1.3

1.2

302.62

267.83

u/ml

2.88

574

3153

Mixed hyperlipidaemia

195

2.24

5.66

1.3

1.2

276.12

269.65

u/ml

0.05

115

Allergic rhinitis

443

3461

1.28

5.66

1.2

1.4

243.37

246.02

u/ml

0.08

266

2166

Seronegative rheumatoid arthritis

100

601

1.68

5.65

1.2

314.65

268.17

u/ml

0.85

367

Dental caries 1, only avohilmo

902

3876

1.19

5.64

1.2

1.3

260.81

260.38

u/ml

0.02

567

2502

Other and unspecified nail disorders

110

2.70

5.63

1.2

265.11

219.94

u/ml

0.38

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

330

2507

1.32

5.61

1.2

1.3

252.62

245.21

u/ml

0.20

211

1638

Somnolence, stupor and coma

242

2.10

5.60

1.3

261.59

269.22

u/ml

0.07

140

Injuries to the shoulder and upper arm

889

6302

1.19

5.58

1.2

1.3

255.75

266.86

u/ml

0.59

574

4014

Psoriasis vulgaris

193

1347

1.44

5.57

1.3

298.04

274.53

u/ml

0.56

134

846

Carcinoma in situ of skin of trunk

3.03

5.55

1.3

1.2

255.94

276.95

u/ml

0.14

Vitamin deficiency, wide

277

2.02

5.54

1.3

260.45

243.39

u/ml

0.23

158

Vitamin deficiency

277

2.02

5.54

1.3

260.45

243.39

u/ml

0.23

158

Other/unspecified rheumatoid arthritis

101

612

1.66

5.54

1.2

323.11

274.99

u/ml

0.72

366

Dental caries 3, only avohilmo

978

4240

1.18

5.53

1.2

1.3

260.41

257.28

u/ml

0.13

630

2715

Respiratory disorders in diseases classified elsewhere

3.23

5.53

1.2

1.3

241.60

255.72

u/ml

0.08

Other prurigo

3.58

5.52

1.4

1.2

220.00

252.39

u/ml

0.15

Spondylopathies

776

3926

1.20

5.51

1.2

1.3

285.36

275.86

u/ml

0.41

475

2576

Bronchiectasis

347

1.89

5.51

1.4

1.2

329.03

263.21

u/ml

0.74

201

Malignant melanoma, excluding all cancers (controls excluding all cancers)

116

729

1.60

5.49

1.3

1.2

248.41

286.57

u/ml

0.93

460

Anosmia

3.28

5.48

1.2

1.1

259.85

262.03

u/ml

0.01

Alcoholic gastritis

3.03

5.48

1.3

1.2

333.25

274.72

u/ml

0.31

Amyloidosis, other/unspecified

3.03

5.47

1.4

1.1

221.88

298.82

u/ml

0.56

Tooth eruption problems

262

1917

1.37

5.45

1.6

1.3

231.43

230.79

u/ml

0.01

161

1140

Other forms of systemic lupus erythematosus

3.69

5.40

1.2

1.5

373.10

265.06

u/ml

—

Amenorrhoea

107

664

1.63

5.40

1.2

286.49

249.41

u/ml

0.63

436

Diseases of the myoneural junction and muscle

114

718

1.60

5.38

1.3

305.96

272.72

u/ml

0.50

434

Unspecified fall

518

4151

1.24

5.38

1.3

265.03

260.61

u/ml

0.15

323

2594

Other noninflammatory disorders of vulva and perineum

100

610

1.66

5.37

1.2

256.67

261.87

u/ml

0.07

396

Pain in thoracic spine

161

1094

1.48

5.36

1.2

1.3

269.05

277.74

u/ml

0.09

107

708

Abrasion of teeth

251

1347

1.38

5.35

1.3

1.2

287.34

267.41

u/ml

0.55

163

849

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

168

2.30

5.34

1.3

1.2

266.57

249.93

u/ml

0.18

Retinal detachment with retinal break

103

634

1.64

5.33

1.4

1.2

257.60

288.30

u/ml

0.64

390

Congenital malformations of heart and great arteries

195

1334

1.43

5.31

1.8

1.5

250.74

236.31

u/ml

0.30

127

758

Visual impairment including blindness (binocular or monocular)

352

1.87

5.29

1.4

1.3

255.58

267.26

u/ml

0.10

198

Retinal breaks without detachment

131

855

1.54

5.29

1.3

1.2

256.70

284.99

u/ml

0.60

535

COPD, hospital admissions 3, with asthma pneumonia sepsis

171

998

1.46

5.27

1.2

330.38

290.59

u/ml

0.75

110

609

Unspecified/other endometriosis

116

738

1.59

5.27

1.2

246.39

266.35

u/ml

0.49

500

Intracranial and intraspinal abscess and granuloma

3.33

5.24

1.3

1.2

216.33

309.34

u/ml

0.72

Pollen allergy

312

2356

1.32

5.22

1.2

1.4

247.15

234.10

u/ml

0.36

181

1442

Carcinoma in situ of skin of ear and external auricular canal

4.10

5.20

1.6

1.1

257.63

288.78

u/ml

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

987

5724

1.17

5.19

1.2

1.3

272.88

257.67

u/ml

0.91

639

3697

Triptan medication for migraine, single purchase ok

987

5724

1.17

5.19

1.2

1.3

272.88

257.67

u/ml

0.91

639

3697

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

555

1.67

5.18

1.3

1.2

249.57

267.52

u/ml

0.27

356

Amyloidosis

2.78

5.15

1.4

1.1

221.88

308.35

u/ml

0.68

Acne vulgaris

151

1025

1.49

5.14

1.4

1.3

228.94

224.91

u/ml

0.07

100

623

Other immunodeficiencies

2.87

5.14

1.8

1.5

233.73

221.42

u/ml

0.06

Fracture of lower leg, including ankle

567

4634

1.22

5.09

1.3

258.57

267.76

u/ml

0.30

393

2934

Agoraphobia

287

1.96

5.08

1.2

215.68

243.77

u/ml

0.41

179

Thyrotoxicosis, other and/or unspecified

193

1372

1.42

5.07

1.3

1.2

285.12

277.56

u/ml

0.14

128

873

Psoriasis

283

2138

1.33

5.06

1.2

1.3

294.73

272.53

u/ml

0.61

186

1368

Other eating disorders

576

1.66

5.05

1.4

1.3

201.09

225.04

u/ml

0.51

342

Benign neoplasm: Duodenum

2.74

5.04

1.1

1.2

312.56

255.06

u/ml

0.46

Polyuria

178

1249

1.43

5.02

1.1

1.2

251.82

277.03

u/ml

0.72

101

784

Attention to artificial openings

160

2.28

5.01

1.8

1.3

244.57

255.32

u/ml

0.10

Injuries to the hip and thigh

404

2926

1.27

5.00

1.3

280.02

268.36

u/ml

0.37

248

1842

Supplementary factors related to causes of morbidity and mortality classified elsewhere

339

2631

1.30

4.99

1.5

1.3

250.50

260.29

u/ml

0.28

230

1650

Emotional disorders starting during childhood or adolecense, excluding more controls

105

650

1.61

4.97

1.4

261.92

192.68

u/ml

1.67

358

Other and unspecified acne

124

2.51

4.97

1.5

1.2

217.79

220.25

u/ml

0.02

Other and unspecified disorders of vitreous body

290

2193

1.32

4.95

1.3

1.2

280.96

294.07

u/ml

0.25

198

1356

Bullous disorders

282

1.94

4.94

1.3

245.18

261.00

u/ml

0.13

166

Other factor of the environment

3.01

4.94

1.7

1.2

195.47

276.77

u/ml

0.70

Other/unspecified reactive arthropathies

472

1.72

4.93

1.3

254.06

264.53

u/ml

0.12

289

Disorders of phosphorus metabolism and phosphatases

4.04

4.92

2.1

1.4

238.67

196.19

u/ml

—

Fall on same level involving ice and snow

576

4753

1.22

4.91

1.3

260.80

270.07

u/ml

0.37

387

3008

Other salmonella infections

201

2.12

4.89

1.2

186.79

265.97

u/ml

1.75

127

Trigger finger

132

879

1.51

4.89

1.3

1.2

266.81

280.29

u/ml

0.23

551

Familial hypercholesterolemia

105

665

1.59

4.86

1.4

1.2

266.55

283.74

u/ml

0.23

397

Acute gastritis

377

1.79

4.85

1.3

1.2

346.72

258.79

u/ml

1.32

227

Other specified and unspecified disorders of eye and adnexa

222

2.06

4.85

1.2

281.97

251.93

u/ml

0.23

129

Dental pulpitis 1, only avohilmo

1377

6324

1.14

4.84

1.3

251.91

258.81

u/ml

0.42

883

4039

Benign neoplasm: Pancreas

107

2.57

4.83

1.2

322.67

342.57

u/ml

0.09

Corneal ulcer

195

1402

1.40

4.83

1.4

1.2

288.31

267.42

u/ml

0.36

133

891

Dislocation, sprain and strain of joints and ligaments at neck level

196

1412

1.40

4.82

1.1

1.3

218.20

255.79

u/ml

1.61

119

906

Other aneurysm

236

2.01

4.81

1.4

1.2

307.26

274.05

u/ml

0.32

130

conjunctival haemorrhage

364

1.80

4.79

1.2

343.42

266.08

u/ml

1.15

217

Substance use, excluding alcohol

242

1804

1.35

4.79

1.2

1.3

297.40

247.50

u/ml

1.80

168

1162

All dysplastic lesions of the vulva

230

2.03

4.78

1.4

1.2

327.04

269.23

u/ml

0.65

143

Benign neoplasm: Descending colon

237

2.00

4.75

1.3

1.2

326.54

271.01

u/ml

0.48

147

Other noninfective disorders of lymphatic vessels and lymph nodes

177

2.18

4.75

1.4

1.2

226.69

227.76

u/ml

0.01

105

Viral meningitis

280

1.93

4.73

1.1

1.2

262.05

252.39

u/ml

0.09

173

Vascular diseases of the intestine

139

2.33

4.70

1.1

1.2

261.33

273.87

u/ml

0.09

Substance abuse

638

5107

1.20

4.64

1.2

1.3

282.73

262.54

u/ml

1.08

430

3325

LSIL lesion of the vulva

153

2.26

4.63

1.4

1.2

336.31

286.46

u/ml

0.41

Sciatica+with lumbago

492

3817

1.23

4.62

1.2

1.3

279.15

275.14

u/ml

0.10

320

2525

Sequelae of other external causes

325

1.84

4.62

1.3

1.2

225.08

254.07

u/ml

0.36

191

Intracranial trauma

690

4339

1.19

4.61

1.3

256.33

249.88

u/ml

0.28

439

2792

Hypermobility syndrome

444

1.71

4.61

1.2

1.3

262.91

253.61

u/ml

0.11

283

Right hemicolectomy

240

1.98

4.60

1.3

1.2

398.86

286.50

u/ml

1.11

137

Nontraumatic intracranial haemmorrhage

130

874

1.49

4.60

1.4

1.2

268.80

282.82

u/ml

0.25

535

Other and unspecified visual disturbances

597

1.61

4.60

1.2

1.3

282.13

273.25

u/ml

0.10

366

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

604

1.60

4.60

1.3

1.2

243.43

280.19

u/ml

0.79

383

Urethritis and urethral syndrome

116

2.46

4.59

1.5

1.2

185.70

226.59

u/ml

0.57

Other disorders of pigmentation

234

1.99

4.57

1.2

1.3

357.52

231.44

u/ml

1.34

134

Abnormalities of gait and mobility

101

645

1.58

4.56

1.4

1.3

265.44

265.38

u/ml

0.00

367

Superficial injury of lower leg

277

2122

1.31

4.55

1.3

289.65

259.54

u/ml

1.01

187

1317

Cluster headache, strict

249

1.96

4.53

1.2

225.15

234.73

u/ml

0.14

156

Use of antiglaucoma preparations and miotics

305

1.85

4.52

1.4

1.1

338.76

288.99

u/ml

0.60

171

Benign neoplasm: Adrenal gland

327

1.82

4.52

1.2

282.76

263.48

u/ml

0.17

201

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

586

3978

1.21

4.52

1.3

1.2

286.93

269.21

u/ml

0.72

403

2607

TMD related operations

189

1371

1.39

4.48

1.4

1.3

290.81

266.76

u/ml

0.51

127

884

Cluster headache, wide

264

1.92

4.48

1.2

234.03

247.77

u/ml

0.19

169

Melanocytic naevi of lower limb, including hip

264

1.92

4.48

1.5

1.2

292.96

229.62

u/ml

0.60

153

Follow-up examination after treatment for malignant neoplasms

335

1.80

4.47

1.2

269.81

271.44

u/ml

0.01

203

Fall on and from stairs and steps

243

1833

1.33

4.46

1.2

1.3

270.71

267.71

u/ml

0.06

154

1141

Papilloedema, unspecified

176

2.15

4.45

1.6

1.3

185.57

239.03

u/ml

0.99

103

Thoracic aortic aneurysm

102

657

1.56

4.44

1.4

1.2

297.96

277.26

u/ml

0.27

400

Other nonscarring hair loss

3.20

4.42

1.2

1.3

420.64

224.42

u/ml

1.50

Fracture of shoulder and upper arm

351

2781

1.27

4.40

1.2

1.3

249.63

263.32

u/ml

0.42

229

1710

170

2.16

4.39

1.8

1.2

286.08

253.55

u/ml

0.31

108

Other extrapyramidal and movement disorders in other diseases

182

1316

1.39

4.39

1.2

322.43

279.14

u/ml

0.67

114

815

Viral encephalitis, not elsewhere classified/unspecified

119

2.41

4.37

1.2

1.3

411.85

270.13

u/ml

0.66

Disorders of ocular muscles, binocular movement, accommodation and refraction

566

4682

1.20

4.37

1.5

1.3

261.90

255.15

u/ml

0.19

345

2978

Alcohol-induced chronic pancreatitis

413

1.72

4.36

1.3

1.2

333.02

287.29

u/ml

0.59

264

Other disorders of nervous system

339

1.79

4.34

1.3

1.2

289.68

268.41

u/ml

0.20

202

Other and unspecified epidermal thickening

158

2.19

4.32

1.8

1.5

270.11

234.94

u/ml

0.30

Nonspecific lymphadenitis

437

1.69

4.32

1.3

1.2

273.38

265.50

u/ml

0.09

266

COPD

323

2089

1.28

4.31

1.2

315.03

285.32

u/ml

0.80

206

1293

Inflammatory disorders of male genital organs, not elsewhere classified

2.77

4.30

1.5

1.2

363.31

207.09

u/ml

0.84

Arthropathy in Crohn disease

3.13

4.30

1.5

1.2

409.73

200.07

u/ml

1.26

Other inflammation of eyelid

125

849

1.48

4.27

1.4

1.2

270.27

269.58

u/ml

0.01

499

Malignant neoplasm of digestive organs

243

1815

1.32

4.26

1.3

1.2

345.67

281.90

u/ml

2.16

166

1112

Other surgical follow-up care

199

2.04

4.26

1.3

1.2

230.89

220.01

u/ml

0.12

115

Exclusions for E4_PCOS_BROAD

209

1554

1.35

4.25

1.5

1.4

263.52

251.79

u/ml

0.23

147

938

Dissociative [conversion] disorders

284

1.86

4.23

1.4

1.2

248.00

246.38

u/ml

0.01

178

Adult respiratory distress syndrome

2.98

4.22

1.7

1.2

221.42

293.79

u/ml

0.47

Other disorders of optic disc

2.74

4.22

1.3

1.4

300.57

227.19

u/ml

0.54

Type 1 diabetes, definitions combined

170

1224

1.40

4.21

1.6

1.4

241.05

231.37

u/ml

0.18

119

726

Cervicalgia

185

1352

1.38

4.20

1.3

248.73

282.55

u/ml

1.04

123

855

Ingrowing nail

418

1.70

4.20

1.4

1.3

206.53

251.04

u/ml

1.10

254

Other disorders of eyelid

303

2292

1.28

4.20

1.2

267.99

287.81

u/ml

0.65

197

1415

Lifestyle-related condition

2.88

4.18

1.7

1.2

186.69

267.03

u/ml

0.62

Other keratitis

124

847

1.48

4.14

1.3

1.2

237.31

262.36

u/ml

0.39

536

Episcleritis

337

1.77

4.14

1.3

1.2

203.08

240.99

u/ml

0.90

219

Oesophagitis

286

1.84

4.12

1.5

1.2

260.19

260.66

u/ml

0.00

171

Diseases of tongue

315

1.80

4.12

1.4

1.1

277.40

282.18

u/ml

0.03

175

Soft tissue disorders related to use, overuse and pressure

227

1717

1.33

4.12

1.3

1.2

289.98

276.14

u/ml

0.19

143

1090

Abnormal involuntary movements

131

906

1.46

4.10

1.4

1.2

284.28

273.45

u/ml

0.18

554

Other endocrine disorders

104

662

1.54

4.10

2.5

1.7

268.47

188.87

u/ml

1.75

335

Restless leg syndrome

108

719

1.51

4.09

1.1

1.2

333.34

273.20

u/ml

0.64

445

Hyperhidrosis

155

2.16

4.08

1.3

1.2

220.86

236.47

u/ml

0.13

101

Superficial injury of hip and thigh

128

882

1.46

4.07

1.3

1.2

269.40

261.56

u/ml

0.12

532

Hydrocele

107

712

1.51

4.06

1.4

1.3

244.64

253.17

u/ml

0.13

443

Polyarthrosis

129

853

1.46

4.05

1.2

296.50

294.03

u/ml

0.03

525

Mouth breathing

430

3522

1.22

4.02

1.4

262.24

269.45

u/ml

0.16

264

2235

Superficial injury of wrist and hand

254

1960

1.30

4.02

1.3

259.82

252.79

u/ml

0.14

148

1230

Hypersensitivity pneumonitis due to organic dust

2.65

4.01

1.5

1.2

314.86

281.89

u/ml

0.16

Thyrotoxicosis

224

1699

1.32

4.00

1.3

1.2

279.68

280.88

u/ml

0.02

146

1070

Striking against or struck by other objects

411

3356

1.23

3.99

1.3

255.37

251.63

u/ml

0.10

263

2098

Eating disorders

164

1187

1.39

3.99

1.4

1.3

221.54

240.64

u/ml

0.52

109

730

Volvulus

2.46

3.99

1.3

308.29

245.86

u/ml

0.42

Varicella [chickenpox]

440

1.66

3.99

1.7

1.4

314.52

237.65

u/ml

0.94

253

Disorder of the sleep-wake schedule

171

2.11

3.98

1.3

1.5

268.90

231.18

u/ml

0.36

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

2.79

3.97

1.4

1.3

200.46

227.97

u/ml

0.25

Left ventricular outflow tract obstruction, narrow definition

480

1.63

3.95

2.0

1.6

274.38

233.37

u/ml

0.56

261

Use of memantine

606

0.52

3.95

1.1

262.14

298.74

u/ml

0.31

337

Use of other anti-dementia drugs

606

0.52

3.95

1.1

262.14

298.74

u/ml

0.31

337

Campylobacter enteritis

171

2.08

3.94

1.3

280.50

256.27

u/ml

0.17

104

Nummular dermatitis

456

1.64

3.94

1.5

1.3

285.42

262.14

u/ml

0.27

289

Benign neoplasm: Duodenum

106

2.40

3.93

1.1

1.2

312.56

301.90

u/ml

0.06

Dysplasia of cervi uteri

262

1570

1.30

3.89

1.3

1.2

286.64

268.79

u/ml

0.49

183

1055

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

411

1.66

3.88

1.1

1.2

298.71

279.14

u/ml

0.24

263

Other disorders of bone

221

1682

1.32

3.88

1.3

287.38

260.98

u/ml

0.47

134

1058

Other disorders of conjunctiva

112

760

1.48

3.88

1.3

1.2

312.51

276.28

u/ml

0.67

466

Other female pelvic inflammatory diseases

143

1016

1.42

3.88

1.3

1.2

313.97

276.85

u/ml

0.40

659

N06DA Anticholinesterases

850

0.61

3.88

1.1

1.2

276.41

291.86

u/ml

0.16

500

Use of anticholinesterases

850

0.61

3.88

1.1

1.2

276.41

291.86

u/ml

0.16

500

Outcome of delivery

235

1108

1.32

3.86

1.1

1.2

203.93

270.22

u/ml

5.34

170

701

Intracranial injury

612

5025

1.18

3.86

1.3

251.01

258.46

u/ml

0.33

383

3165

Anti-inflammatory and antirheumatic products, non-steroids

471

1948

1.22

3.86

1.3

1.4

241.28

255.54

u/ml

0.45

274

1240

Vitamin B12 deficiency anaemia

435

1.64

3.85

1.3

1.2

326.93

271.90

u/ml

0.84

262

Other symptoms and signs involving the circulatory and respiratory systems

405

1.67

3.85

1.3

331.26

241.57

u/ml

0.64

239

Glaucoma

396

2834

1.23

3.85

1.3

1.2

288.06

289.70

u/ml

0.04

270

1754

Coronary revascularization (ANGIO or CABG)

328

1821

1.26

3.84

1.4

1.2

312.41

280.24

u/ml

1.10

207

1123

Malignant neoplasm of breast

234

2192

0.77

3.84

1.1

1.2

279.26

293.00

u/ml

0.28

144

1403

Other malignant neoplasms of skin (=non-melanoma skin cancer)

340

2151

1.25

3.81

1.2

295.42

294.75

u/ml

0.01

200

1332

Panniculitis, unspecified

3.27

3.81

1.0

1.1

149.78

225.15

u/ml

—

Carcinoma in situ of skin of scalp and neck

2.88

3.81

1.2

1.0

245.18

327.25

u/ml

0.74

Type of accident

304

2417

1.26

3.80

1.5

1.3

252.18

261.14

u/ml

0.23

204

1505

Vulvovaginal ulceration/inflammation in other diseases

461

1.62

3.80

1.2

237.35

246.57

u/ml

0.13

304

Certolizumab pegol

121

2.29

3.79

1.0

1.2

498.80

234.11

u/ml

—

Adhesive capsulitis of shoulder

137

971

1.42

3.78

1.4

1.2

240.76

290.18

u/ml

1.54

610

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

140

2.16

3.77

1.1

310.90

278.70

u/ml

0.26

Unspecific neurodegenerative disorder

1006

0.67

3.76

1.1

1.2

270.56

288.93

u/ml

0.28

594

Familial hypercholesterolemia, with ischemic heart disease

354

1.71

3.76

1.5

1.1

332.67

307.07

u/ml

0.21

210

Impotence

295

1.78

3.76

1.7

1.2

230.15

263.44

u/ml

0.46

184

Papulosquamous disorders

357

2893

1.24

3.76

1.3

301.47

274.01

u/ml

0.92

231

1855

Cerebral aneurysm, nonruptured

462

1.62

3.75

1.5

1.2

300.74

280.43

u/ml

0.23

281

COPD related to multimorbidity

251

1638

1.29

3.75

1.2

310.61

288.48

u/ml

0.48

156

1001

Type 1 diabetes, strict (exclude DM2)

168

1233

1.37

3.75

1.6

1.4

241.48

230.37

u/ml

0.21

118

732

Tuberculosis of other organs, strict

2.60

3.73

1.6

1.2

271.91

302.95

u/ml

0.16

Pregnancy examination and test

238

1140

1.31

3.72

1.2

232.40

259.31

u/ml

1.00

169

717

Etanercept

496

1.59

3.69

1.3

1.4

314.41

248.44

u/ml

0.77

299

Suggestive for eosinophilic asthma

535

1.56

3.69

1.1

1.2

257.99

279.45

u/ml

0.26

324

Seropositive rheumatoid arthritis, strict definition

125

876

1.44

3.68

1.1

1.2

311.51

289.08

u/ml

0.33

545

Malignant neoplasm of small intestine

2.42

3.68

1.6

1.2

351.36

311.68

u/ml

0.19

Superficial injury of ankle and foot

162

1189

1.37

3.67

1.3

206.48

246.12

u/ml

1.54

107

730

Lupus erythematosus

123

2.23

3.64

1.2

1.3

277.50

222.30

u/ml

0.50

Neuralgia and neuritis, unspecified

299

1.76

3.61

1.1

290.39

250.75

u/ml

0.44

183

Personal history of malignant neoplasm

184

1.98

3.60

1.3

1.1

239.45

248.78

u/ml

0.05

100

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

117

2.25

3.60

1.5

1.2

339.93

268.72

u/ml

0.43

Ovarian dysfunction

101

684

1.49

3.59

1.1

1.2

251.85

249.46

u/ml

0.03

460

Carcinoma in situ of skin of trunk

2.38

3.59

1.3

1.1

255.94

309.98

u/ml

0.40

Benign neoplasm of other and unspecified endocrine glands

114

790

1.45

3.59

1.2

242.67

282.59

u/ml

0.76

498

Granuloma annulare

2.63

3.59

1.3

1.4

268.50

250.28

u/ml

—

Rheumatism, unspecified

111

765

1.46

3.58

1.2

315.26

273.60

u/ml

0.80

460

Monoarthritis, not elsewhere classified

234

1.86

3.57

1.2

218.95

248.24

u/ml

0.39

142

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

608

5114

1.17

3.57

1.2

1.3

256.94

257.74

u/ml

0.02

386

3291

Dementia, including avohilmo

129

1247

0.71

3.57

1.1

1.2

277.17

287.55

u/ml

0.15

755

Other specified/unspecified soft tissue disorders

234

1.86

3.57

1.2

1.1

282.96

266.49

u/ml

0.13

137

Perineal laceration during delivery

123

1538

0.71

3.55

1.1

1.2

239.35

251.61

u/ml

0.20

1030

130

926

1.42

3.54

1.1

1.2

241.11

252.71

u/ml

0.25

639

Dementia

117

1149

0.70

3.54

1.1

1.2

282.04

284.09

u/ml

0.03

682

Other nonthrombocytopenic purpura

3.27

3.54

1.2

1.4

301.67

252.24

u/ml

—

Other protozoal intestinal diseases

2.43

3.53

1.2

1.4

245.31

240.82

u/ml

0.02

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

127

891

1.43

3.53

2.1

1.6

199.78

198.83

u/ml

0.02

488

Obsessive-compulsive disorder

100

681

1.48

3.48

1.3

261.75

235.49

u/ml

0.34

424

Benign neoplasm: Small intestine

152

2.06

3.47

1.1

1.2

279.65

248.36

u/ml

0.27

Visual field defects

448

1.60

3.47

1.4

1.3

302.68

273.23

u/ml

0.39

274

Congenital malformations of aortic and mitral valves

395

1.65

3.47

2.0

1.5

271.06

234.29

u/ml

0.43

215

Ulcer of oesophagus

295

1.74

3.47

1.1

1.2

293.89

271.75

u/ml

0.22

180

Hidradenitis suppurativa

281

1.77

3.46

1.4

1.2

257.43

229.21

u/ml

0.42

182

Hereditary deficiency of other clotting factors

3.07

3.45

1.5

1.2

318.56

157.52

u/ml

—

Benign neoplasm of urinary organs

180

1.96

3.44

1.0

1.2

268.58

250.58

u/ml

0.20

105

Benign neoplasm: Skin of lip

3.04

3.44

1.4

1.2

204.38

266.96

u/ml

—

Eating disorder

144

1050

1.38

3.42

1.4

1.3

221.36

237.51

u/ml

0.38

640

Benign neoplasm: Skin of other and unspecified parts of face

497

1.56

3.42

1.3

1.2

307.65

262.47

u/ml

0.67

307

Injury of eye and orbit

168

1257

1.35

3.39

1.3

255.19

257.92

u/ml

0.05

108

800

Preparation and fitting of bite rail to mouth

150

1103

1.37

3.38

1.4

1.2

288.85

263.49

u/ml

0.44

100

706

Other symptoms and signs involving the urinary system

603

1.50

3.38

1.3

1.2

235.15

256.19

u/ml

0.34

362

Benign neoplasm of mouth and pharynx

555

1.52

3.36

1.3

1.2

337.27

270.49

u/ml

0.54

351

Melanocytic naevi of lower limb, including hip

291

1.74

3.36

1.5

1.3

292.96

244.63

u/ml

0.41

172

Melanoma in situ of other and unspecified parts of face

3.51

3.36

1.4

1.2

278.50

320.69

u/ml

—

Schizophrenia

101

1449

0.69

3.36

1.2

1.3

233.64

256.88

u/ml

0.50

945

Malignant neoplasm of skin

407

2539

1.21

3.35

1.3

1.2

290.28

290.07

u/ml

0.00

244

1589

Polyhydramnios

375

1.65

3.35

1.3

1.2

259.90

273.33

u/ml

0.17

255

Malignant neoplasm of breast, HER2-negative

228

2139

0.78

3.34

1.1

1.2

281.52

292.36

u/ml

0.21

141

1364

Benign paroxysmal vertigo

211

1632

1.30

3.34

1.3

1.2

306.15

286.80

u/ml

0.27

135

1009

Macular pucker

581

1.51

3.31

1.2

309.97

290.91

u/ml

0.25

359

Superficial injury of head

225

1758

1.29

3.30

1.2

1.3

234.68

262.19

u/ml

0.84

147

1096

Perioral dermatitis

122

2.17

3.29

1.8

1.4

166.11

220.74

u/ml

0.61

Basal cell carcinoma

344

2241

1.23

3.28

1.3

1.2

292.71

294.43

u/ml

0.04

203

1399

Mixed disorders of conduct and emotions, excluding more controls

325

1.70

3.27

1.4

201.78

190.19

u/ml

0.19

191

Hypoparathyroidism

149

2.04

3.27

1.4

1.3

325.76

264.96

u/ml

0.45

Other chronic obstructive pulmonary disease

299

2005

1.24

3.26

1.2

306.95

285.85

u/ml

0.49

189

1241

Cholera

156

2.01

3.26

1.2

1.1

356.51

281.91

u/ml

0.57

Smoking dependency

560

1.51

3.25

1.3

1.2

312.15

268.58

u/ml

0.53

357

Mental and behavioural disorders due to tobacco

560

1.51

3.25

1.3

1.2

312.15

268.70

u/ml

0.52

359

Fracture of femur

160

1089

1.35

3.25

1.3

1.2

305.65

273.79

u/ml

0.76

640

Traumatic subdural haemorrhage

518

1.53

3.25

1.2

293.47

278.56

u/ml

0.22

327

Pneumonia derived septicemia

235

1.81

3.24

1.4

1.3

227.29

232.12

u/ml

0.05

132

Peritonsillar abscess

241

1905

1.27

3.24

1.3

237.65

265.84

u/ml

1.06

174

1254

Assault

176

1337

1.33

3.22

1.2

1.3

249.68

245.50

u/ml

0.07

124

860

Prolonged pregnancy

109

1397

0.71

3.21

1.1

1.2

250.51

254.43

u/ml

0.06

924

Disorders of synovium and tendon

520

3993

1.18

3.21

1.3

269.39

268.79

u/ml

0.02

328

2622

Moderate visual impairment, binocular

110

2.21

3.20

1.5

1.3

200.94

317.86

u/ml

1.47

Appendectomy

717

6035

1.15

3.20

1.3

256.34

265.14

u/ml

0.42

479

3966

Disorders of refraction and accommodation

327

2668

1.23

3.20

1.7

1.4

279.34

253.32

u/ml

0.59

198

1646

Barrett oesophagus

229

1.81

3.17

1.1

1.2

360.18

289.19

u/ml

0.51

136

Mental and behavioural disorders due to alcohol

532

4432

1.17

3.16

1.2

1.3

282.32

262.80

u/ml

0.96

356

2873

Malignant neoplasm of eye and adnexa, excluding all cancers (controls excluding all cancers)

2.67

3.16

1.2

1.5

248.11

271.25

u/ml

—

Other benign neoplasms of skin

295

2393

1.24

3.15

1.4

1.2

282.40

282.02

u/ml

0.01

177

1524

Atrophic disorders of skin

121

870

1.40

3.15

1.4

1.2

293.04

256.77

u/ml

0.57

523

Anogenital herpesviral [herpes simplex] infection

541

1.51

3.14

1.4

1.2

265.44

233.25

u/ml

0.50

350

Ptosis of eyelid

516

1.52

3.13

1.2

260.76

277.04

u/ml

0.18

300

Alzheimer disease, including avohilmo

797

0.66

3.12

1.0

1.1

262.23

293.37

u/ml

0.47

460

Bell's palsy

108

763

1.42

3.12

1.3

1.2

248.27

266.95

u/ml

0.28

462

Abnormal findings in secretions and smears from cervix uteri vagina vulva

491

3279

1.18

3.11

1.3

1.2

286.12

264.20

u/ml

0.90

349

2173

Chronic iridocyclitis

321

1.67

3.10

1.3

1.2

240.05

259.69

u/ml

0.23

193

Fracture at wrist and hand level

389

3249

1.20

3.10

1.3

236.40

261.54

u/ml

1.06

244

2079

Single delivery by forceps and vacuum extractor

133

1100

0.73

3.09

1.2

1.3

273.97

258.19

u/ml

0.29

720

Other condition

152

1139

1.34

3.07

1.5

1.3

231.85

254.89

u/ml

0.50

113

718

Tuberculosis of other organs

2.53

3.06

1.7

1.1

231.10

334.17

u/ml

—

Separation of retinal layers (serosa)

247

1.76

3.05

1.7

1.2

326.25

272.89

u/ml

0.58

160

Erythema intertrigo

106

2.20

3.05

1.8

1.2

393.64

304.53

u/ml

0.46

Other and unspecified psoriasis

393

1.59

3.03

1.3

1.2

241.04

259.93

u/ml

0.25

246

Spondylosis

425

3070

1.19

3.03

1.2

1.3

292.13

282.84

u/ml

0.27

247

2001

Defects in the complement system

2.74

3.02

1.9

1.5

174.90

249.79

u/ml

—

Other/unspecified synovitis and tenosynovitis

107

760

1.42

3.01

1.3

1.2

307.64

265.01

u/ml

0.65

479

Benign neoplasm of major salivary glands

441

1.55

3.00

1.3

1.2

366.87

266.66

u/ml

1.30

276

Mixed and other personality disorders

686

1.44

3.00

1.2

336.58

259.10

u/ml

1.55

457

Superficial injury of abdomen, lower back and pelvis

165

1256

1.32

3.00

1.2

1.3

244.21

249.43

u/ml

0.09

112

791

Postmenopausal osteoporosis with pathological fracture

161

1.94

3.00

1.2

1.1

234.96

344.85

u/ml

1.99

Epilepsy

310

2536

1.22

3.00

1.3

1.4

280.95

256.93

u/ml

0.75

197

1574

Car occupant injured in other and unspecified transport accidents

220

1740

1.27

2.98

1.3

1.2

260.78

257.78

u/ml

0.05

137

1117

Other specified/unspecified inflammatory spondylopathies

356

1.62

2.98

1.1

1.2

254.39

273.60

u/ml

0.25

227

Malignant neoplasm of breast, HER-positive

132

1750

0.74

2.97

1.1

1.2

266.86

297.13

u/ml

0.50

1098

Cervicobrachial syndrome

201

1572

1.28

2.97

1.2

1.3

254.77

285.55

u/ml

1.07

140

1026

Benign neoplasm: Kidney

141

2.01

2.97

1.0

1.2

244.61

251.80

u/ml

0.06

Alzheimer’s disease, wide definition

572

0.58

2.96

1.1

265.23

302.51

u/ml

0.34

325

Rotator cuff syndrome

521

3317

1.17

2.96

1.3

1.2

283.42

279.42

u/ml

0.10

343

2162

Glaucoma suspect

244

1954

1.25

2.95

1.3

1.2

281.02

290.62

u/ml

0.21

171

1226

Melanoma in situ of other and unspecified parts of face

3.21

2.95

1.4

1.1

278.50

359.22

u/ml

—

Emotional disorders and disorders of social functioning with onset specific to childhood

118

847

1.39

2.95

1.4

1.5

249.37

196.82

u/ml

1.31

461

Haemorrhage in early pregnancy

266

2100

1.24

2.94

1.2

252.72

275.58

u/ml

0.85

169

1364

Certain zoonotic bacterial diseases

108

2.17

2.93

1.0

1.3

307.09

263.12

u/ml

0.32

Allergic colitis

351

1.63

2.93

2.1

1.8

153.25

171.61

u/ml

0.32

195

Redundant prepuce, phimosis and paraphimosis

237

1887

1.26

2.92

1.3

242.36

244.84

u/ml

0.05

147

1214

Disorders of porphyrin and bilirubin metabolism

2.31

2.91

1.4

1.3

231.10

261.19

u/ml

—

Psoriatic arthropathies

632

1.45

2.91

1.2

333.05

278.26

u/ml

0.74

407

Benign neoplasm: Parotid gland

358

1.60

2.90

1.3

1.2

309.58

261.55

u/ml

0.56

228

Infective dermatitis

101

716

1.42

2.89

1.5

1.2

255.23

270.67

u/ml

0.22

459

Pure hyperglyceridaemia

136

2.02

2.88

1.5

1.3

226.55

265.95

u/ml

0.40

Benign neoplasm: Skin of trunk

207

1.81

2.88

1.6

1.2

321.67

223.26

u/ml

1.06

127

Other and unspecified myopathies

446

1.54

2.88

1.3

322.92

269.19

u/ml

0.66

270

Traumatic subarachnoid haemorrhage

150

1.95

2.86

1.2

1.1

222.11

254.49

u/ml

0.41

Chronic laryngitis and laryngotracheitis

108

776

1.40

2.86

1.3

1.2

329.02

294.60

u/ml

0.59

477

Speech disturbances, not elsewhere classified

423

1.55

2.85

1.2

284.54

261.81

u/ml

0.24

250

Acute inflammation of orbit

2.74

2.85

1.4

1.8

214.62

150.47

u/ml

—

Non-selective monoamine reuptake inhibitors

303

2419

1.22

2.84

1.2

1.3

269.81

288.82

u/ml

0.66

188

1569

Benign neoplasm: Adrenal gland

376

1.58

2.84

1.2

282.76

275.58

u/ml

0.06

223

Other superficial mycoses

151

1.96

2.83

1.5

1.2

325.86

219.61

u/ml

0.76

Benign neoplasm: Parathyroid gland

3.12

2.83

1.3

1.1

327.33

229.71

u/ml

—

Menorrhagia

342

1565

1.21

2.82

1.4

1.2

269.99

278.43

u/ml

0.24

216

1026

Endometriosis

357

1768

1.20

2.80

1.2

256.18

272.18

u/ml

0.40

225

1165

Malignant neoplasm of prostate

178

1445

0.78

2.80

1.2

281.10

290.74

u/ml

0.18

111

904

Benign neoplasm of meninges

409

1.55

2.79

1.2

300.79

287.05

u/ml

0.15

246

Alzheimer disease

675

0.65

2.79

1.1

273.08

300.37

u/ml

0.32

386

Supervision of high-risk pregnancy

266

1301

1.24

2.79

1.2

1.3

240.98

272.25

u/ml

1.30

183

829

Disorders of continuity of bone

688

1.42

2.79

1.3

276.00

261.17

u/ml

0.18

414

Scar conditions and fibrosis of skin

262

1.70

2.78

1.4

1.2

258.93

229.34

u/ml

0.20

149

Monoplegia

2.35

2.77

1.5

1.2

287.33

257.21

u/ml

0.12

Endometriosis of pelvic peritoneum

162

1229

1.31

2.76

1.1

1.2

281.57

277.30

u/ml

0.04

101

824

Overexertion and strenuous or repetitive movements

104

748

1.40

2.76

1.3

1.2

219.60

263.04

u/ml

1.10

474

Other other unspecified disorders of the circulatory system

188

1.83

2.76

1.5

1.3

272.04

301.44

u/ml

0.20

100

Deficiency of other B group vitamins

2.34

2.76

1.4

1.3

284.17

285.61

u/ml

0.01

Autoimmune hyperthyroidism

316

1.63

2.76

1.3

1.2

321.97

242.94

u/ml

1.17

203

Open wound of head

518

4412

1.16

2.76

1.3

288.51

261.79

u/ml

1.19

313

2787

Enterobiasis

3.13

2.75

1.5

1.8

181.00

168.94

u/ml

—

Impetigo

444

1.53

2.75

2.0

1.5

229.54

242.28

u/ml

0.10

261

COPD, hospital admissions

301

2100

1.22

2.74

1.2

306.68

284.87

u/ml

0.52

190

1293

Basal cell carcinoma, including avohilmo

349

2296

1.20

2.74

1.3

1.2

291.73

293.89

u/ml

0.05

207

1432

Degenerative diseases of the nervous system

877

0.69

2.73

1.1

1.2

273.11

294.84

u/ml

0.29

519

Other bullous disorders

153

1.92

2.73

1.3

1.2

185.15

254.90

u/ml

0.92

Allergic conjunctivitis

633

5470

1.14

2.72

1.2

1.3

257.17

258.50

u/ml

0.04

403

3529

Cluster headache, wide,, including avohilmo

373

1.57

2.71

1.3

1.2

302.02

250.65

u/ml

0.29

240

Family history of other conditions

2.22

2.71

1.4

1.2

240.64

220.94

u/ml

0.12

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

471

4047

1.17

2.70

1.3

227.20

254.30

u/ml

1.46

287

2593

Other and unspecified mood [affective] disorders

677

1.42

2.68

1.3

1.2

259.98

243.05

u/ml

0.26

433

Melanocytic naevi of scalp and neck

147

1.93

2.68

1.2

258.77

248.21

u/ml

0.06

Dementia in Alzheimer disease

404

0.53

2.67

1.1

358.53

320.27

u/ml

0.24

230

Disorders in reading

244

1.73

2.67

1.7

1.6

317.03

181.06

u/ml

2.16

129

Other and unspecified disease of Bartholin gland

126

2.01

2.67

1.1

1.2

291.94

256.06

u/ml

0.27

Inflammatory disease of uterus

147

1122

1.32

2.67

1.3

1.2

245.38

265.82

u/ml

0.54

746

Poor fetal growth

153

1175

1.31

2.66

1.3

1.2

278.82

252.53

u/ml

0.61

111

798

Cysts of oral region, not elsewhere classified

235

1.72

2.66

1.3

1.1

249.89

265.98

u/ml

0.15

132

Single spontaneous delivery

303

1945

0.83

2.62

1.2

250.12

267.03

u/ml

0.53

194

1183

Malignant neoplasm of kidney, except renal pelvis

432

1.51

2.62

1.4

1.2

257.37

295.00

u/ml

0.52

252

Other predominantly sexually transmitted diseases, not elsewhere classified

208

1664

1.26

2.61

1.3

1.2

296.04

247.38

u/ml

1.70

142

1100

Disorder of pancreatic internal secretion, other and/or unspecified

2.98

2.61

1.7

1.5

324.00

268.15

u/ml

—

Causalgia

100

2.14

2.61

1.7

1.2

246.43

225.58

u/ml

0.19

Aneurysms, operations, SAH

117

867

1.36

2.59

1.4

1.2

278.15

282.15

u/ml

0.05

534

Gestational [pregnancy-induced] hypertension

262

2146

1.22

2.59

1.3

1.2

270.19

261.76

u/ml

0.21

176

1428

Gonarthrosis,primary

575

4133

0.87

2.58

1.2

1.3

278.54

289.23

u/ml

0.37

348

2695

L02BA Anti-estrogens

897

0.67

2.57

1.1

1.2

266.71

289.74

u/ml

0.28

562

Rheumatic fever incl heart disease

128

1.97

2.56

1.6

1.2

221.47

292.82

u/ml

0.72

Asthma/COPD (KELA code 203)

1089

6964

1.10

2.55

1.3

271.63

255.84

u/ml

0.94

712

4455

Pediculosis, acariasis and other infestations

460

1.49

2.54

1.3

284.33

257.95

u/ml

0.25

281

Tuberculosis, IBD comorbidity

284

1.63

2.54

1.4

1.2

286.42

286.68

u/ml

0.00

167

Medical abortion

644

3076

1.14

2.54

1.2

273.97

264.20

u/ml

0.34

427

1969

Triptan medication for migraine, min. 3 purchases

658

4587

1.13

2.54

1.2

1.3

274.48

257.75

u/ml

0.77

426

3028

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

285

1.62

2.51

1.1

1.2

252.57

278.65

u/ml

0.27

175

Otorrhagia

2.91

2.51

2.4

1.7

180.50

298.95

u/ml

—

Deep bite

181

1252

1.27

2.51

1.9

1.5

235.38

217.89

u/ml

0.30

685

Other disorders of bladder

601

1.42

2.51

1.4

1.2

257.50

266.83

u/ml

0.14

361

Benign neoplasm: Cerebral meninges

356

1.55

2.51

1.2

318.78

276.41

u/ml

0.52

210

Orchitis and epididymitis

610

1.42

2.50

1.5

1.3

325.16

250.34

u/ml

1.10

381

Cluster headache, strict, including avohilmo

365

1.55

2.50

1.4

1.2

296.26

248.94

u/ml

0.25

233

Other congenital malformations of upper alimentary tract

2.64

2.48

2.6

1.3

180.00

257.83

u/ml

—

Other and unspecified iridocyclitis

271

1.64

2.48

1.2

1.3

297.64

238.84

u/ml

0.74

170

COPD, early/later onset

300

2113

1.20

2.45

1.2

306.68

285.96

u/ml

0.48

190

1299

Inhalation and ingestion of food causing obstruction of respiratory tract

0.00

2.45

0.0

1.7

—

235.16

—

Alzheimer’s disease (Late onset)

491

0.59

2.45

1.0

1.1

279.36

308.36

u/ml

0.21

277

Correction of physiology of bite - demanding therapy visit

530

1.45

2.45

1.3

1.2

282.91

256.05

u/ml

0.40

334

Abdominal aortic aneurysm (AAA)

308

1.58

2.44

1.2

331.96

283.81

u/ml

0.51

178

Benign neoplasm: Kidney

152

1.86

2.44

1.0

1.2

244.61

291.82

u/ml

0.52

478

1.48

2.42

2.9

1.9

206.80

163.14

u/ml

0.39

222

Thyroiditis

465

1.47

2.42

1.2

322.18

267.62

u/ml

0.37

278

Bicuspidal aortic valve syndrome

297

1.60

2.41

1.2

1.4

284.55

253.62

u/ml

0.30

172

Algoneurodystrophy

212

1.72

2.41

1.1

1.2

266.77

237.34

u/ml

0.32

130

Other orthopaedic follow-up care

281

1.61

2.40

1.2

332.20

246.18

u/ml

0.88

167

Personal history of risk-factors, not elsewhere classified

2.11

2.40

1.8

1.2

243.00

198.85

u/ml

0.33

Other disorders starting during childhood or adolescence

118

884

1.34

2.39

2.1

1.6

193.49

194.01

u/ml

0.01

469

Carcinoma in situ of skin of scalp and neck

2.24

2.39

1.2

1.1

245.18

344.19

u/ml

0.82

Personal history of medical treatment

2.67

2.38

1.5

1.1

370.17

176.04

u/ml

—

Follicular cysts of skin and subcutaneous tissue

162

1274

1.28

2.38

1.3

1.2

276.85

266.26

u/ml

0.23

116

798

Enthesopathies of lower limb, excluding foot

204

1648

1.24

2.38

1.3

270.14

274.88

u/ml

0.06

134

1070

Seminoma of testis, excluding all cancers (controls excluding all cancers)

2.31

2.38

1.1

1.2

325.09

280.19

u/ml

0.25

Gestational diabetes (for exclusion)

430

2624

1.16

2.36

1.2

249.63

256.80

u/ml

0.26

306

1768

Impacted teeth

311

2440

1.19

2.35

1.4

1.3

207.68

226.56

u/ml

0.80

200

1502

All dysplastic lesions of the cervix uteri, vagina or vulva

293

2441

1.20

2.35

1.3

1.2

294.10

260.77

u/ml

1.34

209

1623

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

147

1.87

2.35

1.3

227.71

248.54

u/ml

0.23

Preterm labour and delivery

235

1929

1.22

2.35

1.3

1.2

258.46

280.68

u/ml

0.44

158

1289

Guillain-Barre syndrome

2.13

2.35

1.3

245.31

257.84

u/ml

0.08

Sulfonylureas

209

1348

1.24

2.35

1.3

1.2

292.83

291.05

u/ml

0.03

121

840

Carcinoma in situ of other and unspecified digestive organs

2.11

2.34

1.1

1.2

430.17

268.12

u/ml

1.07

Fasciculation

2.23

2.34

1.5

1.3

212.50

204.09

u/ml

0.07

Tularaemia

2.22

2.34

1.1

1.3

282.00

269.81

u/ml

—

Inguinal or femoral hernia, bilateral

568

1.42

2.34

1.5

1.2

270.64

292.75

u/ml

0.28

363

Benign neoplasm: Descending colon

299

1.58

2.34

1.3

1.2

326.54

282.24

u/ml

0.36

178

Contact with blunt object, undetermined intent

2.95

2.33

1.0

1.3

220.20

175.30

u/ml

—

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

395

1.50

2.33

1.3

1.4

273.47

255.43

u/ml

0.13

240

Gluteal tendinitis

184

1.76

2.33

1.3

1.2

429.00

282.27

u/ml

0.48

107

Benign intracranial hypertension

2.18

2.33

1.6

1.3

184.38

208.80

u/ml

0.20

Other arthrosis

420

2588

1.16

2.33

1.3

301.56

281.15

u/ml

0.52

262

1732

Other and unspecified erythematous conditions

162

1.81

2.32

1.6

1.2

286.47

257.71

u/ml

0.19

Secondary polycythaemia

126

1.93

2.32

1.2

334.56

292.73

u/ml

0.28

Urticaria due to cold and heat

2.44

2.32

1.0

1.3

272.54

238.82

u/ml

—

Persons encountering health services in circumstances related to reproduction

742

4498

1.12

2.32

1.4

246.74

256.87

u/ml

0.49

484

2817

Scabies

364

1.53

2.32

1.3

250.39

245.79

u/ml

0.04

218

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

486

1.45

2.32

1.4

1.3

292.33

259.01

u/ml

0.46

291

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

177

1.77

2.31

1.3

1.2

225.05

265.40

u/ml

0.46

108

Inguinal hernia, bilateral

561

1.42

2.31

1.5

1.2

270.64

294.69

u/ml

0.32

358

Chronic Coagulation defects

170

1.79

2.31

1.5

1.3

239.32

238.86

u/ml

0.00

101

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

340

1.54

2.30

1.4

1.2

309.61

237.25

u/ml

1.00

213

Pneumococcal septicemia

239

1.65

2.28

1.2

1.4

231.74

252.77

u/ml

0.22

130

malignant neoplasm of male genital organs

200

1567

0.81

2.28

1.2

277.78

288.72

u/ml

0.24

126

992

Pemphigoid

2.04

2.27

1.2

1.3

314.43

299.43

u/ml

0.05

Tuberculosis, wide

309

1.56

2.27

1.4

1.2

298.72

288.82

u/ml

0.07

179

Malignant neoplasm, without specification of site

2.04

2.27

1.1

1.2

299.47

312.98

u/ml

0.07

Other intracranial haemorrhages

106

2.00

2.26

1.0

1.2

246.00

294.20

u/ml

0.40

COPD, hospital admissions 1, only main diagnosis

213

1478

1.23

2.26

1.2

297.97

286.79

u/ml

0.19

134

913

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

2.07

2.23

1.4

203.54

255.44

u/ml

0.69

Contact with and exposure to communicable diseases

436

3779

1.15

2.23

1.5

1.3

256.24

240.42

u/ml

0.63

291

2382

Arthropathic psoriasis

102

761

1.35

2.23

1.1

1.2

315.32

277.43

u/ml

0.50

474

Malignant neoplasm of endocrine gland

416

1.48

2.23

1.5

1.2

293.78

258.96

u/ml

0.40

253

Other meningitis

100

2.03

2.23

1.6

1.4

233.54

237.99

u/ml

0.04

Parkinson's disease, including avohilmo

629

0.63

2.22

1.1

1.2

309.80

305.27

u/ml

0.03

382

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

209

1671

0.82

2.22

1.1

1.2

278.21

289.81

u/ml

0.21

132

1105

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

209

1671

0.82

2.22

1.1

1.2

278.21

289.81

u/ml

0.21

132

1105

Medicines for HER+ breast cancer

160

1955

0.80

2.21

1.1

1.2

257.95

294.54

u/ml

0.79

1236

Anankastic personality disorder

296

1.57

2.21

1.2

358.78

247.23

u/ml

1.13

189

Benign neoplasm: Parathyroid gland

2.67

2.20

1.3

1.1

327.33

269.81

u/ml

—

Benign neoplasm: Small intestine

180

1.74

2.20

1.1

1.2

279.65

282.91

u/ml

0.02

102

Disorders of iron metabolism

2.11

2.19

1.3

1.2

302.43

284.00

u/ml

—

Disorders of vestibular function (Vertigo)

340

2887

1.17

2.19

1.2

294.75

281.76

u/ml

0.26

212

1825

TMD related pain

234

1.64

2.18

1.2

1.3

242.33

244.03

u/ml

0.02

145

Atypical facial pain

273

1.59

2.18

1.3

1.2

211.68

269.90

u/ml

1.26

164

Other and specified injuries of hip and thigh

122

1.91

2.18

1.4

1.3

338.38

257.64

u/ml

0.65

Other and unspecified glaucoma

265

1.59

2.17

1.4

1.2

305.39

301.37

u/ml

0.03

152

Benign lipomatous neoplasm

201

1639

1.23

2.17

1.2

1.3

271.85

283.24

u/ml

0.23

128

1079

Hypertrophy of (infrapatellar) fat pad

2.34

2.17

1.1

1.3

456.75

237.64

u/ml

—

Malignant neoplasm of other connective and soft tissue

101

2.00

2.17

1.4

1.2

318.00

268.15

u/ml

—

Patellar tendinitis

159

1.79

2.16

1.4

1.2

258.12

239.30

u/ml

0.10

Benign neoplasm: Skin of lip

2.33

2.16

1.4

1.2

204.38

313.11

u/ml

—

Any dementia

105

979

0.75

2.16

1.0

1.2

287.66

285.36

u/ml

0.03

579

Malignant neoplasm of urinary organs

460

1.44

2.16

1.4

1.2

257.37

295.33

u/ml

0.53

272

Other disorders of veins

292

2468

1.19

2.15

1.2

290.20

281.09

u/ml

0.22

198

1586

Left bundle-branch block

266

1.59

2.14

1.1

1.2

273.69

277.61

u/ml

0.04

159

Pneumothorax

379

1.49

2.13

1.3

1.2

329.74

267.99

u/ml

0.54

234

Paraplegia, diplegia of upper limbs

123

1.90

2.13

1.4

1.2

324.73

259.79

u/ml

0.40

Abnormal blood-pressure reading, without diagnosis

275

1.58

2.12

1.7

1.2

320.20

237.62

u/ml

0.71

165

Carpal tunnel syndrome

508

4042

1.14

2.12

1.2

296.47

281.93

u/ml

0.41

300

2660

Mental and behavioural disorders due to alcohol, excluding acute intoxication

434

3786

1.15

2.12

1.2

1.3

278.11

270.41

u/ml

0.25

293

2468

Cardiomyopathies, Secondary/extrinsic

3.28

2.11

1.3

1.1

278.88

312.13

u/ml

—

Lichen simplex chronicus

190

1.70

2.11

1.6

1.2

290.68

257.38

u/ml

0.22

112

Other enthesopathies

262

2200

1.19

2.11

1.2

279.62

276.77

u/ml

0.05

164

1437

Human immunodeficiency virus [HIV] disease

146

1.81

2.09

1.0

1.2

354.69

236.49

u/ml

0.71

Carcinoma in situ of cervix uteri

701

1.35

2.09

1.3

1.2

321.16

261.62

u/ml

1.12

480

Melanocytic naevi of scalp and neck

161

1.76

2.08

1.2

1.3

258.77

252.55

u/ml

0.04

Extrapyramidal and movement disorders

259

2176

1.19

2.07

1.2

314.64

281.42

u/ml

0.68

155

1359

Congenital malformations of the respiratory system

154

1.79

2.07

2.2

1.8

292.30

206.35

u/ml

0.30

Vitamin D deficiency

132

1.85

2.06

1.2

1.3

238.12

245.80

u/ml

0.06

Myocardial infarction, unclassifiable

112

764

1.31

2.04

1.4

1.2

299.67

305.36

u/ml

0.07

470

Other erythematous conditions

192

1.68

2.04

1.6

1.2

285.11

268.18

u/ml

0.12

116

severe traumatic brain injury, does not include concussion

149

1185

1.26

2.04

1.2

276.70

278.37

u/ml

0.03

751

Ulcer of vagina/vulva

147

1.79

2.04

1.5

1.4

214.02

246.63

u/ml

0.30

Suppurative and necrotic conditions of lower respiratory tract

286

1.55

2.04

1.3

325.43

287.55

u/ml

0.37

169

Endovascular or surgical operations to intracerebral aneurysms

310

1.53

2.03

1.5

1.2

273.39

271.99

u/ml

0.01

191

Later onset COPD

800

0.72

2.03

1.1

1.2

272.14

291.04

u/ml

0.21

473

Other/unspecified disorders of vestibular function

177

1.71

2.03

1.1

1.2

230.64

272.12

u/ml

0.44

101

Alzheimer’s disease, wide definition, excluding more controls

362

0.62

2.02

1.1

1.2

268.36

258.54

u/ml

0.07

215

Other congenital malformations

123

958

1.29

2.02

1.6

1.5

242.34

232.81

u/ml

0.14

536

Complications of other internal prosthetic devices, implants and grafts

170

1.72

2.01

1.4

1.2

224.78

263.35

u/ml

0.41

101

529

1.40

2.01

2.9

1.9

200.79

160.72

u/ml

0.38

247

Female infertility, cervigal, vaginal, other or unspecified origin

295

1677

1.18

2.00

1.2

257.83

266.37

u/ml

0.16

197

1120

Other congenital malformations of skin

328

1.51

2.00

1.4

222.87

241.84

u/ml

0.23

197

Myocardial infarction, with ST-elevation

101

766

1.32

2.00

1.2

297.97

300.00

u/ml

0.02

477

D07AA Corticosteroids, weak (group I)

195

1603

1.22

1.98

1.3

1.4

247.94

242.18

u/ml

0.09

115

977

Maltreatment syndromes

520

1.40

1.98

1.2

1.3

268.83

234.58

u/ml

0.58

327

Any dementia, excluding more controls

100

911

0.76

1.97

1.0

1.2

288.91

283.21

u/ml

0.07

528

Impingement syndrome of shoulder

195

1605

1.22

1.97

1.2

257.84

282.68

u/ml

0.71

111

1021

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

428

1.43

1.96

1.4

1.2

357.98

261.13

u/ml

0.71

265

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

701

1.34

1.95

1.2

1.3

299.58

241.00

u/ml

1.40

457

Congenital malformations of the musculoskeletal system, not elsewhere classified

120

1.87

1.95

1.6

1.4

237.00

177.46

u/ml

0.48

Other congenital malformations of intestine

2.17

1.95

2.0

1.6

269.00

196.40

u/ml

—

Alzheimer’s disease (Late onset), excluding more controls

319

0.60

1.95

1.0

1.1

283.76

263.60

u/ml

0.13

185

Correction of physiology of bite - very demanding therapy visit

195

1.66

1.95

1.1

1.3

305.68

244.63

u/ml

0.61

124

Blepharochalasis

173

1408

1.23

1.95

1.2

299.64

296.41

u/ml

0.05

110

859

Short stature, not elsewhere classified

451

1.42

1.94

2.8

1.8

261.61

165.96

u/ml

1.46

220

Artificial joint operation, meniscal resection

665

4911

0.90

1.94

1.2

1.3

270.33

279.54

u/ml

0.28

412

3201

Benign neoplasm: Liver/bile ducts

120

1.85

1.94

1.3

1.2

180.55

237.45

u/ml

0.94

Trochanteric bursitis

701

1.33

1.94

1.2

288.19

274.13

u/ml

0.09

420

Postpartum haemorrhage due to retained placenta

1051

0.74

1.93

1.2

266.57

258.14

u/ml

0.08

733

Kela-code for severe mental illness

296

3449

0.86

1.93

1.2

1.3

270.58

264.06

u/ml

0.16

166

2277

Poisoning by drugs, medicaments and biological substances

275

2341

1.18

1.93

1.3

271.91

257.96

u/ml

0.35

177

1513

Family history of certain disabilities and chronic diseases leading to disablement

339

1.49

1.93

1.4

1.1

259.89

237.47

u/ml

0.24

205

Alcohol use disorder, ICD-based

400

3502

1.14

1.92

1.2

1.3

276.29

270.02

u/ml

0.19

270

2287

Mental disorders, not otherwise specified

755

1.32

1.92

1.3

1.2

268.62

252.85

u/ml

0.27

487

Congenital malformation syndromes predominantly affecting facial appearance

0.00

1.92

0.0

2.1

—

148.79

—

Other localized connective tissue disorders

2.02

1.91

1.5

1.2

310.17

216.12

u/ml

0.45

Other melanin hyperpigmentation

2.02

1.91

1.1

1.2

332.40

275.37

u/ml

—

Crossbite

127

929

1.28

1.90

2.3

1.6

179.73

199.48

u/ml

0.42

476

Ascorbic acid deficiency

4.79

1.90

1.0

2.6

357.20

152.29

u/ml

—

Asthma and opportunity respiratory infection

196

1.65

1.90

1.5

1.2

237.21

282.87

u/ml

0.42

111

Propionic acid derivatives

441

1943

1.14

1.90

1.2

1.4

233.31

255.13

u/ml

0.82

252

1238

Parkinson's disease

604

0.66

1.89

1.1

1.2

309.80

303.08

u/ml

0.04

368

Hyperplasia of prostate

294

1429

1.18

1.88

1.3

272.85

279.10

u/ml

0.14

189

933

Medical treatment for female infertility

224

1875

1.20

1.87

1.2

231.60

261.22

u/ml

1.19

157

1276

Astigmatism

628

1.35

1.87

1.8

1.5

245.68

229.01

u/ml

0.20

350

Benign neoplasm of eye and adnexa

466

1.40

1.86

1.3

1.2

277.30

266.80

u/ml

0.13

288

Benign neoplasm: Skin of upper limb, including shoulder

1.96

1.86

1.3

1.2

384.36

265.12

u/ml

0.90

LSIL lesion of the cervix uteri, vagina or vulva

136

1085

1.26

1.86

1.3

1.2

327.53

268.46

u/ml

1.42

717

Bulimia nervosa (incl. atypical)

334

1.48

1.86

1.2

243.13

236.88

u/ml

0.06

217

Alcohol-induced acute pancreatitis

229

1.59

1.86

1.4

1.2

332.63

286.21

u/ml

0.35

142

Pain associated with micturition

750

1.31

1.85

1.4

1.3

243.22

266.44

u/ml

0.42

445

Benign neoplasm of urinary organs

221

1.60

1.85

1.0

1.2

268.58

276.08

u/ml

0.07

127

Other otitis externa (chronic)

425

1.42

1.85

1.3

1.2

222.31

263.13

u/ml

0.63

255

Diseases of inner ear

405

3484

1.14

1.85

1.2

291.87

279.97

u/ml

0.28

256

2227

Dental pulpitis 3

288

1776

1.17

1.85

1.4

178.90

206.64

u/ml

1.48

179

1019

Acute nasopharyngitis (common cold)

124

974

1.27

1.84

1.3

297.01

258.62

u/ml

0.61

653

Other abnormal products of conception

362

2098

1.15

1.84

1.2

245.10

262.26

u/ml

0.68

262

1392

Transient ischemic attack

334

2398

1.16

1.83

1.2

314.22

285.15

u/ml

0.69

223

1516

Primary ovarian failure

130

1.79

1.83

1.2

1.4

286.93

227.51

u/ml

0.36

Toxic effect of alcohol

145

1.75

1.83

1.4

1.2

366.65

280.79

u/ml

0.75

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

579

1.36

1.83

1.4

1.2

234.78

263.42

u/ml

0.44

395

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

124

980

1.27

1.83

1.1

1.2

295.70

288.64

u/ml

0.12

630

2.05

1.83

1.4

1.3

377.91

224.57

u/ml

—

Glucosamine medication

217

2062

0.84

1.82

1.1

1.2

306.80

300.59

u/ml

0.09

123

1268

Other specified and unspecified personality disorders

102

788

1.30

1.82

1.2

305.06

259.93

u/ml

0.80

511

Pregnancy with abortive outcome

671

3165

1.11

1.81

1.2

265.61

263.12

u/ml

0.08

450

2021

Other congenital malformations of peripheral vascular system

116

1.85

1.81

1.1

1.6

229.79

216.29

u/ml

0.12

Memory loss

385

1.44

1.81

1.1

1.2

304.50

283.93

u/ml

0.22

231

Male infertility

436

1.41

1.81

1.4

1.3

283.56

236.22

u/ml

0.62

283

Use of donepezil

528

0.65

1.79

1.1

246.00

308.52

u/ml

0.93

301

Schizoaffective disorder

631

0.68

1.79

1.2

310.64

255.67

u/ml

0.55

418

Malignant neoplasm of head and neck

386

1.43

1.79

1.1

1.2

309.12

282.44

u/ml

0.30

233

Schizophrenia, schizotypal and delusional disorders

260

3037

0.85

1.78

1.2

1.3

280.46

260.66

u/ml

0.56

158

1993

Spirochaetal infections, other/unspecified

505

1.37

1.77

1.1

1.2

293.28

259.77

u/ml

0.30

305

Tinnitus

187

1552

1.21

1.77

1.2

318.81

283.99

u/ml

0.50

117

1007

Status epilepticus

224

1.58

1.77

1.4

1.3

193.80

245.46

u/ml

0.56

133

Female infertility

326

1742

1.16

1.77

1.2

256.55

263.98

u/ml

0.15

216

1166

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

1.97

1.77

1.1

1.3

385.58

203.67

u/ml

—

Benign leiomyoma with endometriosis

703

1.31

1.77

1.3

1.2

284.32

292.95

u/ml

0.11

444

Haemorrhagic and haematological disorders of fetus and newborn

429

1.42

1.76

2.1

176.15

170.75

u/ml

0.04

194

Wet age-related macular degeneration

487

1.37

1.76

1.3

1.1

327.47

304.24

u/ml

0.23

282

Precocious puberty

2.00

1.76

1.5

1.7

189.20

183.89

u/ml

—

Abscess of Bartholin gland

162

1.68

1.76

1.1

1.2

258.26

250.81

u/ml

0.05

105

Benign neoplasm: Skin of other and unspecified parts of face

574

1.35

1.76

1.3

1.2

307.65

280.63

u/ml

0.34

345

Superficial injury of shoulder and upper arm

107

836

1.29

1.76

1.2

1.3

233.50

261.42

u/ml

0.53

523

Coronary artery bypass grafting

161

999

1.23

1.75

1.3

1.2

307.74

294.37

u/ml

0.25

102

614

Hyperosmolality and hypernatraemia

2.25

1.75

1.3

347.86

311.45

u/ml

—

Artrosis, including avohilmo

743

4477

0.91

1.75

1.2

1.3

282.30

277.51

u/ml

0.16

450

3007

Arthrosis

650

3227

1.11

1.74

1.2

1.3

273.08

277.22

u/ml

0.12

397

2173

Biomechanical lesions, not elsewhere classified

249

1.54

1.74

1.3

1.2

243.83

276.10

u/ml

0.39

149

Emergency coronary revascularization (for ACS)

351

2200

1.15

1.74

1.4

1.2

309.97

284.32

u/ml

0.86

221

1373

Poisoning by medicine

249

2125

1.18

1.74

1.3

272.77

257.12

u/ml

0.37

161

1364

Delivery

322

1963

0.87

1.73

1.2

227.97

266.42

u/ml

2.18

207

1190

Stenosis and insufficiency of lacrimal passages

516

1.36

1.72

1.2

280.45

256.65

u/ml

0.27

291

Crowding of teeth, including avohilmo

176

1202

1.22

1.72

2.1

1.4

181.16

200.63

u/ml

0.49

657

Disturbances of smell and taste

202

1.60

1.72

1.2

240.27

250.54

u/ml

0.07

117

Lesion of ulnar nerve

119

945

1.26

1.72

1.4

1.2

306.14

278.20

u/ml

0.50

603

Pyothorax

210

1.58

1.71

1.4

1.2

334.60

289.12

u/ml

0.33

122

Unstable angina pectoris

230

1614

1.18

1.71

1.2

337.92

289.41

u/ml

1.25

136

993

Other/unspecified soft tissue disorders related to use, overuse and pressure

179

1.64

1.71

1.2

248.05

237.12

u/ml

0.09

105

Coronary angioplasty

236

1537

1.18

1.70

1.4

1.2

303.91

288.65

u/ml

0.31

146

942

Disorder of external ear, unspecified

187

1.62

1.70

1.2

191.99

263.47

u/ml

0.85

116

Malignant neoplasm of bronchus and lung

662

0.70

1.70

1.1

1.2

256.00

303.93

u/ml

0.79

388

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

299

1.48

1.70

1.1

1.2

295.80

296.58

u/ml

0.01

179

Monoamine oxidase A inhibitors

752

1.30

1.70

1.2

281.24

280.05

u/ml

0.02

492

Bronchitis, not specified as acute or chronic

535

1.35

1.69

1.4

1.2

233.28

264.61

u/ml

0.48

342

Other and unspecified bullous disorders

2.22

1.69

1.4

1.3

224.00

221.04

u/ml

—

Benign neoplasm of mouth and pharynx

639

1.32

1.69

1.3

1.2

337.27

269.78

u/ml

0.54

397

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

149

1.70

1.69

1.1

1.2

274.94

268.67

u/ml

0.04

Cervical disc disorders

290

2510

1.16

1.68

1.2

1.3

284.35

283.41

u/ml

0.01

165

1640

Other disorders of bone density and structure

172

1.65

1.68

1.2

1.3

153.79

234.85

u/ml

1.79

Dislocation, sprain and strain of joints and ligaments of head

375

1.43

1.68

1.5

1.4

185.92

244.09

u/ml

1.41

224

Tic and related disorders

165

1.67

1.68

1.3

1.5

331.38

199.78

u/ml

0.84

Tooth agenesis EXCLUDE clefts and syndromes

503

1.37

1.67

1.8

1.5

259.13

196.03

u/ml

0.81

265

Other misadventures during surgical and medical care

119

1.79

1.67

1.3

1.2

209.94

276.09

u/ml

0.53

Benign neoplasm: salivary glands, exclude unknown (D119)

468

1.37

1.67

1.3

1.2

376.31

280.90

u/ml

1.08

288

Use of levodopa decarboxylase inhibitor

491

0.65

1.67

1.0

1.1

277.63

302.46

u/ml

0.22

290

Endometriosis ASRM stages 1,2

167

1381

1.21

1.67

1.1

1.2

279.81

268.58

u/ml

0.13

104

901

Tobacco use

359

1.43

1.66

1.1

1.2

259.92

261.46

u/ml

0.02

227

Contusion of ankle

351

1.44

1.66

1.2

1.3

156.40

253.50

u/ml

3.76

209

Oral leukoplakia and related diseases, including avohilmo

486

1.37

1.65

1.1

1.2

273.70

282.51

u/ml

0.09

292

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

181

1.62

1.64

1.2

1.1

194.45

240.87

u/ml

0.72

117

Other diseases of peritoneum

205

1.57

1.63

1.2

265.48

261.95

u/ml

0.02

115

Pneumonitis due to solids and liquids

369

1.42

1.62

1.3

1.2

288.81

273.90

u/ml

0.12

218

Contusion of toe(s) without damage to nail

206

1.57

1.61

1.5

1.2

184.47

236.63

u/ml

0.76

122

Oter anti-inflammatory and antirheumatic agents, non-steroids

141

960

0.81

1.61

1.2

1.4

293.03

291.74

u/ml

0.01

660

Early lumbar disc prolapse operation

1007

0.76

1.61

1.3

261.19

258.27

u/ml

0.03

696

Benign neoplasm: Skin of trunk

246

1.52

1.61

1.6

1.2

321.67

252.17

u/ml

0.64

151

Endometriosis of ovary

145

1184

1.23

1.61

1.2

299.20

286.07

u/ml

0.13

790

Schizophrenia or delusion

262

3029

0.86

1.61

1.2

1.3

279.30

260.87

u/ml

0.51

159

1991

Lactose intolerance

214

1.56

1.60

1.3

229.95

243.18

u/ml

0.13

126

Coxarthrosis [arthrosis of hip](FG)

363

2312

1.14

1.59

1.2

306.87

284.60

u/ml

0.69

211

1469

Polycystic ovarian syndrome

533

1.34

1.59

1.1

1.2

248.57

245.09

u/ml

0.04

357

Felty syndrome

3.06

1.59

1.5

1.3

186.00

266.18

u/ml

—

Other spirochaetal diseases

204

1727

1.18

1.59

1.2

1.3

261.07

277.90

u/ml

0.32

133

1074

Parkinson's disease, strict definition

544

0.68

1.58

1.1

1.2

319.98

304.55

u/ml

0.10

323

Ankylosing spondylitis

664

1.30

1.58

1.2

288.48

276.40

u/ml

0.14

420

Open bite

639

1.31

1.58

2.2

1.5

173.77

213.67

u/ml

0.84

351

Hypersomnia

1.88

1.57

1.2

213.15

251.19

u/ml

0.31

Emotional disorders starting during childhood or adolescence

106

836

1.27

1.57

1.4

1.5

259.95

191.82

u/ml

1.69

452

Leiomyoma of uterus

373

1852

1.14

1.57

1.3

1.2

293.56

283.62

u/ml

0.29

237

1277

All dysplastic lesions of the cervix uteri

256

2206

1.16

1.57

1.3

1.2

288.23

258.76

u/ml

1.01

180

1491

Labour and delivery complicated by fetal stress [distress]

226

1763

0.85

1.56

1.2

237.83

254.64

u/ml

0.56

155

1195

Congenital malformations of ovaries, fallopian tubes and broad ligaments

440

1.37

1.56

1.3

1.2

263.68

263.51

u/ml

0.00

295

Symptoms and signs involving emotional state

240

1.52

1.56

1.6

1.5

233.05

247.38

u/ml

0.12

142

Other and unspecified nonorganic psychotic disorders

169

2017

0.83

1.55

1.3

283.59

249.63

u/ml

0.89

107

1308

Other acute skin changes due to ultraviolet radiation

176

1.60

1.55

1.3

1.2

285.57

292.06

u/ml

0.05

104

Perforation of tympanic membrane

710

1.29

1.55

1.6

1.3

295.42

252.19

u/ml

0.67

417

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

579

1.32

1.55

1.3

285.41

232.42

u/ml

0.85

350

Benign neoplasm: Parotid gland

415

1.38

1.55

1.3

1.2

309.58

276.25

u/ml

0.35

257

Injuries to the elbow and forearm

730

6053

1.09

1.55

1.3

253.42

260.56

u/ml

0.31

476

3825

Human immunodeficiency virus [HIV] disease resulting in other conditions

130

1.72

1.55

1.0

1.2

371.87

235.30

u/ml

0.80

Exposure to other and unspecified animate mechanical forces

257

1.50

1.54

1.3

1.5

230.61

242.67

u/ml

0.10

151

Bruxism

130

1.71

1.54

1.4

1.3

338.50

227.51

u/ml

1.01

Disorders of brain, other and unspecified

2.31

1.54

1.2

1.1

342.60

241.96

u/ml

—

Type1 diabetes, definitions combined, early onset

121

975

1.25

1.54

1.6

1.5

238.65

215.89

u/ml

0.44

570

Benign neoplasm: Eye, unspecified

3.41

1.53

2.2

1.9

253.80

129.56

u/ml

—

Other chronic obstructive pulmonary disease, including avohilmo

358

2631

1.13

1.53

1.2

292.79

287.89

u/ml

0.10

229

1641

Dipeptidyl peptidase 4 (DPP-4) inhibitors

562

1.32

1.53

1.4

1.2

321.48

292.89

u/ml

0.28

355

Carbimazole or st.post thyroidectomy, condition for graves disease

174

1459

1.20

1.53

1.3

1.2

279.08

279.50

u/ml

0.01

118

925

Fibroblastic disorders

162

1350

1.20

1.52

1.3

1.2

246.53

283.16

u/ml

1.11

107

846

Carcinoma in situ of other and unspecified digestive organs

108

1.78

1.51

1.1

430.17

316.03

u/ml

0.64

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

417

1.37

1.51

1.4

1.2

301.76

252.19

u/ml

0.66

257

Lateral epicondylitis

116

935

1.25

1.51

1.2

277.72

274.48

u/ml

0.04

596

Radiculopathy

111

890

1.25

1.51

1.2

268.56

294.87

u/ml

0.44

558

Lung cancer and mesothelioma

563

1.29

1.50

1.1

1.2

302.51

274.94

u/ml

0.42

348

Other and unspecified disorders of skin and subcutaneous tissue

350

1.41

1.50

1.2

254.90

258.38

u/ml

0.03

209

122

875

1.24

1.49

1.3

1.2

313.47

290.45

u/ml

0.32

523

Disorders of eyelid in diseases classified elsewhere

178

1.59

1.49

1.4

1.2

243.14

249.35

u/ml

0.05

100

Coxarthrosis

352

2108

1.13

1.49

1.2

308.54

283.03

u/ml

0.83

207

1373

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

727

1.27

1.49

1.1

1.2

279.88

288.80

u/ml

0.11

473

Severe visual impairment, monocular

2.47

1.49

1.3

153.00

249.48

u/ml

—

Other puerperal infections

697

1.28

1.49

1.2

212.09

264.76

u/ml

1.74

473

Hypertrophic disorders of skin

453

1.36

1.48

1.4

1.3

240.86

225.30

u/ml

0.17

279

Convalescence

259

1.48

1.5

1.1

233.76

247.91

u/ml

0.15

146

Dermatitis herpetiformis

1.83

1.48

1.2

1.3

163.95

267.80

u/ml

1.43

Cerebral palsy and other paralytic syndromes

100

795

1.26

1.47

1.5

1.3

274.43

256.28

u/ml

0.27

471

Follow-up care involving plastic surgery

155

1.62

1.47

1.2

1.1

217.10

243.57

u/ml

—

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

742

1.27

1.46

1.1

1.2

303.67

288.98

u/ml

0.19

470

Suppurative otitis media, unspecified

228

1.51

1.45

1.3

1.2

337.10

235.40

u/ml

0.98

127

Other noninflammatory disorders of uterus, except cervix

144

810

1.22

1.45

1.1

1.2

329.26

290.27

u/ml

0.40

512

Faecal incontinence

344

1.40

1.44

1.2

1.1

346.05

273.81

u/ml

0.36

197

Fracture of forearm

520

4417

1.10

1.44

1.3

262.40

263.99

u/ml

0.05

341

2737

Complications peculiar to reattachment and amputation

2.77

1.44

1.3

1.1

438.33

312.50

u/ml

—

Testicular hypofunction

253

1.48

1.44

1.3

1.2

286.76

278.31

u/ml

0.06

157

Salpingitis and oophoritis

130

1067

1.22

1.44

1.2

257.48

282.08

u/ml

0.49

691

Congenital malformations of cardiac septa

102

790

1.26

1.44

1.7

259.69

217.63

u/ml

0.77

411

Benign neoplasm of major salivary glands

516

1.32

1.43

1.3

1.2

366.87

279.84

u/ml

1.06

315

Benign neoplasm: Skin, unspecified

204

1.53

1.43

1.5

1.2

269.73

238.38

u/ml

0.20

126

Postpartum haemorrhage due to anatomy

977

0.77

1.43

1.1

1.2

259.00

247.94

u/ml

0.14

695

Social disorders starting during childhood or adolecense, excluding more controls

111

1.76

1.42

1.3

1.6

197.00

191.95

u/ml

0.05

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

330

2924

1.13

1.42

1.2

1.3

252.62

260.33

u/ml

0.22

211

1918

Panniculitis affecting regions of neck and back

229

1.50

1.42

1.1

1.2

308.00

260.89

u/ml

0.32

138

Benign neoplasm of meninges

474

1.33

1.41

1.2

300.79

292.01

u/ml

0.09

277

Respiratory tuberculosis, confirmed

1.87

1.41

1.3

1.1

355.11

279.10

u/ml

—

Macular hole

205

1.52

1.40

1.2

1.1

302.68

301.20

u/ml

0.01

122

Tic disorders

174

1.58

1.40

1.3

1.6

331.38

170.33

u/ml

1.12

101

Other and unspecified primary disorders of muscles

2.05

1.40

1.8

1.5

109.33

259.45

u/ml

—

Hypopituitarism

668

1.28

1.40

1.7

1.5

250.07

237.49

u/ml

0.18

377

Pemphigus

2.45

1.40

1.1

238.57

248.21

u/ml

—

Lesion of lateral popliteal nerve

296

1.43

1.40

1.5

1.2

335.57

271.96

u/ml

0.73

182

Maternal care for other known or suspected fetal problems

303

1709

1.14

1.40

1.3

239.33

254.22

u/ml

0.51

210

1138

Seminoma of testis

1.83

1.39

1.1

1.2

325.09

277.66

u/ml

0.27

Progressive vascular leukoencephalopathy

1.90

1.39

1.0

1.1

232.71

345.23

u/ml

—

Other and unspecified thalassaemias

3.12

1.39

1.4

3.1

254.00

127.36

u/ml

—

Other congenital malformations of heart

1.81

1.39

2.4

2.1

204.17

168.81

u/ml

0.17

Right bundle-branch block

142

1.63

1.39

1.4

1.1

431.42

259.21

u/ml

0.94

Other and unspecified mononeuropathies, also in other diseases

150

1.61

1.38

1.8

1.2

281.07

293.00

u/ml

0.08

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

1.82

1.38

1.1

1.2

351.11

292.88

u/ml

—

Lyme disease

197

1688

1.17

1.37

1.1

1.3

262.08

278.82

u/ml

0.31

130

1049

Tongue abnormality

314

1.41

1.37

1.5

1.2

269.96

267.25

u/ml

0.02

181

Foreign body in alimentary tract

408

0.66

1.37

1.3

1.4

302.83

251.38

u/ml

0.43

238

Flat foot [pes planus] (acquired)

538

1.31

1.36

1.2

282.43

274.81

u/ml

0.09

331

Benign neoplasm: Larynx

135

1.64

1.36

1.1

1.2

198.93

257.45

u/ml

0.75

Gonarthrosis, primary, with knee surgery

279

2590

0.88

1.36

1.2

310.80

297.18

u/ml

0.25

156

1623

Acute otitis externa, noninfective

1.77

1.36

1.5

1.2

274.50

254.01

u/ml

—

Congenital iodine-deficiency syndrome/hypothyroidism

143

1.62

1.36

1.1

1.3

242.42

272.20

u/ml

0.18

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

274

2408

1.14

1.35

1.2

1.3

252.29

269.38

u/ml

0.50

184

1566

Assault by bodily force

734

1.26

1.35

1.1

1.2

259.89

246.67

u/ml

0.16

462

Car occupant injured in noncollision transport accident

307

1.41

1.35

1.3

1.2

285.65

253.99

u/ml

0.24

190

Benign neoplasm: Conjunctiva

167

1.57

1.35

1.1

1.2

279.65

224.54

u/ml

0.54

101

Achalasia of cardia

1.89

1.35

1.0

1.1

274.17

246.91

u/ml

—

Conotruncal defects

225

1.50

1.35

2.6

2.0

214.88

183.17

u/ml

0.29

111

Gilbert syndrome

2.01

1.35

1.3

1.4

217.00

193.50

u/ml

—

Benign neoplasm: Tongue

120

1.68

1.35

1.4

1.2

533.50

238.69

u/ml

0.74

Benign neoplasm: Skin of upper limb, including shoulder

105

1.73

1.34

1.3

1.2

384.36

254.11

u/ml

1.01

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

401

1.35

1.33

1.3

1.2

288.89

273.02

u/ml

0.17

254

Type 1 diabetes, strict definition, subgroup 1

122

1004

1.22

1.33

1.6

1.4

240.13

225.36

u/ml

0.26

599

Somnolence

1.76

1.32

1.3

1.4

197.70

236.81

u/ml

—

Internal derangement of knee

341

3035

1.12

1.32

1.2

1.3

268.05

270.57

u/ml

0.06

208

2022

Respiratory tuberculosis, bacteriologically and histologically confirmed

1.82

1.32

1.3

1.2

355.11

275.55

u/ml

—

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

1.75

1.31

1.1

1.2

243.30

255.22

u/ml

—

Mixed disorders of conduct and emotions

404

1.36

1.31

1.4

1.5

201.78

192.35

u/ml

0.15

233

Embedded teeth, including avohilmo

131

1090

1.21

1.31

1.4

1.3

249.79

232.91

u/ml

0.21

660

Allergic urticaria

684

1.26

1.30

1.3

243.62

252.19

u/ml

0.10

406

Unspecified visual impairment (binocular)

1.78

1.30

1.3

1.6

224.43

278.45

u/ml

—

Erectile dysfunction, exclusion

2.85

1.29

1.2

201.80

226.17

u/ml

—

Distal bite

567

1.29

2.8

1.6

205.71

194.50

u/ml

0.09

282

Early lumbar disc prolapse, operated

940

0.78

1.29

1.3

265.91

254.59

u/ml

0.11

639

Alzheimer disease, excluding more controls

419

0.73

1.29

1.1

1.2

272.29

260.42

u/ml

0.11

254

Carcinoma in situ of cervix uteri

757

1.25

1.28

1.3

1.2

321.16

261.58

u/ml

1.12

511

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

694

1.26

1.28

1.3

1.2

287.95

292.10

u/ml

0.04

434

Trigeminal neuralgia

302

1.40

1.27

1.1

1.2

298.58

264.01

u/ml

0.37

184

Benign neoplasm: Liver/bile ducts

138

1.61

1.27

1.3

1.2

180.55

270.71

u/ml

1.57

Malignant neoplasm of corpus uteri

260

1.43

1.27

1.1

268.29

306.04

u/ml

0.31

156

Benign neoplasm: Liver

107

1.70

1.26

1.3

1.2

176.50

223.52

u/ml

—

Hypertrophic scar

415

1.33

1.25

1.4

1.3

246.33

227.48

u/ml

0.19

249

608

1.26

1.24

1.3

1.1

303.84

296.02

u/ml

0.07

367

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

379

1.35

1.24

1.2

1.3

246.21

295.21

u/ml

0.49

243

Idiopathic urticaria

139

1.60

1.24

1.5

1.2

266.35

245.00

u/ml

0.14

Right ventricular outflow tract obstruction

148

1.60

1.24

3.0

2.0

187.19

165.44

u/ml

0.17

Toxic effects of substances chiefly nonmedicinal as to source

120

996

1.21

1.24

1.3

274.30

247.05

u/ml

0.49

624

Post-traumatic wound infection, not elsewhere classified

163

1.55

1.24

1.4

1.3

286.63

254.62

u/ml

0.26

104

Benign neoplasm: Skin of scalp and neck

139

1.60

1.24

1.6

1.4

234.69

214.38

u/ml

0.16

Other blood glucose lowering drugs, excl. Insulins

101

824

1.23

1.3

1.2

278.82

285.79

u/ml

0.09

509

374

0.67

1.23

1.2

268.74

299.18

u/ml

0.26

227

Use of selegiline

189

0.53

1.22

1.2

199.20

291.05

u/ml

—

102

Other and unspecified injuries of thorax

116

1.66

1.22

1.5

1.2

328.64

231.30

u/ml

0.60

Endocrine disorders, other/unspecified

116

1.65

1.22

1.5

1.2

286.92

240.22

u/ml

0.30

Spontaneous rupture of synovium and tendon

425

1.32

1.22

1.2

238.84

283.23

u/ml

0.68

263

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

196

1.49

1.22

1.3

264.94

232.19

u/ml

0.21

115

Dental pulpitis 3, only avohilmo

263

1696

1.14

1.22

1.3

1.4

181.33

206.22

u/ml

1.15

161

972

Pyoderma

124

1.63

1.22

2.1

1.4

254.08

253.28

u/ml

0.00

Herpesviral keratitis and keratoconjunctivitis

238

1.44

1.21

1.3

1.2

256.19

252.77

u/ml

0.02

147

Other hearing loss

155

1297

1.18

1.20

1.3

1.2

281.18

288.60

u/ml

0.13

800

Unspecified chronic bronchitis

148

1.56

1.20

1.5

1.2

256.50

279.96

u/ml

0.16

Complications predominantly related to the puerperium

245

2159

1.14

1.20

1.2

250.57

268.07

u/ml

0.57

158

1439

Other obstructed labour

535

0.73

1.20

1.3

1.2

249.21

280.29

u/ml

0.27

362

Meningitis, viral

2.36

1.20

1.0

1.3

350.33

273.63

u/ml

—

Dependent personality disorder

117

1.64

1.19

1.2

221.90

260.32

u/ml

—

Conductive hearing loss, unspecified

604

1.26

1.18

1.6

1.3

256.95

255.70

u/ml

0.01

365

Complications following abortion and ectopic and molar pregnancy

165

1.53

1.18

1.2

1.1

239.21

295.97

u/ml

0.70

Primary angle-closure glaucoma

165

1.52

1.18

1.4

1.1

374.33

323.70

u/ml

0.26

Other disorders of choroid

1.95

1.17

1.0

1.2

259.83

256.28

u/ml

—

Chondrocostal junction syndrome [Tietze]

198

1.47

1.17

1.1

1.2

190.06

244.70

u/ml

0.62

122

Muscle strain

223

1.45

1.17

1.2

324.20

250.91

u/ml

0.54

139

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

282

1.39

1.17

1.2

1.3

302.11

253.46

u/ml

0.46

176

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

133

1278

0.84

1.17

1.1

1.2

266.86

294.30

u/ml

0.43

837

Pneumonia due to Streptococcus pneumoniae

223

1.44

1.17

1.4

1.3

219.50

246.76

u/ml

0.23

138

Meralgia paraesthetica

190

1.48

1.17

1.1

1.2

256.53

276.52

u/ml

0.16

119

Inguinal hernia

579

3596

1.09

1.17

1.4

1.3

266.03

261.12

u/ml

0.17

387

2304

Bitten or struck by other mammals

116

967

1.20

1.16

1.2

1.3

254.81

255.75

u/ml

0.01

605

Superficial injury of thorax

125

1049

1.20

1.16

1.4

1.3

318.45

260.68

u/ml

1.19

658

Malignant melanoma

731

1.23

1.16

1.3

1.2

263.38

287.16

u/ml

0.39

445

Malignant neoplasm of tonsil, excluding all cancers (controls excluding all cancers)

1.82

1.16

1.2

283.75

310.03

u/ml

—

Maternal care for known or suspected fetal abnormality and damage

174

1335

1.16

1.15

1.2

222.53

255.53

u/ml

1.34

132

890

Sleep disorders, other/unspecified

283

1.39

1.15

1.5

1.3

190.62

222.89

u/ml

0.55

174

Cardiovascular disorders originating in the perinatal period

1.75

1.15

2.4

1.9

269.20

145.74

u/ml

—

Melanoma in situ

142

1.56

1.14

1.8

1.2

267.42

253.68

u/ml

0.09

Other maltreatment syndromes

275

1.39

1.14

1.2

302.85

248.91

u/ml

0.38

178

Neonatal jaundice from other and unspecified causes

343

1.36

1.14

2.3

2.2

133.28

172.52

u/ml

0.50

149

Thyrotoxicosis with diffuse goitre

116

969

1.20

1.14

1.2

281.37

281.04

u/ml

0.00

619

Cervicocranial syndrome

697

1.24

1.14

1.2

380.30

295.65

u/ml

0.70

435

Strabismus

275

2447

1.12

1.14

1.4

229.32

258.25

u/ml

1.35

170

1502

Acetic acid derivatives and related substances

337

1575

1.12

1.13

1.1

1.4

270.14

267.59

u/ml

0.05

210

1083

Mental and behavioural disorders due to opioids

353

1.34

1.13

1.2

310.94

229.69

u/ml

1.07

229

Coxibs

337

1611

1.12

1.1

1.4

243.30

266.82

u/ml

0.83

200

1103

Nasal polyp

144

1228

1.18

1.12

1.2

260.76

284.87

u/ml

0.41

789

Ectropion of eyelid

111

1.63

1.12

1.2

1.1

173.25

303.85

u/ml

1.68

Congenital malformations of pulmonary and tricuspid valves

128

1.61

1.12

3.0

2.0

167.60

155.19

u/ml

0.09

Birth trauma

1.78

1.12

2.1

2.0

160.33

170.15

u/ml

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

302

1.37

1.11

1.1

1.3

148.50

244.61

u/ml

3.36

190

Premature rupture of membranes

189

1593

0.87

1.11

1.2

261.59

257.32

u/ml

0.05

120

1056

Tic and related disorders

185

1.48

1.11

1.3

1.6

331.38

185.48

u/ml

0.98

108

Psoriatic arthropathies, ICD10

718

1.23

1.10

1.2

334.33

276.86

u/ml

0.77

448

Infections of genitourinary tract in pregnancy

700

1.23

1.10

1.2

219.94

271.63

u/ml

1.27

440

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

736

1.23

1.10

1.2

237.98

278.16

u/ml

0.92

472

Meningitis

337

1.34

1.10

1.4

1.3

253.87

254.04

u/ml

0.00

210

Benign neoplasm: Cerebral meninges

424

1.30

1.10

1.2

318.78

297.99

u/ml

0.21

243

Paralytic ileus

168

1.50

1.10

1.1

1.3

433.82

262.65

u/ml

0.78

Burns and corrosions confined to eye and internal organs

219

0.59

1.10

1.5

1.2

181.25

238.50

u/ml

—

133

Other bursal cyst

1.75

1.10

1.4

1.1

258.56

280.15

u/ml

—

Testicular dysfunction

286

1.37

1.09

1.3

1.2

297.65

264.49

u/ml

0.30

178

Clear cell adenocarcinoma of kidney

218

1.43

1.09

1.3

1.2

225.05

301.02

u/ml

1.04

125

Benign neoplasm: Conjunctiva

177

1.48

1.08

1.1

1.2

279.65

269.76

u/ml

0.07

106

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

111

777

1.20

1.08

1.1

1.2

277.00

290.66

u/ml

0.21

487

Polypectomy (DHB20)

421

0.71

1.08

1.2

301.47

285.10

u/ml

0.08

267

Other secondary coxarthrosis

177

1.48

1.08

1.2

320.25

280.92

u/ml

0.30

103

Unspecified urinary incontinence

452

1.29

1.07

1.2

1.3

236.03

266.67

u/ml

0.33

258

Other and unspecified paralytic syndromes

1.78

1.07

1.6

1.2

393.88

240.50

u/ml

—

Other noninflammatory disorders of vagina

470

1.28

1.07

1.5

1.2

250.48

273.07

u/ml

0.30

306

Injury of urinary and pelvic organs

145

1.53

1.07

1.4

1.3

180.53

270.61

u/ml

1.28

Injury of muscle and tendon at lower leg level

128

1087

1.18

1.06

1.2

265.83

272.38

u/ml

0.09

693

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

105

1.63

1.06

1.1

1.2

279.90

293.80

u/ml

—

Other demyelinating diseases of the central nervous system

279

1.37

1.06

1.2

1.3

344.96

258.12

u/ml

0.53

181

Presbycusis

398

1.30

1.06

1.2

1.1

287.84

308.21

u/ml

0.18

237

Metatarsalgia

596

1.25

1.05

1.2

257.38

269.09

u/ml

0.11

363

Other disorders of the musculoskeletal system and connective tissue

105

877

1.20

1.05

1.2

305.49

286.69

u/ml

0.13

557

Alcohol abuse, main dg, excluding more controls

139

1190

1.17

1.05

1.3

235.85

262.83

u/ml

0.71

756

Benign neoplasm of middle ear and respiratory system

366

1.32

1.05

1.1

1.2

212.15

255.21

u/ml

0.68

229

Other psoriatic arthropathies

687

1.23

1.04

1.2

346.33

277.82

u/ml

0.94

428

Malignant neoplasm of eye, brain and central nervous system

280

1.37

1.04

1.3

1.4

275.84

256.59

u/ml

0.09

174

Endometriosis in cutaneous scar

2.33

1.04

1.8

1.2

261.68

139.67

u/ml

—

Osteosarcoma, excluding all cancers (controls excluding all cancers)

2.32

1.04

1.8

1.5

185.20

141.50

u/ml

—

Use of rivastigmine

359

0.69

1.04

1.1

301.47

305.71

u/ml

0.02

205

Haemangioma, any site

508

1.26

1.04

1.4

1.3

300.16

246.92

u/ml

0.59

312

Malignant neoplasm of rectum

406

0.71

1.04

1.1

1.2

218.32

297.10

u/ml

1.25

238

Routine general health check-up of defined subpopulation

1.64

1.03

1.6

1.2

228.55

213.63

u/ml

0.12

Other and unspecified injuries of lower leg

634

1.24

1.03

1.4

1.3

261.14

236.07

u/ml

0.31

385

Parapsoriasis

122

1.57

1.03

1.4

1.2

257.75

219.33

u/ml

0.31

Disorders of globe

106

1.62

1.03

1.4

1.2

182.94

298.25

u/ml

—

Dental caries 3 and operation codes, only avohilmo

410

2254

0.91

1.03

1.2

1.5

234.20

251.71

u/ml

0.67

253

1439

Congenital deformities of hip

230

1.41

1.03

1.6

1.8

242.74

192.97

u/ml

0.36

112

Other disorders of breast

100

834

1.20

1.03

1.2

258.41

272.74

u/ml

0.24

536

Mental and behavioural disorders due to sedatives or hypnotics

527

1.26

1.02

1.2

1.3

303.98

249.12

u/ml

0.79

336

Prepatellar bursitis

290

1.35

1.02

1.2

298.52

258.83

u/ml

0.24

191

Pathological resorption of teeth

180

1.45

1.01

1.2

1.1

352.94

275.04

u/ml

0.32

Intentional self-harm by unspecified means

107

1.61

1.01

1.3

1.2

299.36

220.31

u/ml

0.44

Hereditary retinal dystrophy

1.63

1.01

1.3

1.4

254.56

230.07

u/ml

—

Diffuse brain injury

222

1.40

1.01

1.1

1.2

297.26

255.65

u/ml

0.35

144

Effects of other external causes

265

1.37

1.01

1.4

1.3

228.47

223.98

u/ml

0.03

167

Hypertrophy of breast

104

1235

0.84

1.01

1.2

298.72

270.31

u/ml

0.25

806

Malignant melanoma of skin

546

1.25

1.01

1.3

1.2

262.25

288.53

u/ml

0.38

331

Disorder of visual pathways, unspecified

0.00

1.00

0.0

1.7

—

243.00

—

Other specified/unspecified deforming dorsopathies

1.63

1.00

1.3

1.2

263.09

318.53

u/ml

0.50

Unspecified human immunodeficiency virus [HIV] disease

1.74

1.00

1.1

1.2

239.17

230.49

u/ml

—

Wide developmental disorders

504

0.75

1.00

1.4

1.7

277.63

201.15

u/ml

—

279

Leisure time condition

166

1448

1.15

1.00

1.5

1.3

261.56

252.88

u/ml

0.15

102

904

Infections specific to the perinatal period

250

1.39

0.99

2.2

2.0

207.75

169.38

u/ml

0.31

110

Other deformities of toe(s)

156

1.48

0.99

1.2

250.60

254.39

u/ml

—

Benign neoplasm: Eye, unspecified

2.21

0.99

2.2

1.8

253.80

258.27

u/ml

—

Benign neoplasm: Skin of scalp and neck

148

1.50

0.98

1.6

1.4

234.69

244.93

u/ml

0.07

Malignant neoplasm of thyroid gland

379

1.30

0.98

1.4

1.2

314.14

262.78

u/ml

0.55

239

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

283

1.35

0.98

1.3

318.57

247.49

u/ml

0.69

168

Olecranon bursitis

353

1.31

0.98

1.7

1.2

264.50

266.53

u/ml

0.01

236

Disorders of magnesium metabolism

1.97

0.98

1.1

195.14

344.96

u/ml

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

104

1231

0.84

0.97

1.3

1.2

281.11

286.96

u/ml

0.08

774

Benign neoplasm: Other and unspecified parts of mouth

165

1.46

0.97

1.3

1.2

254.92

264.22

u/ml

0.06

Papillary adenocarcinoma of thyroid gland

284

1.34

0.97

1.5

1.2

318.92

252.34

u/ml

0.64

177

Overjet

397

1.29

0.97

2.9

1.8

152.30

189.03

u/ml

0.50

202

Type 1 diabetes, strict definition

126

1078

1.17

0.96

1.6

1.4

238.33

225.26

u/ml

0.23

643

Burn and corrosion of hip and lower limb, except ankle and foot

174

1.45

0.96

1.4

1.2

227.93

252.10

u/ml

0.21

102

Von Willebrand disease

1.71

0.96

1.1

1.2

140.00

236.79

u/ml

—

Other and unspecified nerve root and plexus disorders, also in other diseases

153

1332

1.15

0.95

1.2

244.15

279.50

u/ml

0.95

101

864

Dental caries 2 and operation codes, only avohilmo

875

5122

1.06

0.95

1.3

1.4

254.56

260.63

u/ml

0.27

552

3313

Parkinson's disease, excluding more controls

511

0.76

0.95

1.1

1.2

309.80

268.74

u/ml

0.33

313

Occupant of pick-up truck or van injured in other and unspecified transport accidents

1.92

0.95

1.6

1.2

180.57

180.81

u/ml

—

Other intervertebral disc disorders

791

4554

1.06

0.94

1.2

1.3

285.26

269.34

u/ml

0.70

526

3010

Benign neoplasm: Connective and other soft tissue of head, face and neck

1.63

0.94

1.2

1.3

266.33

200.08

u/ml

—

Injury of intra-abdominal organs

200

1.41

0.94

1.6

1.2

263.75

245.15

u/ml

0.10

113

Benign neoplasm: Liver

117

1.55

0.94

1.3

1.2

176.50

274.05

u/ml

—

1.62

0.94

1.1

1.2

373.57

335.31

u/ml

—

Other enthesopathy of foot (+metatarsalgia)

651

1.22

0.94

1.2

249.17

269.03

u/ml

0.23

399

Divergent concomitant strabismus

597

1.23

0.94

1.3

245.59

260.17

u/ml

0.20

369

Subacute thyroiditis

200

1.41

0.94

1.2

395.60

266.43

u/ml

0.39

123

Synovial cyst of popliteal space [Baker]

382

1.29

0.94

1.0

1.2

399.48

273.73

u/ml

1.28

235

Social disorders starting during childhood or adolescence

126

1.54

0.93

1.3

1.6

197.00

185.85

u/ml

0.11

Lactose intolerance, other/unspecified

175

1.44

0.93

1.3

247.76

229.63

u/ml

0.15

105

Other bursopathies

752

1.20

0.93

1.3

1.2

364.39

274.28

u/ml

1.40

474

Viral conjunctivitis

142

1.49

0.93

1.6

1.2

161.67

246.30

u/ml

1.52

Disorders of orbit

269

1.35

0.93

1.3

258.87

247.25

u/ml

0.07

161

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

304

1.32

0.92

1.4

273.13

247.75

u/ml

0.14

183

Brachial plexus disorders

708

1.20

0.91

1.2

299.23

266.05

u/ml

0.59

452

Hereditary corneal dystrophies

126

1.52

0.91

1.1

1.2

223.58

250.28

u/ml

0.14

Gonarthrosis [arthrosis of knee](FG)

576

3159

1.07

0.91

1.2

273.92

279.10

u/ml

0.16

354

2075

Lichen sclerosus et atrophicus

500

1.24

0.91

1.4

1.2

324.48

262.37

u/ml

0.86

299

Superficial injury of neck

168

1.44

0.90

1.3

247.95

219.55

u/ml

0.22

101

Open wound of shoulder and upper arm

143

1.48

0.90

1.3

181.22

250.06

u/ml

1.10

Injury of muscle and tendon at hip and thigh level

673

1.21

0.90

1.4

1.2

302.49

268.55

u/ml

0.42

414

Haemangioma and lymphangioma, any site

564

1.23

0.90

1.4

1.3

299.07

247.89

u/ml

0.59

340

1.71

0.89

1.3

1.2

347.57

213.43

u/ml

—

Maternal care for known or suspected abnormality of pelvic organs

265

1651

1.11

0.89

1.2

249.29

260.19

u/ml

0.31

185

1100

Ankylosing spondylitis, ICD10

692

1.20

0.89

1.2

298.79

267.13

u/ml

0.43

440

Other abnormal immunological findings in serum

127

1.51

0.89

1.2

1.3

287.80

217.47

u/ml

—

Benign neoplasm: Skin, unspecified

228

1.37

0.89

1.5

1.2

269.73

258.25

u/ml

0.06

133

Other diseases of spinal cord

177

1.42

0.89

1.6

1.2

260.33

257.27

u/ml

0.02

106

Postpartum haemorrhage

218

2115

0.90

0.88

1.2

254.18

266.03

u/ml

0.23

145

1427

Alopecia areata

186

1.41

0.88

1.3

1.4

303.92

230.02

u/ml

0.70

107

Other specified congenital malformation syndromes affecting multiple systems

238

1.36

0.87

2.1

1.9

299.15

184.48

u/ml

0.90

125

Other and unspecified injuries of ankle and foot

387

1.27

0.87

1.4

1.3

184.26

238.50

u/ml

0.97

228

Asthma mixed form (mode)

272

1.33

0.87

1.4

1.2

216.12

228.55

u/ml

0.15

151

Asthma mixed form (mode), excluding more controls

272

1.33

0.87

1.4

1.2

216.13

229.99

u/ml

0.17

148

Benign neoplasm: Tongue

136

1.48

0.87

1.4

1.2

533.50

303.51

u/ml

0.53

Anorexia (incl.atypical)

603

1.22

0.87

1.3

220.04

240.40

u/ml

0.34

372

Hypertrophy of tongue papillae

1.74

0.87

1.6

1.3

200.60

257.66

u/ml

—

!Aliquae complicationes praecoces traumatis

290

1.32

0.87

1.3

1.2

279.33

257.89

u/ml

0.22

183

Early complications of trauma

290

1.32

0.87

1.3

1.2

279.33

257.89

u/ml

0.22

183

Deforming dorsopathies

245

2213

1.11

0.86

1.2

1.3

302.75

269.05

u/ml

0.99

150

1371

Respiratory and cardiovascular disorders specific to the perinatal period

483

1.24

0.86

2.5

2.0

207.18

166.29

u/ml

0.34

222

Disorders of puberty

274

1.33

0.86

1.8

1.5

180.20

187.71

u/ml

0.10

145

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

204

1.38

0.86

1.0

1.3

317.94

235.27

u/ml

0.58

130

Personal history of certain other diseases

145

1.46

0.85

1.5

1.2

347.43

209.70

u/ml

0.56

Embolic stroke

153

1.44

0.85

1.0

1.2

217.82

299.12

u/ml

0.83

Brain glioblastoma and astrocytoma, excluding all cancers (controls excluding all cancers)

1.64

0.85

1.2

1.1

212.93

245.00

u/ml

—

Exposure to other and unspecified inanimate mechanical forces

605

1.21

0.85

1.5

1.3

215.18

248.78

u/ml

0.70

364

Postpartum hemorraghe, all women as controls

218

2410

0.90

0.84

1.2

254.18

257.85

u/ml

0.06

145

1641

Other benign neoplasm of uterus: Other parts/unspecified

1.57

0.84

1.1

316.00

341.96

u/ml

—

Examination and encounter for administrative purposes

179

1.40

0.84

1.4

1.2

247.53

276.47

u/ml

0.12

113

Malignant neoplasm of brain

222

1.36

0.84

1.3

301.34

256.25

u/ml

0.19

137

284

1.32

0.83

1.5

1.3

201.33

181.88

u/ml

0.17

151

Other and unspecified abdominal hernia

188

1.39

0.83

1.6

1.2

304.80

273.03

u/ml

0.15

114

Additional codes for the location of defect, injury or illness

381

1.27

0.82

1.1

1.3

257.06

257.30

u/ml

0.00

230

Nontoxic goitre/thyroid nodule

188

1679

1.12

0.82

1.2

278.89

289.85

u/ml

0.16

114

1049

Obstructed labour due to malposition and malpresentation of fetus

184

1940

0.89

0.82

1.3

1.2

246.40

269.62

u/ml

0.74

130

1322

Colorectal cancer

1048

0.85

0.82

1.2

284.81

291.34

u/ml

0.07

645

Sequelae of infectious and parasitic diseases

453

1.24

0.82

1.4

1.2

323.34

277.61

u/ml

0.41

285

Spinal stenosis

330

2374

1.09

0.82

1.1

1.3

276.57

287.22

u/ml

0.31

198

1509

Lichen planus, including avohilmo

1036

0.85

0.82

1.3

1.2

278.82

284.41

u/ml

0.07

642

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

272

0.70

0.82

1.3

1.2

296.85

258.00

u/ml

0.27

163

Plantar fascial fibromatosis

571

1.21

0.82

1.2

259.06

279.80

u/ml

0.30

354

Oligomenorrhoea

267

1.32

0.81

1.2

243.19

256.84

u/ml

0.14

179

Acute alcohol intoxication

227

2052

1.11

0.81

1.3

279.97

261.42

u/ml

0.51

150

1305

Exclusion endpoint for clefts

277

1.31

0.80

1.9

1.8

279.59

206.63

u/ml

0.53

143

Use of glatiramer acetate

114

1.50

0.80

1.1

1.2

263.25

215.60

u/ml

0.26

Disorders of puberty, all

304

1.30

0.80

1.8

1.6

200.62

200.69

u/ml

0.00

161

Complications following myocardial infarction

0.00

0.79

0.0

1.1

—

309.83

—

Dental caries 1 and operation codes, only avohilmo

352

1920

0.92

0.79

1.2

1.5

238.89

256.22

u/ml

0.60

207

1250

Neuroendocrine tumor and carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

0.00

0.79

0.0

1.2

—

207.46

—

Failed attempted abortion

1.57

0.79

1.1

1.2

200.00

186.64

u/ml

—

Unspecified maternal hypertension

1.64

0.79

1.2

100.43

217.20

u/ml

—

Macular cyst

1.54

0.79

1.3

1.2

303.57

274.61

u/ml

—

Tuberculosis

242

1.33

0.78

1.3

1.2

310.78

278.38

u/ml

0.19

135

Other/unspecified enthesopathies, not elsewhere classified

501

1.22

0.78

1.2

1.1

330.22

272.76

u/ml

0.43

312

Inflammation of lacrimal passages (acute and unspecified)

1.60

0.78

1.7

1.2

386.50

194.45

u/ml

—

Abnormal findings on antenatal screening of mother

749

1.18

0.78

1.1

1.2

255.44

256.03

u/ml

0.01

491

Injury of other and unspecified intrathoracic organs

406

0.76

0.78

1.4

1.2

267.35

253.13

u/ml

0.09

247

Hirsutism in women

140

1.44

0.77

1.1

1.3

210.20

238.22

u/ml

—

Simple and mucopurulent chronic bronchitis

208

1.35

0.77

1.4

1.5

345.17

240.10

u/ml

0.75

116

Endometriosis ASRM stages 3,4

180

1612

1.12

0.77

1.1

1.2

288.85

275.81

u/ml

0.16

111

1064

Thyrotoxicosis with toxic multinodular goitre

243

1.32

0.77

1.2

294.13

267.45

u/ml

0.25

147

Benign neoplasm of breast

612

1.20

0.77

1.1

1.2

300.59

267.60

u/ml

0.33

394

Neuroendocrine tumor and carcinoma of pancreas

0.00

0.76

0.0

1.2

—

294.14

—

Malignant neoplasm of mesothelium and soft tissue

200

1.36

0.76

1.4

1.2

364.00

274.56

u/ml

0.60

111

Hallux valgus (acquired)

187

1507

0.90

0.76

1.2

306.68

282.43

u/ml

0.71

123

988

Injury of nerves at wrist and hand level

279

1.30

0.76

1.3

1.2

357.15

266.54

u/ml

0.52

180

Exposure to other specified electric current

124

1.47

0.76

1.7

1.4

192.50

225.91

u/ml

—

Family history of malignant neoplasm

659

1.19

0.76

1.1

269.32

257.50

u/ml

0.16

413

Glaucoma, exfoliation

348

0.75

0.76

1.2

1.1

307.82

314.06

u/ml

0.05

199

Other disorders of amniotic fluid and membranes

112

1272

0.87

0.76

1.1

1.2

242.85

257.03

u/ml

0.35

847

Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)

1.61

0.75

1.0

1.1

272.50

277.46

u/ml

—

Disorders of pituitary gland, other and/or unspecified

2.11

0.75

1.6

1.3

343.80

285.08

u/ml

—

Torsion of ovary, ovarian pedicle and fallopian tube

158

1.40

0.75

1.2

200.50

272.34

u/ml

0.90

101

Autoimmune thyroiditis

116

1.48

0.75

1.4

1.3

291.32

208.86

u/ml

0.52

Oral lichen ruber planus

108

1.49

0.74

1.8

1.2

413.14

295.42

u/ml

—

HSIL lesion of the cervix uteri, vagina or vulva

184

1656

1.11

0.74

1.3

1.2

282.92

269.73

u/ml

0.28

129

1110

Other strabismus

236

2146

1.10

0.73

1.4

225.89

253.95

u/ml

1.16

141

1321

Parkinson's disease, strict definition, excluding more controls

459

0.79

0.72

1.1

1.2

319.98

266.31

u/ml

0.44

282

Caries in Clefts patients

109

1.49

0.72

1.6

1.4

107.82

194.01

u/ml

1.91

Iridocyclitis in diseases classified elsewhere

134

1.43

0.72

1.2

1.3

216.96

226.83

u/ml

—

Pediculosis and phthiriasis

1.96

0.71

1.8

1.2

462.20

148.00

u/ml

—

Spondylolisthesis/Spondylolysis

129

1140

1.13

0.71

1.1

1.3

295.92

294.67

u/ml

0.02

725

Exclusions for E4_PCOS_CONSORTIUM

769

4582

1.05

0.70

1.3

266.56

261.31

u/ml

0.22

499

2933

Congenital absence, atresia and stenosis of large intestine

1.94

0.70

4.0

1.7

144.60

203.62

u/ml

—

Foreign body in respiratory tract

410

0.78

0.70

1.4

256.95

234.93

u/ml

0.22

230

Benign neoplasm of eye and adnexa

545

1.20

0.70

1.3

1.2

277.30

272.54

u/ml

0.05

332

Fenamates

154

926

1.12

0.70

1.2

1.4

323.71

279.66

u/ml

0.92

107

648

Other benign neoplasm of uterus: Other parts/unspecified

101

1.49

0.70

1.1

316.00

343.72

u/ml

—

Lichen planus

696

0.83

0.70

1.4

1.2

300.81

281.37

u/ml

0.21

422

Respiratory tuberculosis, confirmed and not-confirmed

221

1.32

0.69

1.2

310.19

277.68

u/ml

0.17

122

Respiratory tuberculosis

221

1.32

0.69

1.2

310.19

277.68

u/ml

0.17

122

Laparoscopic right hemicolectomy

230

1.31

0.69

1.0

1.2

278.50

294.63

u/ml

0.12

131

Cramp and spasm

319

1.26

0.69

1.3

279.34

252.99

u/ml

0.25

193

Oesophageal obstruction

135

1.41

0.69

1.3

1.2

343.67

284.60

u/ml

0.40

Myopia

142

1266

1.12

0.69

1.6

1.3

273.64

255.27

u/ml

0.28

796

Hypertrichosis

161

1.38

0.69

1.1

1.3

202.00

240.64

u/ml

0.33

108

Burns and corrosions of external body surface, specified by site

112

984

1.14

0.68

1.3

1.4

239.75

241.78

u/ml

0.03

604

Psoriasis (vulgaris), strict definition

222

1.31

0.68

1.2

289.50

264.08

u/ml

0.22

140

Primary gonarthrosis, bilateral

267

2536

0.92

0.68

1.2

301.22

296.32

u/ml

0.08

158

1602

Adenomyosis (Endometriosis of uterus)

760

1.16

0.68

1.2

214.86

290.05

u/ml

2.73

493

Impacted cerumen

557

1.19

0.67

1.6

1.3

235.49

261.20

u/ml

0.29

319

LSIL lesion of the cervix uteri

103

901

1.15

0.67

1.2

332.04

262.52

u/ml

1.36

612

Malignant neoplasm of oropharynx

1.50

0.67

1.1

377.50

317.98

u/ml

—

Respiratory distress of newborn

332

1.25

0.67

2.2

161.11

153.34

u/ml

0.04

146

Congenital malformations of eye, ear, face and neck

756

0.84

0.67

1.9

1.5

203.95

218.73

u/ml

0.23

439

Dermatitis due to ingested food

627

1.18

0.67

1.8

1.7

149.89

187.14

u/ml

0.74

334

Malignant neoplasm of respiratory system and intrathoracic organs

796

0.85

0.66

1.1

1.2

243.56

291.07

u/ml

0.95

485

Other and unspecified trigeminal disorders

1.52

0.66

1.2

225.00

264.51

u/ml

—

Sequelae of poliomyelitis

1.80

0.66

1.2

1.1

152.00

388.50

u/ml

—

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

241

1.29

0.66

1.1

1.2

259.90

268.36

u/ml

0.05

152

Abscess of external ear

103

1.47

0.65

1.3

143.07

243.80

u/ml

—

Ménière disease

483

0.81

0.65

1.1

1.2

284.48

285.35

u/ml

0.01

297

Benign neoplasm: Connective and other soft tissue of head, face and neck

103

1.47

0.65

1.2

1.3

266.33

244.98

u/ml

—

Pneumoconiosis due to asbestos and other mineral fibres

1.62

0.65

1.0

1.1

282.00

282.61

u/ml

—

Pilonidal cyst

829

1.15

0.65

1.3

1.2

240.89

255.41

u/ml

0.19

536

Benign neoplasm of ovary

810

1.15

0.65

1.2

211.27

282.49

u/ml

2.26

515

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

318

0.76

0.64

3.1

2.1

146.88

168.07

u/ml

0.17

140

Lumbar disc prolapse

566

4258

1.06

0.64

1.2

1.3

287.46

271.82

u/ml

0.54

386

2816

Behavioural disorders

292

0.75

0.64

1.3

1.4

250.50

208.48

u/ml

0.38

164

Hypermetropia

690

1.16

0.64

2.2

1.5

256.53

232.66

u/ml

0.30

383

Unequal limb length (acquired)

1.51

0.64

1.7

1.3

240.00

200.96

u/ml

—

Hyperkinetic disorders (excl. ADHD)

294

1.26

0.64

1.6

237.08

186.73

u/ml

0.43

153

Malignant neoplasm of testis

155

1.37

0.63

1.1

1.2

253.20

271.06

u/ml

0.14

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

426

0.80

0.63

1.2

200.56

296.45

u/ml

2.10

249

Other congenital malformations of nervous system

104

1.46

0.63

1.8

1.7

242.67

214.51

u/ml

—

Residual foreign body in soft tissue

369

1.22

0.63

1.2

231.54

253.67

u/ml

0.29

224

Procedures for purposes other than remedying health state

104

1.45

0.62

1.4

1.1

153.66

234.67

u/ml

—

Nontoxic single thyroid nodule

415

1.21

0.62

1.5

1.2

249.36

265.00

u/ml

0.17

249

Hyperfunction of pituitary gland

388

1.22

0.62

1.3

275.87

246.87

u/ml

0.26

238

Postmenopausal bleeding

166

823

1.11

0.62

1.2

299.05

303.82

u/ml

0.07

109

515

Carcinoma in situ of rectum

1.68

0.61

1.0

1.1

364.40

255.25

u/ml

—

Malignant neoplasm of floor of mouth, excluding all cancers (controls excluding all cancers)

1.68

0.61

1.2

1.1

308.60

203.00

u/ml

—

Malignant neoplasm of gum, excluding all cancers (controls excluding all cancers)

1.68

0.61

1.0

1.2

358.80

273.00

u/ml

—

Acute alcohol intoxication, ICD10

188

1716

1.10

0.61

1.3

256.65

259.49

u/ml

0.05

125

1101

Septal defects

752

1.15

0.61

1.6

1.7

276.29

213.31

u/ml

1.15

397

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

299

2783

1.08

0.61

1.3

226.11

260.87

u/ml

1.70

178

1793

Acute epiglottitis

1.49

0.61

1.4

1.3

313.13

241.13

u/ml

—

Other infective otitis externa

398

1.21

0.61

1.6

1.3

198.16

249.46

u/ml

1.12

238

Mucinous and mucinous cystic tumor of rectum

0.00

0.61

0.0

1.2

—

331.30

—

Infective bursitis

175

0.68

0.60

1.5

1.1

293.00

289.63

u/ml

—

107

Endometriosis of rectovaginal septum and vagina

444

1.20

0.60

1.1

1.2

255.15

266.81

u/ml

0.14

299

Congenital malformations of the nervous system

245

1.28

0.60

1.7

1.6

253.89

205.32

u/ml

0.38

129

Fracture of skull and facial bones

197

1804

1.09

0.60

1.3

257.56

259.95

u/ml

0.04

131

1149

148

1.36

0.60

1.2

284.36

222.32

u/ml

0.45

Benign neoplasm: Skin of eyelid, including canthus

685

1.16

0.60

1.2

274.61

283.96

u/ml

0.09

434

Puerperal sepsis

798

1.14

0.59

1.2

289.67

285.12

u/ml

0.05

522

Oral leukoplakia and related diseases

272

1.25

0.59

1.1

1.2

237.86

274.66

u/ml

0.32

155

Contusion of other and unspecified parts of foot

482

1.19

0.59

1.4

1.3

205.85

252.87

u/ml

1.04

284

Transitory endocrine and metabolic disorders specific to fetus and newborn

324

0.77

0.59

3.0

2.1

142.39

167.60

u/ml

0.22

141

Embolic stroke with flimmer

1.53

0.59

1.1

304.00

334.19

u/ml

—

Female infertility, associated with anovulation

771

1.14

0.59

1.2

227.40

261.43

u/ml

0.71

528

Multiple gestation

771

1.14

0.59

1.3

1.2

260.99

269.20

u/ml

0.10

520

Other specified disorders of muscle

166

1.33

0.59

1.1

1.2

343.43

239.52

u/ml

1.03

Mixed conductive and sensorineural hearing loss

640

1.16

0.58

1.3

1.2

306.34

280.66

u/ml

0.29

393

Other disorders of binocular movement

175

1.32

0.58

1.7

1.3

250.50

233.86

u/ml

0.11

106

Conduct disorder

287

0.76

0.58

1.3

1.5

250.50

207.78

u/ml

0.39

168

L02BG Aromatase inhibitors

132

1466

0.90

0.58

1.1

1.2

271.07

295.96

u/ml

0.38

892

Other neurotic disorders

264

1.25

0.58

1.1

1.2

337.64

263.87

u/ml

0.52

165

Endometriosis diagnosis and infertility diagnosis occurring together

847

1.14

0.58

1.2

281.88

263.81

u/ml

0.14

571

Multiple delivery

641

1.16

0.58

1.3

1.2

261.91

294.78

u/ml

0.47

431

Urethral stricture

282

1.24

0.58

1.4

1.2

281.37

250.12

u/ml

0.39

160

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

481

1.18

0.58

1.1

1.2

295.20

294.28

u/ml

0.01

293

Other and unspecified injuries of head

419

1.20

0.58

1.2

1.3

253.03

267.72

u/ml

0.13

235

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

298

0.77

0.57

1.1

1.2

287.50

272.40

u/ml

0.12

194

Evidence of alcohol involvement determined by blood alcohol level

115

1.40

0.57

1.1

1.2

282.91

255.24

u/ml

0.15

HSIL lesion of the cervix uteri

171

1561

1.10

0.57

1.3

1.2

280.62

268.95

u/ml

0.23

121

1053

Motor disorders, excluding more controls

289

1.24

0.55

2.8

1.8

165.20

150.14

u/ml

0.13

138

Gonarthrosis

501

2724

1.06

0.55

1.2

1.3

271.74

283.60

u/ml

0.40

308

1822

Other disorders of Eustachian tube

168

1.32

0.55

1.5

1.2

331.33

245.83

u/ml

0.49

101

Malignant neoplasm of tonsil

1.48

0.55

1.2

1.1

304.29

320.86

u/ml

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

182

1671

1.09

0.54

1.2

1.3

320.57

284.62

u/ml

0.82

1084

Non-allergic asthma

692

1.14

0.54

1.5

1.4

277.52

242.35

u/ml

0.42

399

Maternal care for known or suspected disproportion

328

0.79

0.54

1.4

1.2

188.53

271.87

u/ml

1.46

222

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

250

0.76

0.54

1.3

1.2

296.85

242.02

u/ml

0.42

149

Specific development disorders of speech and language

821

1.13

0.54

2.2

1.6

207.32

192.72

u/ml

0.22

457

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

1.50

0.54

1.2

164.00

244.99

u/ml

—

Contact with heat and hot substances

469

1.18

0.54

1.3

1.4

231.52

248.55

u/ml

0.22

276

Obstructed labour due to maternal pelvic abnormality

952

0.88

0.53

1.3

1.2

225.42

288.37

u/ml

2.01

626

Benign neoplasm: Larynx

169

1.31

0.53

1.1

198.93

287.89

u/ml

1.32

100

Other specified/unspecified hearing loss

405

1.19

0.52

1.5

1.2

281.16

266.96

u/ml

0.18

244

Bacterial sepsis of newborn

144

1.35

0.52

2.7

2.0

176.38

175.33

u/ml

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

442

1.18

0.52

1.9

1.7

231.47

203.15

u/ml

0.24

237

Other specified and unspecified strabismus

1.46

0.52

1.1

1.5

411.57

211.84

u/ml

—

Alcohol abuse counselling and surveillance

126

1.36

0.52

1.1

1.3

219.57

280.05

u/ml

—

Retinoschisis and retinal cysts

100

1.41

0.52

1.1

1.2

302.80

286.19

u/ml

—

Radial styloid tenosynovitis [de Quervain]

369

1.20

0.52

1.4

1.2

311.59

255.09

u/ml

0.73

231

Allergic contact dermatitis

114

1026

1.11

0.52

1.2

251.53

273.94

u/ml

0.43

665

Congenital malformations and deformations of the musculoskeletal system

122

1097

1.11

0.51

1.5

1.6

259.94

217.72

u/ml

0.80

619

Injuries involving multiple body regions

269

1.23

0.51

1.2

350.53

250.30

u/ml

0.81

160

Noise effects on inner ear

270

0.77

0.51

1.2

288.31

297.93

u/ml

0.06

172

Hyperprolactinaemia

260

1.24

0.51

1.4

1.2

189.65

249.25

u/ml

0.79

165

Recurrent dislocation and subluxation of joint

546

1.16

0.51

1.1

1.3

302.71

241.71

u/ml

1.03

355

Dislocation, sprain and strain of joints and ligaments of knee

590

5727

0.96

0.51

1.2

1.3

236.29

262.75

u/ml

2.04

393

3688

Long labour

209

1967

0.93

0.50

1.2

252.57

266.95

u/ml

0.38

135

1323

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

463

1.17

0.50

1.3

1.2

288.89

279.05

u/ml

0.10

278

Bicipital tendinitis

288

1.22

0.50

1.2

1.1

285.85

266.89

u/ml

0.14

179

Benign neoplasm: Pituitary gland, craniopharyngeal duct

343

1.20

0.50

1.1

1.3

148.50

257.79

u/ml

3.93

212

Injury of muscle and tendon at shoulder and upper arm level

254

2374

1.07

0.50

1.2

1.3

267.55

292.60

u/ml

0.85

161

1538

Benign neoplasm: Other and unspecified parts of mouth

189

1.28

0.49

1.3

1.2

254.92

278.45

u/ml

0.16

108

Dislocation, sprain and strain of joints and ligaments of thorax

225

1.25

0.49

1.1

1.2

212.00

231.73

u/ml

0.18

138

Injury of muscle and tendon at wrist and hand level

117

1058

1.11

0.49

1.2

271.08

271.34

u/ml

0.00

682

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

198

1.27

0.49

1.1

1.2

189.49

249.95

u/ml

0.64

121

Congenital malformations of uterus and cervix

163

1.30

0.48

1.4

1.2

189.29

240.53

u/ml

0.55

106

Habitual aborter

163

1.30

0.48

1.4

1.2

222.00

244.85

u/ml

0.18

108

Golimumab

253

1.23

0.48

1.1

1.3

386.10

238.68

u/ml

—

157

Impacted maxillary molar

710

0.87

0.48

1.5

1.3

190.43

211.03

u/ml

0.45

433

Brain glioblastoma and astrocytoma

1.41

0.48

1.2

1.1

212.93

279.49

u/ml

—

Effects of foreign body entering through natural orifice

207

2226

0.93

0.48

1.3

283.07

252.33

u/ml

0.80

132

1408

Rubella [German measles]

226

1.24

0.48

1.2

1.3

294.14

260.90

u/ml

0.35

146

Normotensive glaucoma

317

1.20

0.48

1.4

1.2

335.00

314.57

u/ml

0.17

174

Malignant neoplasm of ovary

172

1.28

0.48

1.0

1.2

269.88

263.38

u/ml

0.03

107

Slow fetal growth and fetal malnutrition

152

0.70

0.48

2.7

1.8

133.00

153.35

u/ml

—

malignant neoplasm of female genital organs

634

1.14

0.47

1.1

1.2

259.89

289.37

u/ml

0.36

379

Benign leiomyoma with endometriosis

823

1.12

0.47

1.3

1.2

284.32

286.93

u/ml

0.03

503

Anomalies of pupillary function

137

1.32

0.47

1.2

1.4

222.50

230.30

u/ml

—

Open wound of forearm

729

1.13

0.47

1.4

1.2

254.67

251.97

u/ml

0.04

444

Acute and transient psychotic disorders

973

0.89

0.47

1.3

1.2

299.47

260.46

u/ml

0.71

629

Respiratory tuberculosis, clinically confirmed

1.46

0.47

1.3

1.2

279.86

282.96

u/ml

—

Scissor bite

466

1.16

0.46

2.3

1.7

197.58

191.63

u/ml

0.06

220

Otalgia

636

1.14

0.46

1.3

1.4

311.95

245.28

u/ml

0.44

373

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

374

1.18

0.46

1.1

1.2

395.88

292.52

u/ml

0.86

231

Erosion and ectropion of cervix uteri

129

1.32

0.46

1.1

1.2

213.08

249.98

u/ml

0.36

Adenocarcinoma and ductal carcinoma of pancreas

129

1.32

0.46

1.1

243.30

327.04

u/ml

—

Twin gestation

750

1.12

0.46

1.3

1.2

256.72

271.58

u/ml

0.20

505

Haemangioma, any site

562

1.14

0.45

1.4

1.3

300.16

259.44

u/ml

0.41

348

Coxarthrosis, primary, with hip surgery

221

2239

0.93

0.44

1.1

1.2

323.41

291.19

u/ml

0.86

129

1393

Nontoxic multinodular goitre

112

1018

1.10

0.44

1.2

303.31

290.60

u/ml

0.12

613

Epiphora

1.37

0.44

1.2

1.3

272.33

250.57

u/ml

—

Event of undetermined intent

555

1.14

0.43

1.4

1.3

186.11

248.19

u/ml

1.56

347

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

323

0.82

0.43

2.6

2.2

235.13

167.90

u/ml

0.46

149

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

122

1.33

0.43

1.6

191.60

188.70

u/ml

—

Later onset COPD, excluding more controls

483

1.13

0.43

1.2

272.54

275.30

u/ml

0.03

291

Palmar fascial fibromatosis [Dupuytren]

763

1.12

0.43

1.4

1.2

235.61

291.86

u/ml

1.22

470

Adenocarcinoma and papilloma adenocarcinoma of rectum

404

0.84

0.43

1.2

200.56

299.61

u/ml

2.18

240

Use of disulfiram, acamprosate or naltrexone

681

0.88

0.42

1.2

1.3

276.85

263.58

u/ml

0.16

445

Sensorineural hearing loss

531

3874

0.96

0.42

1.3

277.05

278.27

u/ml

0.03

323

2481

Maternal care for cervical incompetence

230

1.22

0.42

1.3

1.2

270.62

256.01

u/ml

0.10

148

Varicose veins of other sites

462

1.15

0.42

1.3

303.52

252.35

u/ml

0.59

278

Status post-ami

170

0.77

0.42

1.1

246.38

318.09

u/ml

—

Cleft lip, lip and palate or palate

167

1.27

0.42

1.6

1.5

129.69

215.98

u/ml

1.56

Congenital musculoskeletal deformities of head, face, spine and chest

150

0.73

0.42

1.8

1.5

202.33

212.42

u/ml

—

Mild mental retardation

294

0.81

0.42

2.1

1.5

194.70

215.59

u/ml

—

153

Other disorders of prostate

140

1.29

0.42

1.2

296.38

264.11

u/ml

0.18

Suicide or other Intentional self-harm

244

2297

1.06

0.42

1.3

263.29

262.66

u/ml

0.01

153

1485

Unspecified dementia

246

0.81

0.42

1.0

1.1

260.19

318.21

u/ml

0.53

138

Digeorge syndrome

0.00

0.42

0.0

1.9

—

138.10

—

Other congenital malformations of digestive system

0.00

0.41

0.0

1.6

—

173.00

—

Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours

0.00

0.41

0.0

1.3

—

249.14

—

Other infestations

0.00

0.41

0.0

1.2

—

154.44

—

Injury of blood vessels at hip and thigh level

0.00

0.41

0.0

1.5

—

145.83

—

Eccrine sweat disorders

0.00

0.41

0.0

1.7

—

368.56

—

Use of riluzole

0.00

0.41

0.0

1.1

—

228.29

—

ICD 8 haemorrhage (epidural, subarachnoid, subduralis)

0.00

0.41

0.0

1.1

—

166.89

—

Other peripheral vertigo

491

1.14

0.41

1.1

1.2

388.97

276.63

u/ml

0.68

296

Disorders of sphingolipid metabolism and other lipid storage disorders

0.00

0.41

0.0

1.3

—

136.67

—

Polycystic ovarian syndrome, broad definition

123

1129

1.09

0.41

1.1

1.2

233.06

254.60

u/ml

0.48

772

Other and unspecified water transport accidents

0.00

0.41

0.0

1.1

—

129.36

—

Paralytic strabismus

370

1.16

0.41

1.4

1.3

238.74

271.22

u/ml

0.41

224

Contact with sharp object, undetermined intent

194

0.77

0.40

1.3

166.80

240.59

u/ml

—

120

Lesion of plantar nerve

304

0.82

0.40

1.2

351.73

283.30

u/ml

0.46

178

Foreign body in ear

159

1.27

0.40

1.2

1.5

208.33

247.19

u/ml

—

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

195

1.23

0.40

1.2

328.29

278.32

u/ml

0.29

121

Complications of labour and delivery

557

3230

0.96

0.40

1.2

268.29

267.91

u/ml

0.01

356

2094

Autism spe

346

0.83

0.40

1.2

1.5

205.86

200.15

u/ml

—

191

Artificial joint re-operation

278

1.19

0.40

1.2

250.11

304.37

u/ml

0.59

164

Alcohol induced polyneuropathy

1.32

0.40

1.3

1.2

259.13

271.54

u/ml

—

Undefined dementia

249

0.81

0.40

1.0

1.1

260.19

325.32

u/ml

0.62

142

Congenital malformations of genital organs

115

1049

1.09

0.39

1.6

1.4

252.15

234.32

u/ml

0.32

643

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

182

1036

1.07

0.39

1.2

1.3

278.29

286.17

u/ml

0.14

114

684

Carcinoma in situ of rectum

1.44

0.39

1.0

1.1

364.40

238.80

u/ml

—

Use of galantamine

171

0.76

0.39

1.1

345.71

341.14

u/ml

—

Contact with other hot metals

115

1.31

0.39

1.5

1.4

224.50

219.89

u/ml

—

LeFortI or BSSRO operation

324

0.83

0.39

1.2

256.00

264.73

u/ml

0.07

206

Open wound of wrist and hand

449

4263

1.04

0.39

1.3

266.78

262.67

u/ml

0.11

280

2779

Eustachian salpingitis and obstruction

741

1.11

0.38

1.4

1.2

271.19

259.17

u/ml

0.12

482

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

693

1.11

0.38

1.1

1.2

298.77

294.60

u/ml

0.04

436

Other or unspecified paralytic strabismus

1.40

0.38

1.8

1.3

316.00

263.27

u/ml

—

Presbyopia

382

1.15

0.38

1.2

325.38

286.02

u/ml

0.24

235

Other degenerative diseases of the nervous system

141

1153

0.93

0.38

1.2

292.25

271.89

u/ml

0.30

735

Colorectal adenocarcinoma

853

0.90

0.38

1.1

1.2

298.77

290.13

u/ml

0.08

524

Assault by unspecified means

197

1.23

0.38

1.3

1.2

189.82

238.30

u/ml

0.94

122

Unspecified mental disorder

373

3899

0.96

0.37

1.2

1.3

268.25

263.33

u/ml

0.14

225

2585

Pleural plaque

345

1.16

0.37

1.1

1.2

355.67

289.04

u/ml

0.78

206

Malignant neoplasm of colon

621

0.88

0.37

1.2

352.38

293.82

u/ml

0.50

380

False labour

342

2048

1.05

0.37

1.2

1.3

237.12

261.42

u/ml

1.11

237

1349

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

116

1.30

0.37

1.2

320.38

236.60

u/ml

—

Complications associated with artificial fertilization

134

1.28

0.37

1.3

1.2

211.11

249.47

u/ml

—

Hydrocephalus

365

0.85

0.37

1.4

1.3

208.20

264.70

u/ml

0.47

209

Benign neoplasm: Long bones of lower limb

216

1.21

0.37

1.5

1.2

184.58

233.09

u/ml

0.62

131

Other specified disorders of external ear

207

1.21

0.36

1.6

1.2

241.67

280.89

u/ml

0.29

119

Postprocedural musculoskeletal disorders, not elsewhere classified

337

1.16

0.36

1.1

1.2

282.88

280.32

u/ml

0.02

199

Deviated nasal septum

272

2582

1.05

0.36

1.2

1.3

269.09

279.39

u/ml

0.18

171

1698

Contact with nonpowered hand tool

321

0.84

0.36

1.5

1.2

253.39

274.75

u/ml

0.15

198

Dislocation, sprain and strain of joint and ligaments of hip

180

1.23

0.36

1.1

1.2

211.00

288.22

u/ml

1.11

101

Calculus of lower urinary tract

263

1.18

0.36

1.3

1.2

377.44

282.77

u/ml

0.53

153

Intussusception

1.32

0.35

1.2

1.4

196.43

221.23

u/ml

—

Chondropathies

144

1342

1.07

0.35

1.3

283.02

253.54

u/ml

0.40

839

Autism

352

0.85

0.35

1.2

1.5

205.86

189.58

u/ml

—

200

Problems related to social environment

162

1.24

0.35

1.3

1.2

290.82

247.31

u/ml

0.24

Intermittent heterotropia

698

1.11

0.35

1.5

192.67

225.24

u/ml

0.75

393

Benign neoplasm: Skin of ear and external auricular canal

153

1.25

0.35

1.3

1.2

163.82

245.25

u/ml

1.04

Other benign neoplasms of uterus

153

1.24

0.35

1.2

1.1

278.77

291.49

u/ml

0.09

Carcinoma in situ of other and unspecified sites

117

1.29

0.35

1.1

1.2

285.50

292.00

u/ml

—

Benign neoplasm: Choroid

236

1.19

0.35

1.3

1.2

308.76

256.24

u/ml

0.46

138

Non-small cell lung cancer, adenocarcinoma, helper endpoint

244

0.82

0.35

1.1

1.2

222.92

299.12

u/ml

1.00

139

Non-small cell lung cancer, adenocarcinoma

244

0.82

0.35

1.1

1.2

222.92

299.12

u/ml

1.00

139

Benign lipomatous neoplasm of other sites/unspecified

437

0.87

0.34

1.2

266.63

279.24

u/ml

0.13

264

Abnormal findings on diagnostic imaging of central nervous system

302

1.16

0.34

1.3

275.44

234.32

u/ml

0.34

186

Brain meningioma, excluding all cancers (controls excluding all cancers)

209

1.20

0.34

1.2

1.1

230.89

279.14

u/ml

0.57

125

Other and unspecified hydrocephalus

1.32

0.34

1.4

180.86

243.43

u/ml

—

Other disorders of penis

748

1.10

0.34

1.4

216.54

244.23

u/ml

0.42

453

Other fall from one level to another

225

2132

1.06

0.33

1.3

1.4

218.66

253.23

u/ml

1.41

135

1300

Psychotic depression

434

1.13

0.33

1.4

1.3

264.19

251.29

u/ml

0.11

276

Superficial injuries involving multiple body regions

182

1.21

0.33

1.1

1.3

325.33

235.45

u/ml

0.49

103

Melanoma in situ

182

1.21

0.33

1.8

1.2

267.42

300.31

u/ml

0.22

Haemangioma and lymphangioma, any site

625

1.11

0.33

1.4

1.3

299.07

259.19

u/ml

0.43

380

Varicose veins

382

3004

0.96

0.32

1.3

1.2

288.38

281.76

u/ml

0.19

233

1916

Spermatocele

407

1.13

0.32

1.2

437.04

275.60

u/ml

1.29

254

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

626

1.10

0.32

1.1

1.3

304.25

248.56

u/ml

0.89

409

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

110

1.28

0.32

1.4

1.3

212.00

251.05

u/ml

—

Other disorders of male genital organs

304

1.15

0.32

1.6

1.3

320.83

233.10

u/ml

0.62

178

Alzheimer’s disease (Atypical or mixed)

208

0.81

0.31

1.1

351.67

337.36

u/ml

0.06

112

Wide developmental disorders, excluding more controls

428

0.87

0.31

1.4

1.6

277.63

206.65

u/ml

—

237

Dystonia

361

1.14

0.31

1.2

1.3

290.43

252.77

u/ml

0.45

218

Superficial injury of forearm

877

1.09

0.31

1.3

257.55

238.91

u/ml

0.30

528

Focal brain injury

361

1.14

0.31

1.3

1.2

247.19

263.56

u/ml

0.19

235

Benign neoplasm: Rectosigmoid junction

147

1.23

0.30

1.6

1.2

356.92

262.31

u/ml

0.59

Extreme obesity with alveolar hypoventilation

218

0.82

0.30

1.1

1.2

369.50

283.80

u/ml

—

131

Meniscus derangement

442

2919

1.04

0.30

1.2

1.3

263.58

279.23

u/ml

0.43

283

1956

Contraceptive management

443

3007

1.04

0.30

1.3

272.86

275.06

u/ml

0.06

292

1950

Left hemicolectomy

102

1.28

0.30

1.1

1.3

363.14

301.69

u/ml

—

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

636

1.09

0.30

1.1

1.2

309.40

290.36

u/ml

0.26

398

Conductive and sensorineural hearing loss

594

4237

0.97

0.29

1.4

1.3

277.19

276.07

u/ml

0.03

362

2714

Accidental poisoning by and exposure to alcohol

157

1.22

0.29

1.7

1.3

202.00

234.66

u/ml

0.26

Other benign neoplasms of connective and other soft tissue

661

0.91

0.29

1.3

1.2

328.39

274.39

u/ml

0.63

410

Open wound of abdomen, lower back and pelvis

269

1.16

0.29

1.2

1.3

203.27

229.44

u/ml

0.25

161

Gonococcal infection

213

1.18

0.29

1.1

1.2

223.38

234.47

u/ml

0.09

135

Colorectal cancer, excluding all cancers (controls excluding all cancers)

120

1085

1.07

0.29

1.2

272.14

292.57

u/ml

0.32

702

Other osteochondropathies

564

1.10

0.28

1.3

1.2

225.85

262.68

u/ml

0.66

349

Benign neoplasm of brain and other parts of central nervous system

364

1.13

0.28

1.4

1.3

210.82

250.48

u/ml

0.77

217

Other specified/unspecified dorsopathies

195

1.18

0.28

1.1

1.2

291.39

260.64

u/ml

0.22

113

Fracture of neck

317

1.14

0.28

1.1

1.2

297.76

277.49

u/ml

0.16

190

Sequelae of injuries of upper limb

709

1.09

0.28

1.2

274.49

269.43

u/ml

0.06

449

Dislocation, sprain and strain of joints and ligaments of elbow

606

0.91

0.28

1.4

172.79

230.84

u/ml

1.66

350

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

173

1641

1.06

0.27

1.3

249.85

254.08

u/ml

0.07

108

1063

Sequelae of other and unspecified infectious and parasitic diseases

384

1.12

0.27

1.4

1.2

343.48

272.95

u/ml

0.59

247

Alcohol withdrawal state with delirium

432

1.11

0.27

1.2

1.3

294.48

289.03

u/ml

0.04

281

Mental retardation, wide definition

531

0.90

0.27

1.6

1.8

250.46

211.17

u/ml

0.45

272

Use of biperiden

332

0.87

0.27

1.3

1.2

257.28

262.17

u/ml

0.04

214

Desensitization to allergens

634

1.09

0.27

1.2

1.4

222.89

233.28

u/ml

0.14

384

Sequelae of injuries of head

374

0.88

0.27

1.2

258.74

259.27

u/ml

0.00

236

Carcinoma in situ, bladder

113

1.24

0.26

1.1

1.2

282.60

295.87

u/ml

—

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

109

980

1.07

0.26

1.1

1.2

291.43

290.46

u/ml

0.01

621

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

252

1.15

0.26

1.1

1.2

298.69

289.64

u/ml

0.06

140

Antepartum haemorrhage, not elsewhere classified

750

1.08

0.26

1.2

223.36

265.00

u/ml

1.12

506

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

104

1.25

0.26

1.2

338.43

234.43

u/ml

—

Benign neoplasm of middle ear and respiratory system

433

1.11

0.26

1.1

1.2

212.15

275.53

u/ml

1.15

263

Pregnancy, childbirth and the puerperium

259

1414

0.96

0.26

1.2

1.3

228.23

258.28

u/ml

1.10

164

829

Melanocytic naevi of upper limb, including shoulder

141

1.21

0.26

1.8

1.3

287.92

228.79

u/ml

0.23

Other contact dermatitis

539

1.10

0.26

1.8

1.2

320.60

261.23

u/ml

0.69

346

Ovarian hyperstimulation (induction)

132

1.22

0.26

1.3

211.11

213.01

u/ml

—

Postpartum hemorraghe, parous women as controls

218

1994

0.96

0.25

1.2

254.18

256.04

u/ml

0.03

145

1389

Postmenopausal atrophic vaginitis

150

854

1.06

0.25

1.1

1.2

297.68

299.67

u/ml

0.02

536

Hypertrophy of breast in women and men

139

1469

0.95

0.25

1.2

299.43

269.68

u/ml

0.33

946

Unspecified event, undetermined intent

207

1.16

0.25

1.3

212.82

235.48

u/ml

0.24

131

Lesion of radial nerve

207

1.16

0.25

1.3

1.2

298.67

289.32

u/ml

0.06

125

Burn and corrosion of wrist and hand

340

0.88

0.25

1.2

1.3

252.88

235.93

u/ml

0.15

194

Chronic suppurative otitis media

531

1.09

0.25

1.2

1.3

212.03

234.87

u/ml

0.39

307

Atopic conjunctivitis

378

1.11

0.24

1.5

1.3

297.81

228.59

u/ml

1.15

220

Melanocytic naevi of upper limb, including shoulder

142

1.20

0.24

1.8

1.3

287.92

243.73

u/ml

0.16

Congenital deformities of feet

255

0.86

0.24

1.2

1.4

290.15

231.00

u/ml

0.45

138

Other obstetric trauma

445

1.10

0.24

1.2

268.11

260.90

u/ml

0.05

312

Benign neoplasm of thyroid gland

142

1.20

0.24

1.3

1.2

299.67

228.04

u/ml

—

Transient synovitis

1.27

0.24

1.6

158.83

203.52

u/ml

—

Other and unspecified mononeuropathies of upper limb

191

0.84

0.24

1.3

1.2

252.50

249.60

u/ml

—

119

Venous complications and haemorrhoids in pregnancy

133

1.21

0.24

1.3

1.2

185.80

246.44

u/ml

—

Retained placenta and membranes, without haemorrhage

841

1.07

0.24

1.3

1.2

214.69

280.70

u/ml

2.44

553

Gender identity disorders

169

0.82

0.24

1.1

1.4

145.00

197.79

u/ml

—

Other symptoms and signs involving general sensations and perceptions

246

1.14

0.23

1.2

1.3

295.61

245.62

u/ml

0.44

145

Sudden idiopathic hearing loss

552

1.09

0.23

1.3

1.2

265.47

279.74

u/ml

0.15

341

Pustular psoriasis

254

0.86

0.23

1.2

434.33

278.64

u/ml

0.67

157

Hypothermia

106

1.23

0.23

1.2

241.83

284.71

u/ml

—

Behavioural disorders, excluding more controls

253

0.86

0.23

1.3

1.4

250.50

214.44

u/ml

0.32

146

Mental and behavioural disorders due to cannabinoids

348

0.89

0.23

1.1

1.3

209.24

218.74

u/ml

0.14

225

Toxic effect of ethanol

361

1.11

0.23

1.4

1.3

308.52

259.02

u/ml

0.51

219

Other specified/unspecified nutritional deficiencies

1.29

0.23

1.2

154.00

240.26

u/ml

—

Calcific tendinitis of shoulder

342

1.11

0.23

1.3

1.1

299.96

277.83

u/ml

0.19

214

Mental retardation

514

0.91

0.22

1.7

1.8

250.46

213.33

u/ml

0.42

264

Foreign body or object entering through skin

525

1.09

0.22

1.2

251.97

254.38

u/ml

0.02

317

Coxarthrosis, primary

325

2912

0.97

0.22

1.2

311.57

291.50

u/ml

0.51

190

1821

Other secondary gonarthrosis

276

1.13

0.22

1.1

1.2

282.79

287.32

u/ml

0.03

172

Exposure to smoke, fire and flames

178

0.84

0.22

1.7

1.2

222.10

252.65

u/ml

—

102

Acute appendicitis, with complications

147

1401

1.05

0.22

1.2

1.3

272.61

276.22

u/ml

0.05

894

Benign neoplasm of bone and articular cartilage

545

1.08

0.22

1.4

1.2

254.17

258.48

u/ml

0.03

348

Chalazion

834

0.93

0.22

1.3

228.83

267.46

u/ml

0.88

520

Polyp of the female genital tract

213

1290

0.96

0.21

1.3

1.2

286.67

291.72

u/ml

0.08

133

853

Mandibular prognathia

182

1.16

0.21

1.5

1.6

176.14

221.07

u/ml

0.61

Plasmodium falciparum malaria

0.00

0.21

0.0

1.4

—

267.80

—

Other cestode infections

0.00

0.21

0.0

1.2

—

434.20

—

Combinations of oral blood glucose lowering drugs

163

1704

0.96

0.21

1.1

1.2

314.09

286.54

u/ml

0.52

1104

Benign neoplasm of breast

681

1.07

0.21

1.1

1.2

300.59

268.79

u/ml

0.32

430

Optic neuritis

315

1.11

0.21

1.2

303.91

250.73

u/ml

0.43

193

Benign neoplasm: Penis

0.00

0.21

0.0

1.1

—

144.50

—

Mucinous and mucinous cystic tumor of rectum, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.2

—

188.71

—

Benign lipomatous neoplasm

201

1932

1.04

0.21

1.2

271.85

284.74

u/ml

0.27

128

1238

Demyelinating diseases of the central nervous system

701

1.07

0.21

1.2

303.66

265.13

u/ml

0.36

462

Medial epicondylitis

239

1.13

0.21

1.4

1.1

258.58

252.85

u/ml

0.04

148

Mental retardation, excluding more controls

423

1.09

0.21

1.7

1.6

250.46

204.88

u/ml

0.54

208

Congenital malformations of breast

126

1.20

0.21

1.1

1.2

312.57

233.22

u/ml

—

Carcinoma in situ of breast, intraductal

344

1.11

0.21

1.1

1.2

296.13

285.88

u/ml

0.07

216

Benign neoplasm: Penis

0.00

0.21

0.0

1.2

—

150.71

—

Lesion of sciatic nerve

173

1.16

0.21

1.1

225.60

292.23

u/ml

—

Anisometropia and aniseikonia

219

0.87

0.20

2.3

1.4

173.25

258.01

u/ml

1.80

128

Atrioventricular septal defect

1.26

0.20

2.8

1.9

181.00

142.93

u/ml

—

Pedal cyclist injured in collision with motor vehicle

240

0.87

0.20

1.1

1.3

208.44

259.75

u/ml

0.49

147

Polyp of middle ear

0.00

0.20

0.0

1.4

—

129.60

—

Other sexually transmitted chlamydial diseases

751

1.07

0.20

1.3

1.2

235.97

230.01

u/ml

0.08

498

Hypotension due to drugs

1.25

0.20

2.0

1.2

247.33

297.48

u/ml

—

Fetus and newborn affected by maternal complications of pregnancy

165

0.84

0.20

2.6

2.2

427.33

174.93

u/ml

—

Vertical strabismus

221

1.13

0.20

1.3

1.2

222.50

261.93

u/ml

—

130

Brain meningioma

221

1.13

0.20

1.2

230.89

289.17

u/ml

0.69

120

Alcohol dependence

212

2044

1.04

0.20

1.2

1.3

302.70

274.24

u/ml

0.88

147

1336

Benign neoplasm of other and unspecified sites

176

0.85

0.20

1.1

1.3

188.41

268.91

u/ml

—

106

Vascular syndromes of brain in cerebrovascular disorders

176

0.85

0.20

1.1

380.38

298.59

u/ml

—

Adenocarcinoma of pancreas

1.21

0.19

1.0

1.1

272.50

362.33

u/ml

—

Chronic conjunctivitis

193

1.14

0.19

1.8

1.4

216.90

247.10

u/ml

0.21

110

Motorcycle rider injured in other and unspecified transport accidents

644

0.93

0.19

1.3

193.10

233.44

u/ml

0.70

397

Ill-defined and unknown causes of mortality

281

0.89

0.19

1.0

1.2

282.17

284.91

u/ml

0.02

161

Endometriosis of intestine

122

0.82

0.19

1.0

1.1

366.00

226.15

u/ml

—

Other specified/unspecified disorders of bone/cartilage

165

1.15

0.19

1.0

1.2

373.57

259.07

u/ml

0.48

101

Delivery, wide proxy

300

1645

0.97

0.19

1.2

220.20

262.34

u/ml

2.34

194

985

Maternal care related to the fetus and amniotic cavity and possible delivery problems

464

2666

1.02

0.19

1.2

1.3

260.45

264.56

u/ml

0.10

330

1726

Other benign neoplasms of uterus

165

1.15

0.19

1.2

1.1

278.77

288.36

u/ml

0.07

Other vitreous opacities

184

1.14

0.19

1.2

285.50

273.87

u/ml

—

Other osteochondrodysplasias

1.24

0.19

1.4

1.7

252.60

187.93

u/ml

—

Other inflammation of vagina/vulva

251

1.12

0.18

1.3

223.44

237.93

u/ml

0.15

166

Schizotypal disorder

196

0.86

0.18

1.2

157.20

253.40

u/ml

—

127

Pustulosis palmaris et plantaris

217

0.87

0.18

1.2

378.70

280.29

u/ml

—

131

Sequelae of injuries, of poisoning and of other consequences of external causes

196

1892

1.04

0.18

1.3

251.60

265.57

u/ml

0.38

130

1226

Focal epilepsy

176

1695

1.04

0.18

1.2

1.4

260.72

257.82

u/ml

0.05

113

1027

Hallux rigidus

687

1.06

0.18

1.3

1.2

305.86

297.76

u/ml

0.08

425

Other appendicitis

600

0.93

0.18

1.3

1.2

280.07

273.73

u/ml

0.07

368

Primary coxarthrosis, bilateral

128

1337

0.96

0.17

1.2

344.61

292.10

u/ml

0.98

826

Malignant neoplasm of pancreas

233

1.12

0.17

1.1

1.2

257.38

291.53

u/ml

0.32

133

Benign neoplasm: Skin of lower limb, including hip

138

1.16

0.17

1.6

1.2

339.22

241.41

u/ml

—

Burns and corrosions of multiple and unspecified body regions

184

0.87

0.17

1.3

1.4

251.91

254.96

u/ml

0.02

106

Congenital malformations of spine and bony thorax

0.73

0.17

1.8

257.60

168.60

u/ml

—

Use of fingolimod

0.75

0.17

1.8

1.3

450.80

197.68

u/ml

—

Cerebral palsy

186

1.13

0.17

2.2

1.6

203.83

209.64

u/ml

0.04

Habit and impulse disorders

152

0.85

0.17

1.2

1.4

194.67

209.91

u/ml

—

Other menopausal disorders

184

1023

1.04

0.17

1.3

1.2

315.88

293.14

u/ml

0.45

110

670

Contact with sharp glass

369

1.09

0.16

1.3

226.20

239.75

u/ml

0.12

226

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

391

0.92

0.16

1.1

1.2

375.54

275.49

u/ml

0.70

238

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

331

1.09

0.16

1.1

1.2

375.54

269.80

u/ml

0.75

211

Primary open-angle glaucoma

129

1308

0.96

0.16

1.3

1.2

305.33

285.65

u/ml

0.39

791

203

0.88

0.16

1.3

1.2

170.29

276.82

u/ml

1.25

114

Graves disease, strict definition

730

1.06

0.16

1.2

291.29

260.89

u/ml

0.49

461

Other mental disorders due to brain damage and dysfunction and to physical disease

496

1.07

0.16

1.2

300.64

280.07

u/ml

0.26

307

Placental disorders

1.10

0.16

1.1

1.3

227.36

212.91

u/ml

—

Open bite that required surgery (Lefort1 or BSSRO)

0.78

0.15

1.0

1.2

251.00

220.78

u/ml

—

Other abnormal uterine and vaginal bleeding

155

1066

1.04

0.15

1.2

271.37

280.54

u/ml

0.09

685

Uterine polyps

524

0.93

0.15

1.2

1.3

343.48

286.86

u/ml

0.41

338

Pedal cyclist injured in transport accident

194

2001

0.97

0.15

1.4

1.3

252.84

259.44

u/ml

0.08

121

1250

Benign mammary dysplasia

721

1.05

0.15

1.2

330.74

281.37

u/ml

0.57

439

Persistent delusional disorders

462

0.93

0.15

1.1

1.2

301.89

264.77

u/ml

0.41

284

Oxicams

202

1185

0.97

0.15

1.1

1.4

260.32

280.97

u/ml

0.57

122

830

Bursitis of shoulder

140

1.15

0.15

1.3

1.1

298.55

257.52

u/ml

0.18

Amblyopia ex anopsia

451

0.93

0.15

1.9

1.6

152.23

206.65

u/ml

1.69

241

Exclusion endpoint for supernumerary teeth

150

1.14

0.14

1.8

1.7

136.60

187.21

u/ml

—

Placenta praevia

368

0.92

0.14

1.1

1.2

187.66

264.57

u/ml

2.12

255

Carcinoma in situ of breast, intraductal

409

0.93

0.14

1.1

1.2

296.13

286.64

u/ml

0.07

241

Malignant neoplasm of stomach

198

1.11

0.14

1.2

347.27

291.16

u/ml

0.29

113

Inflammatory diseases of prostate (prostatitis)

782

1.05

0.14

1.2

1.3

244.60

267.02

u/ml

0.39

511

Cyst of Bartholin Gland

227

1.10

0.14

1.2

277.68

255.88

u/ml

0.16

142

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

158

916

1.03

0.14

1.3

277.26

292.30

u/ml

0.28

602

Recurrent dislocation of patella

499

1.06

0.14

1.2

210.20

232.76

u/ml

0.26

323

Melanocytic naevi of other and unspecified parts of face

353

1.08

0.14

1.4

1.2

201.00

239.20

u/ml

0.55

229

Biguanides

794

4958

0.99

0.13

1.2

1.3

291.62

272.98

u/ml

1.05

472

3312

Specific developmental disorder of motor function

338

1.08

0.13

2.8

1.9

165.20

154.83

u/ml

0.08

170

Other/unspecified enthesopathies of lower limb, excluding foot

500

1.06

0.13

1.2

226.30

280.29

u/ml

1.00

305

Disorders of breast

361

3411

0.98

0.13

1.2

288.98

273.57

u/ml

0.36

230

2232

Blood alcohol or alcohol intoxication level

209

1.10

0.13

1.3

1.2

251.25

263.94

u/ml

0.09

127

Struck by thrown, projected or falling objec

417

0.93

0.13

1.4

1.3

281.15

259.97

u/ml

0.22

257

Other disorders of the genitourinary system

599

1.05

0.12

1.3

1.2

307.78

281.02

u/ml

0.27

357

Other and unspecified injuries of wrist and hand

324

0.92

0.12

1.3

224.63

236.48

u/ml

0.11

188

Other congenital malformations, not elsewhere classified

1.18

0.12

2.3

1.8

206.20

201.43

u/ml

—

Other and unspecified disorders of psychological development

196

0.90

0.12

1.1

1.9

178.15

169.53

u/ml

0.09

101

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

865

1.04

0.12

1.2

237.98

275.78

u/ml

0.85

543

Keratoconus

189

0.90

0.12

1.5

1.2

315.25

238.55

u/ml

0.48

117

Premature separation of placenta [abruptio placentae]

162

1.11

0.12

1.2

381.17

258.67

u/ml

0.49

108

Antenatal screening

263

1449

1.02

0.11

1.2

1.3

229.83

265.57

u/ml

1.55

178

906

Congenital malformations of great arteries

350

1.07

0.11

2.5

2.0

229.52

175.71

u/ml

0.47

166

Otosclerosis

425

1.06

0.11

1.3

1.2

278.88

274.23

u/ml

0.04

257

Malignant neoplasm of breast, HER-negative

994

0.96

0.11

1.1

1.2

300.19

294.94

u/ml

0.06

599

Mumps

157

0.89

0.11

1.4

1.2

259.43

252.29

u/ml

—

Colon adenocarcinoma

465

0.95

0.11

1.1

1.2

395.88

298.07

u/ml

0.79

275

Cleft palate

115

1.13

0.10

2.0

1.5

95.00

220.60

u/ml

—

Oral lichen ruber planus, including avohilmo

309

1.07

0.10

1.4

1.2

302.15

267.73

u/ml

0.36

182

Other disorders originating in the perinatal period

212

1.09

0.10

2.5

2.2

216.21

177.52

u/ml

0.31

Generalized epilepsy

407

1.06

0.10

1.3

1.5

269.96

225.78

u/ml

0.37

238

Other disorders of cornea

564

1.05

0.10

1.4

1.2

281.35

262.85

u/ml

0.17

350

Paranoid personality disorder

125

0.88

0.10

1.5

1.2

234.00

255.40

u/ml

—

Glaucoma-related operations

212

1.09

0.10

1.2

312.18

297.84

u/ml

0.06

116

Pedal cyclist injured in other and unspecified transport accidents

901

0.96

0.10

1.5

1.3

241.49

251.70

u/ml

0.16

562

Organic, including symptomatic, mental disorders

241

1774

0.98

0.10

1.1

1.2

295.74

276.73

u/ml

0.50

145

1085

Mental and behavioural disorders due to hallucinogens

1.14

0.10

1.0

1.3

172.60

193.16

u/ml

—

Foreign body entering into or through eye or natural orifice

687

0.96

0.10

1.4

1.3

247.76

259.04

u/ml

0.14

419

Injury of nerves at ankle and foot level

1.11

0.10

1.6

1.3

194.34

232.55

u/ml

—

Crushed, pushed or stepped on by crowd or human stampede

772

1.04

0.09

1.1

1.4

193.60

230.49

u/ml

0.97

465

Systemic atrophies primarily affecting the central nervous system

213

1.08

0.09

1.2

1.3

276.23

285.34

u/ml

0.08

118

Focal epilepsy, mode (most common among epilepsy diagnosis)

143

1465

0.98

0.09

1.2

1.4

265.33

258.56

u/ml

0.12

880

Primary open-angle glaucoma, strict

111

1077

1.03

0.09

1.3

1.2

295.99

292.81

u/ml

0.05

650

Phakomatoses, not elsewhere classified

1.14

0.09

1.1

1.8

217.00

205.47

u/ml

—

Infections of breast associated with childbirth

272

1.07

0.09

1.2

211.39

248.62

u/ml

0.37

181

Cholesteatoma of middle ear

272

1.07

0.09

1.4

1.2

272.71

261.45

u/ml

0.09

162

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

233

1.07

0.09

1.1

1.2

189.49

275.69

u/ml

1.01

140

Heterophoria

756

0.96

0.09

1.3

1.4

242.50

240.11

u/ml

0.03

444

Alcohol abuse, main dg

139

1357

1.02

0.09

1.3

235.85

254.19

u/ml

0.43

865

Open wound of hip and thigh

292

1.06

0.08

1.3

211.60

241.36

u/ml

0.27

177

Maxillary retrognathism

216

0.92

0.08

1.5

201.81

194.86

u/ml

—

114

Unspecified abortion

312

1.06

0.08

1.3

1.2

210.77

287.35

u/ml

1.23

195

Malignant neoplasm of bladder

246

0.93

0.08

1.2

201.42

306.74

u/ml

1.34

137

Benign neoplasm of bone and articular cartilage

612

0.96

0.08

1.4

1.2

254.17

266.06

u/ml

0.09

374

Vascular dementia

198

1.07

0.08

1.0

1.1

342.00

330.49

u/ml

0.04

114

Subarachnoid haemorrhage

490

1.04

0.07

1.3

1.2

265.31

292.87

u/ml

0.30

300

Undescended testicle

204

0.93

0.07

2.6

1.9

213.27

172.97

u/ml

0.44

Ankyloglossia

283

1.06

0.07

1.5

1.8

96.00

192.75

u/ml

3.64

148

Burns and corrosions

131

1282

1.02

0.07

1.3

1.4

236.41

246.86

u/ml

0.22

790

Alzheimer’s disease (Atypical or mixed), excluding more controls

159

0.92

0.07

1.1

351.67

265.61

u/ml

0.45

Ethmoidectomy

946

1.03

0.07

1.1

1.2

328.53

268.17

u/ml

0.96

604

Other benign neoplasms of connective and other soft tissue

580

1.03

0.07

1.3

1.2

328.39

266.90

u/ml

0.75

366

Other and/or unspecified nontoxic goitre

432

1.04

0.07

1.3

1.2

358.12

278.85

u/ml

0.49

251

Sequelae of injuries of lower limb

679

1.03

0.07

1.2

220.62

270.53

u/ml

1.42

433

Fall on and from ladder

458

0.96

0.07

1.3

1.2

225.13

279.92

u/ml

0.76

287

Chondromalacia

167

1.08

0.07

1.3

310.43

251.12

u/ml

—

105

Benign neoplasm: Cranial nerves

128

1.10

0.06

1.5

1.2

198.44

256.09

u/ml

—

Chronic suppurative otitis media, including avohilmo

650

1.03

0.06

1.3

1.4

206.07

249.30

u/ml

0.99

377

Focal epilepsy, strict definition

155

1522

1.02

0.06

1.2

1.4

262.65

255.69

u/ml

0.13

104

919

Mixed specific developmental disorders

435

0.96

0.06

2.1

1.8

204.00

166.36

u/ml

0.55

218

Ectopic pregnancy

127

1245

1.02

0.06

1.2

298.53

274.02

u/ml

0.27

807

Labour and delivery complicated by umbilical cord complications

364

1.04

0.06

1.2

268.85

262.14

u/ml

0.06

255

Other disorders of breast and lactation associated with childbirth

142

0.91

0.06

1.2

1.3

335.29

236.07

u/ml

—

Other hammer toe(s) (acquired)

712

1.03

0.06

1.2

283.35

292.74

u/ml

0.14

442

Anxious personality disorder

162

0.92

0.06

1.3

1.2

188.75

232.30

u/ml

—

Benign neoplasm: Skin of eyelid, including canthus

810

0.97

0.06

1.2

274.61

277.41

u/ml

0.03

499

Other noninflammatory disorders of cervix uteri

217

1.06

0.06

1.1

1.2

225.71

270.73

u/ml

0.47

132

Non-small cell lung cancer

618

0.97

0.06

1.1

1.2

295.20

296.70

u/ml

0.01

363

Contact with machinery

759

0.97

0.05

1.2

1.3

304.11

265.28

u/ml

0.47

484

Inflammatory disease of cervix uteri

304

0.95

0.05

1.1

1.2

292.12

273.79

u/ml

0.12

183

Burn and corrosion of trunk

237

1.06

0.05

1.1

1.3

248.49

238.31

u/ml

0.07

137

Chromosomal abnormalities, not elsewhere classified

303

0.95

0.05

1.3

1.9

304.15

197.52

u/ml

0.55

153

Benign neoplasm of brain and other parts of central nervous system

395

1.04

0.05

1.4

1.3

210.82

253.64

u/ml

0.82

229

Transient global amnesia

395

1.04

0.05

1.2

323.70

285.93

u/ml

0.29

232

L02BB Anti-androgens

324

0.96

0.05

1.2

318.60

289.92

u/ml

0.25

194

Delayed puberty

139

1.08

0.05

2.2

1.5

167.37

185.21

u/ml

—

Maternal care for known or suspected malpresentation of fetus

182

1376

0.99

0.05

1.2

1.3

261.04

256.95

u/ml

0.08

131

926

Other and unspecified injuries of shoulder and upper arm

208

1.06

0.05

1.2

321.91

232.49

u/ml

0.58

132

Benign neoplasm: Skin of lower limb, including hip

149

1.08

0.05

1.6

1.2

339.22

280.93

u/ml

—

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

346

1.04

0.05

1.2

197.41

278.94

u/ml

1.82

214

Inflammatory disorders of breast

475

1.03

0.05

1.2

267.67

254.75

u/ml

0.14

312

Nystagmus and other irregular eye movements

110

1.09

0.05

1.4

1.6

284.20

192.96

u/ml

—

Other disorders of ear

820

5433

1.01

0.05

1.4

1.3

277.42

271.80

u/ml

0.19

495

3492

Burn and corrosion of head and neck

191

0.94

0.04

1.4

1.2

181.44

251.41

u/ml

—

111

Other and unspecified intracranial injuries

191

0.94

0.04

1.2

1.3

284.64

259.51

u/ml

0.21

106

FESS (DNB20)

917

0.98

0.04

1.1

1.2

339.92

268.48

u/ml

1.07

584

Occupational exposure to risk-factors

211

0.95

0.04

1.4

1.2

174.33

274.74

u/ml

—

130

Vestibular neuronitis

514

0.97

0.04

1.1

1.2

253.26

285.13

u/ml

0.41

313

Delayed milestone in childhood

410

0.97

0.04

3.0

2.1

181.93

160.71

u/ml

0.24

184

Failed induction of labour

546

1.03

0.04

1.2

235.46

260.92

u/ml

0.40

384

Generalized epilepsy, strict definition

231

0.95

0.04

1.5

290.21

212.56

u/ml

0.44

127

Single delivery by caesarean section

217

1268

0.99

0.04

1.2

1.3

239.73

262.54

u/ml

0.78

158

823

Foreign body on external eye

126

1278

0.99

0.04

1.3

292.79

259.81

u/ml

0.59

840

Use of interferon beta-1a

170

1.06

0.04

1.3

1.2

303.10

252.41

u/ml

—

108

Benign neoplasm of other and unspecified female genital organs

180

1.06

0.04

1.1

1.2

317.20

259.51

u/ml

—

110

Intentional self-harm by sharp object

279

1.04

0.04

1.7

1.3

254.29

226.87

u/ml

0.23

163

Traumatic amputation of wrist and hand

281

0.96

0.04

1.1

1.2

234.71

287.18

u/ml

0.55

177

Vasomotor rhinitis (mode)

442

0.97

0.03

1.1

1.2

185.59

260.15

u/ml

1.57

277

Female genital prolapse

190

1108

0.99

0.03

1.3

1.2

290.43

292.13

u/ml

0.02

124

731

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

458

1.03

0.03

1.2

236.40

288.14

u/ml

0.69

287

L02BX Other hormone antagonists and related agents

230

1.04

0.03

1.2

316.64

281.63

u/ml

0.23

136

Torsion of testis

240

1.04

0.03

2.0

1.4

150.40

207.82

u/ml

0.69

145

Benign neoplasm: Long bones of lower limb

250

1.04

0.03

1.5

1.3

184.58

239.89

u/ml

0.74

157

Motor disorders

358

1.03

0.03

2.8

2.0

165.20

177.83

u/ml

0.10

176

Burn and corrosion of shoulder and upper limb, except wrist and hand

161

1.06

0.03

1.2

1.4

167.67

258.01

u/ml

—

Toxic effect of contact with venomous animals

290

0.96

0.03

1.1

1.3

224.43

268.27

u/ml

0.40

164

Entropion and trichiasis of eyelid

290

1.03

0.03

1.2

261.62

287.76

u/ml

0.28

160

Atrial septal defect

446

1.02

0.03

1.8

1.7

271.32

207.01

u/ml

0.75

229

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

102

1.08

0.03

2.1

1.3

82.50

241.58

u/ml

—

Juvenile osteochondrosis

350

0.97

0.03

1.6

1.3

471.11

226.17

u/ml

1.32

202

Benign neoplasm: Anus and anal canal

112

1.07

0.03

1.2

319.29

245.40

u/ml

—

Ankylosing spondylitis, strict definition

370

0.97

0.03

1.2

330.41

263.98

u/ml

0.53

231

Oral lichen ruber planus wide, hypothyreosis or thyroxin

221

1.04

0.03

1.1

1.2

213.67

274.29

u/ml

0.58

136

Benign neoplasm: Anus and anal canal

128

0.94

0.02

1.2

319.29

278.09

u/ml

—

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

249

0.96

0.02

1.3

1.4

265.27

253.46

u/ml

0.05

141

Unspecified lump in breast

928

1.01

0.02

1.3

1.2

244.30

281.72

u/ml

0.74

579

Schizophrenia or delusion, excluding more controls

262

2583

1.01

0.02

1.2

1.3

279.30

256.50

u/ml

0.68

159

1708

Carcinoma in situ, bladder

148

0.95

0.02

1.1

1.2

282.60

320.13

u/ml

—

Benign neoplasm of thyroid gland

162

1.05

0.02

1.3

1.2

299.67

262.03

u/ml

—

Disorders of speech understanding and production

579

1.02

0.02

2.5

1.7

212.35

193.37

u/ml

0.20

300

Achilles tendinitis

670

1.02

0.02

1.3

1.2

235.33

296.55

u/ml

1.22

426

Supervision of normal pregnancy

246

1398

1.01

0.02

1.2

1.3

232.65

266.88

u/ml

1.38

166

885

Autism spe, excluding more controls

298

0.97

0.02

1.2

1.4

205.86

209.74

u/ml

—

175

MS-disease / Multiple Sclerosis

591

1.02

0.02

1.2

244.45

262.67

u/ml

0.21

384

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

338

0.98

0.01

1.2

1.1

192.71

244.42

u/ml

0.83

214

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

123

1.06

0.01

1.2

338.43

272.51

u/ml

—

Benign lipomatous neoplasm of other sites/unspecified

372

1.02

0.01

1.2

266.63

276.07

u/ml

0.10

225

Other infections specific to the perinatal period

133

1.06

0.01

1.6

1.9

239.13

174.98

u/ml

—

Spontaneous abortion

392

2675

1.00

0.01

1.2

261.42

267.78

u/ml

0.14

274

1742

Carcinoma in situ of other and unspecified sites

157

0.95

0.01

1.1

1.2

285.50

321.22

u/ml

—

Pedestrian injured in transport accident

458

0.98

0.01

1.6

1.3

260.34

251.35

u/ml

0.09

277

Acute alcohol intoxication ICD-9

173

1.04

0.01

1.1

1.2

422.00

293.92

u/ml

1.08

Benign neoplasm: Skin of ear and external auricular canal

183

1.04

0.01

1.3

1.2

163.82

289.65

u/ml

1.79

107

Bacterial meningitis

227

0.97

0.01

1.2

240.13

265.34

u/ml

0.22

140

Generalized epilepsy, mode (most common among epilepsy diagnosis)

303

1.02

0.01

1.4

284.38

228.04

u/ml

0.35

178

Mandibular retrognathia

745

0.99

0.01

2.0

1.4

206.02

229.32

u/ml

0.29

423

Leiomyoma of uterus

445

2525

1.00

0.01

1.3

1.2

291.00

286.33

u/ml

0.13

274

1687

Pedal cyclist injured in noncollision transport accidents

957

0.99

0.01

1.3

278.23

255.42

u/ml

0.18

599

Fall involving bed

124

1.05

0.00

1.3

1.4

299.14

247.97

u/ml

—

Benign neoplasm: Cranial nerves

146

0.96

0.00

1.5

1.2

198.44

280.15

u/ml

—

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

194

1.03

0.00

1.1

1.2

222.92

277.33

u/ml

0.65

119

Other disorders of patella

140

1403

1.00

0.00

1.2

328.72

265.84

u/ml

0.71

944

Femoral hernia

205

1.02

0.00

1.2

290.43

279.79

u/ml

0.07

126

Other acquired deformities of musculoskeletal system and connective tissue

305

0.98

0.00

1.3

1.2

404.12

265.00

u/ml

0.36

187

Female infertility, tubal origin

345

0.99

0.00

1.3

265.45

274.31

u/ml

0.07

237

Other complications of labour and delivery, not elsewhere classified

122

1177

1.00

0.00

1.2

256.93

246.20

u/ml

0.22

801

Other ill-defined and unspecified causes of mortality

231

1.00

0.00

1.0

1.2

268.06

302.93

u/ml

0.22

129

Convergent concomitant strabismus

565

0.99

0.00

1.2

1.3

207.47

237.67

u/ml

0.63

335

Deep endometriosis

615

1.01

0.00

1.1

1.2

256.87

276.12

u/ml

0.28

407

Benign neoplasm of ovary

925

1.01

0.00

1.2

211.27

290.53

u/ml

2.66

581

Graves ophthalmopathy, strict

105

1.05

0.00

1.2

356.67

264.67

u/ml

—

Graves ophthalmopathy

124

0.97

0.00

1.3

1.2

307.29

254.38

u/ml

—

Pterygium

136

1.03

0.00

1.4

1.2

274.56

268.16

u/ml

—

Benign neoplasm of other and unspecified sites

154

0.97

0.00

1.1

1.2

188.41

230.38

u/ml

—

Postpartum care and examination

160

1024

1.00

0.00

1.3

1.2

217.93

263.40

u/ml

1.96

104

640

Benign neoplasm: Choroid

276

1.01

0.00

1.3

1.2

308.76

276.56

u/ml

0.24

154

Melanocytic naevi of other and unspecified parts of face

384

0.99

0.00

1.4

1.2

201.00

260.06

u/ml

0.96

246

Other and unspecified mental retardation

236

1.02

0.00

1.3

2.0

212.18

193.19

u/ml

0.17

116

Mesial bite

118

1.02

0.00

1.2

1.5

131.80

226.37

u/ml

—

Disorders of synovium and tendon in diseases classified elsewhere

122

0.98

0.00

1.8

1.1

410.33

248.70

u/ml

—

Other and unspecified mononeuropathies of lower limb

138

1.01

0.00

1.4

1.2

219.50

234.15

u/ml

—

Liveborn infants according to place of birth

154

1.02

0.00

2.3

1.9

177.20

148.35

u/ml

—

Benign neoplasm of other and unspecified female genital organs

192

0.99

0.00

1.1

1.2

317.20

254.82

u/ml

—

118

Constitutional tall stature

1.04

0.00

1.0

1.8

308.60

184.83

u/ml

—

Abnormal spermatozoa

597

1.01

0.00

1.5

1.3

257.74

302.55

u/ml

0.62

376

Contact with other hot fluids

282

0.99

0.00

1.3

1.4

247.53

228.77

u/ml

0.17

164

Benign neoplasm: Rectosigmoid junction

181

0.99

0.00

1.6

1.2

356.92

308.39

u/ml

0.25

Dementia in other diseases classified elsewhere

191

0.99

0.00

1.1

1.3

384.90

294.35

u/ml

—

109

Scoliosis

764

0.99

0.00

1.3

277.67

246.22

u/ml

0.32

440

Caught, crushed, jammed or pinched in or between objects

422

1.00

0.00

1.4

1.3

243.70

255.07

u/ml

0.12

250

Hemiplegia

285

0.98

0.00

1.8

1.3

216.76

265.36

u/ml

0.43

166

Other lesions of median nerve

123

0.98

0.00

1.5

1.2

720.80

275.95

u/ml

—

Disorders of lacrimal system and orbit in diseases classified elsewhere

121

0.99

0.00

1.2

307.29

233.79

u/ml

—

Contact with other sharp object(s)

627

1.00

0.00

1.2

1.3

275.22

249.93

u/ml

0.37

388

Motorcycle rider injured in noncollision transport accidents

315

1.02

0.00

1.2

1.3

248.52

221.31

u/ml

0.26

191

Injury of muscle and tendon at ankle and foot level

155

1.03

0.00

1.1

1.3

185.90

270.15

u/ml

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

356

1.01

0.00

1.2

197.41

282.89

u/ml

1.96

222

Other congenital malformations of tongue, mouth and pharynx

229

1.00

0.00

1.5

1.7

78.11

184.27

u/ml

—

119

Other congenital malformations of face and neck

250

1.00

0.00

1.7

1.3

278.83

229.95

u/ml

0.43

151

Complications of the puerperium, not elsewhere classified

310

1.00

0.00

1.2

274.04

252.36

u/ml

0.20

209

Disorders of other digestive organs in diseases classified elsewhere

0.00

0.0

2.5

—

103.67

—

Abnormalities of forces of labour

790

1.00

0.00

1.1

1.2

312.39

276.29

u/ml

0.37

550

Ganglion

162

1620

1.00

0.00

1.3

1.2

256.29

267.74

u/ml

0.21

102

1043

Ovarian dysfunction: estrogen excess

0.00

0.0

1.0

—

164.60

—

Vascular dementia (sudden onset)

0.00

0.0

1.2

—

Other eccrine sweat disorders

0.00

0.0

1.2

—

496.20

—

Injury of muscle and tendon at forearm level

140

1.00

0.00

1.4

1.3

276.13

235.64

u/ml

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS